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We show that Capnocytophaga canimorsus strain 5 (Cc5) is even more 
resistant to phagocytosis and killing by murine macrophages (J774.1) and human 
polymorphonuclear neutrophils (PMNs) than Yersinia enterocolitica, which is 
known as a model bacterium for resistance against phagocytosis due to its type 3 
secretion system (Grosdent et al., 2002).  We observed that Cc5 even becomes 
completely resistant to phagocytosis at high multiplicity of infection (moi of 50).  In 
addition, we demonstrate that the Cc5 transposon mutant Y1C12, identified during 
a serum sensitivity screen, has an increased sensitivity to phagocytosis and killing 
by either murine macrophages or human PMNs even in the unopsonized state.  
This indicated that not an increased susceptibility for antibody binding or 
complement deposition led to an increased phagocytosis of the mutant, but that 
rather the outer surface was more readily recognized by the phagocytes.   
Furthermore, we demonstrate that Cc5 induces the formation of neutrophil 
extracellular traps upon infection of human PMNs in vitro and that Cc5 is trapped 
and killed within neutrophil extracellular traps, indicating sensitivity of Cc5 towards 
antimicrobial peptides present in PMN granules. 
Analysis of serum resistance in Cc5 revealed that serum resistance is probably 
linked to its lipopolysaccharide, which prevents deposition of the membrane attack 
complex on the bacterial surface.   
Moreover, we have observed that upon growth in the presence of cells, Cc5 
releases or modifies factor(s) in the medium, which interfere with the killing ability 
of macrophages.  Investigating the underlying mechanism, we could show that 
Cc5 does not affect phagosome maturation, but blocks the oxidative burst.  This 
capacity was shown to depend on the release of the zinc metallopeptidase 
pitrilysin by Cc5.   
First analyses on the prevalence of the hypothetical virulence factors serum 
resistance and interference with the oxidative burst indicated that C. canimorsus 
strains might display strain variability.  While 59% of the strains (50% of case 
strains, 61% of dog isolates) were able to block the killing ability of macrophages, 
60% of the strains were highly serum resistant (100% of case strains, 54% of dog 
isolates).  However, serum resistance could not be directly linked to a specific 
polysaccharide structure in C. canimorsus.  
Salome Casutt-Meyer 
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1.1. Capnocytophaga canimorsus  
The genus Capnocytophaga contains 7 species, all of them encountered in the 
oral cavity of humans or domestic animals, but Capnocytophaga canimorsus is the 
only one associated with severe human infections (Lion et al., 1996).  
Capnocytophaga species are capnophilic, facultative anaerobic, strictly 
fermentative Gram-negative rods (Brenner et al., 1989).  They belong to the 
phylum of the Bacteroidetes, which is taxonomically far remote from 
Proteobacteria and the common human pathogens, and fall into two groups 
formerly known as Centers for Disease Control groups dysogenic fermenter (DF)-1 
and DF-2.  The DF-1 group species (Capnocytophaga ochracea, Capnocytophaga 
sputigena, Capnocytophaga gingivalis, Capnocytophaga haemolytica, 
Capnocytophaga granulosa) are members of the human oral flora and as 
opportunistic pathogens they can cause infections like endocarditis, bacteraemia, 
septicaemia, eye infections and peritonitis in both immunocompromised and 
immunocompetent patients (Buu-Hoi et al., 1988; Campbell and Edwards, 1991; 
Esteban et al., 1995; Font et al., 1994; Parenti and Snydman, 1985; Rubsamen et 
al., 1993).  The normal habitat of DF-2 species (C. canimorsus, Capnocytophaga 
cynodegmi) is the oral cavity of dogs and cats.   
The major characteristics of C. canimorsus include positive test results for 
oxidase, catalase, arginine dihydrolase, and o-nitrophenyl-β-D-galactopyranoside 
and negative reactions for urease, nitrates and indole.  Fermentation of glucose, 
lactose, and maltose is often observed but not of raffinose and inulin (Janda et al., 
2006).  However, especially differentiation between C. cynodegmi and  
C. canimorsus can be misleading if relying on fermentation assays (Mally et al., 
2009).  Only one third of all Capnocytophaga isolates forwarded to the California’s 
Microbial Disease Laboratory in the years 1972-2004 was submitted with the 
correct species identification.  Many strains were received as either an un-
identified Gram-negative rod or “identification unknown” (55%).  13% were 
submitted with incorrect identifications, such as Streptobacillus spp., Legionella 
spp., or Haemophilus spp., indicating the difficulty to properly diagnose  
C. canimorsus infections (Janda et al., 2006).  Nowadays, identification is mostly 
done by PCR amplification and 16S rDNA gene sequencing (Janda et al., 2006). 
Nevertheless, it has to be noted that differentiation between C. canimorsus and  
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C. cynodegmi is still difficult as sequence similarity is very high (Mally et al., 2009) 
and therefore may lead to misdiagnoses.   
C. canimorsus caused infections 
C. canimorsus infections are associated with dog and cat bites (54% of cases), 
dog and cat scratches (8.5%), or close animal contact (27%), such as licking of 
human wounds (Lion et al., 1996).  Consequently, human-to-human transmissions 
have never been reported apart from one case where it could not be completely 
excluded (Risi and Spangler, 2006).   
It has been estimated that every second person is bitten by an animal or by 
another human once per lifetime (Griego et al., 1995; Yaqub et al., 2004).  The 
majority of these bite wounds is minor and does not need medical treatment but 
nevertheless, 1% of the total costs from emergency treatments in the US result 
from bite wound cases.  Most of these infections are due to Pasteurella, 
Streptococcus, and Staphylococcus sp. and 80-90% of all bite wounds are inflicted 
by dogs, followed by cats.  The annual mortality rate due to dog and cat bites in 
the US is 6.7 per 108 persons, albeit not all of these fatalities are caused by 
infections (Griego et al., 1995; Yaqub et al., 2004).   
There are more than 160 described cases of human patients infected with  
C. canimorsus (Brenner et al., 1989; Conrads et al., 1997; Gaastra and Lipman, 
2009; Macrea et al., 2008; Tierney et al., 2006) since its discovery in 1976 (Bobo 
and Newton, 1976), but there is only one reported case of a dog infected with  
C. canimorsus following a dog bite, even though it was isolated together with other 
organisms (Meyers et al., 2007), and one case of a pet rabbit infection after dog 
bite (van Duijkeren et al., 2006).  No C. canimorsus infections of cats after a bite 
incidence have been reported, but there is a case report of a cat with chronic 
sinusitis and rhinitis due to a C. canimorsus infection (Frey et al., 2003).  As these 
wound infections are usually not reported, it is not possible to estimate the ability 
of C. canimorsus to cause infections in animals.   
The prevalence of C. canimorsus in dogs ranges from 8% to 41% (Bailie et al., 
1978; Westwell et al., 1989; Blanche et al., 1998; Gaastra and Lipman, 2009) 
depending on the sampling method and there is a single report of the isolation of 
C. canimorsus from sheep and cattle (25-30%) (Westwell et al., 1989).   
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Although there is a high occurrence of C. canimorsus in dogs, the number of 
documented clinical infections remains very low.  Low virulence and susceptibility 
to antibiotics frequently used for post-dog bite prophylaxis may result in fast 
clearance after infection (Janda et al., 2006).  Systemic administration of 
antimicrobial agents is controversial for healthy persons, yet patients with a history 
of a dog bite or a wound licked by a dog are usually supplied with systemic 
prophylactic antibiotic treatment (Gaastra and Lipman, 2009; Macrea et al., 2008).  
Nowadays, the first choice antibiotic for infection with C. canimorsus is penicillin G, 
although resistance of isolates has been mentioned (Gaastra and Lipman, 2009; 
Meybeck et al., 2006).  The spread of β-lactamase-producing strains limits the use 
of β-lactams as first-line treatments, underlying the necessity to test the in vitro 
susceptibility of clinical strains (Jolivet-Gougeon et al., 2007).   
In Denmark already between 1982 and 1995, the incidence of C. canimorsus 
infections was estimated to be 0.5 to 1 case per 1’000’000 inhabitants per year 
(Pers et al., 1996).  At present, there are several cases of human C. canimorsus 
infections in Switzerland each year (A. Trampuz, personal communication), but no 
statistics are available for this disease.   
The incubation period of C. canimorsus infections is between 2-3 days, but in 
single cases incubation periods of up to 4 weeks were described (le Moal et al., 
2003; Lion et al., 1996).  The initial symptoms of clinical infections by  
C. canimorsus include fever (78% of the patients), malaise (26%), vomiting (31%), 
diarrhea (26%), myalgia (31%), abdominal pain (26%), dyspnoea (23%),  
chills (46%), confusion (23%) and headache (18%) (Pers et al., 1996).  Skin 
manifestations such as maculopapular rash and purpura are commonly associated 
to C. canimorsus infections (Hermann et al., 1998; Lion et al., 1996).  Clinical 
infections generally appear as fulminant septicemia and peripheral gas gangrene 
(Pers et al., 1996; Tierney et al., 2006).  Some patients also develop meningitis 
upon infection with C. canimorsus, which is accompanied by headache, but rarely 
by fever (le Moal et al., 2003; Tierney et al., 2006).  Less commonly,  
C. canimorsus can also cause endocarditis and myocarditis with a mortality rate of 
25% (Sandoe, 2004).  Renal failure may also be associated to C. canimorsus 
infections, caused by disseminated intravascular coagulation or hypotension 
resulting from systemic infection (Mulder et al., 2001).  Disseminated intravascular 
coagulation can lead to peripheral gangrene and fulminant purpura often leading 
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to amputation (Hantson et al., 1991).  In one case, C. canimorsus could also be 
identified from cultures of pleural fluid from a patient that had developed 
pneumonia (Chambers and Westblom, 1992).   
Fatality rate of systemic infections is as high as 30% (Lion et al., 1996), while 
the mortality rate for meningitis is lower (5%) (de Boer et al., 2007; le Moal et al., 
2003).  In one case, a patient died from a secondary infection by Aspergillus niger, 
suggesting, that C. canimorsus might have induced some sort of 
immunosuppression (J.B. le Polain, personal communication).  The overall clinical 
evolution of C. canimorsus infections suggests that the bacterium elicits little 
inflammation, at least in the early stages of infection, which would allow time for 
multiplication up to a stage at which it causes general sepsis and fatal shock. 
While approximately 60% of the patients had a predisposing condition, 40% 
had no know risk factor.  The most prevalent predisposing conditions were 
splenectomy (33% of systemic cases), alcohol abuse (24%), or other 
immunosuppression (5%) (Lion et al., 1996).  Haemolytic uremic syndrome, 
Waterhouse-Friedrichsen syndrome, Trauma, Hodgkin’s disease, steroid therapy, 
chronic lung disease, and idiopathic thrombocytopenic purpura have also been 
described as identifiable factors for increased risk (Beebe and Koneman, 1995; 
Dire et al., 1994; Lion et al., 1996; Mirza et al., 2000; Mulder et al., 2001; Tierney 
et al., 2006; Tobé et al., 1999).  An explanation as for why these conditions pose a 
risk for a C. canimorsus infection might be the elevated iron levels, which 
eventually support the growth of the poor iron scavenger (Weinberg, 2000).  
However, in a mouse model, addition of iron did not lead to an increased virulence 
(H. Shin, personal communication).  Although the majority of cases are associated 
to immunocompromised patients, mortality is higher in patients without 
predisposing conditions (32% versus 28%).  The reason for this phenomenon is 
not known (Beebe and Koneman, 1995; Lion et al., 1996; Tierney et al., 2006).  
Thus, infections with C. canimorsus cannot only be considered as opportunistic 
infections.  
Studies on the pathogenesis of C. canimorsus 
Few studies have so far investigated the molecular basis underlying severe 
infections caused by C. canimorsus (Fischer et al., 1995; Mally et al., 2008; Shin 
et al., 2007).  The bacterium was reported to multiply in mouse macrophages and 
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to be cytotoxic probably due to the production of a toxin (Fischer et al., 1995).  A 
later report could not detect cytotoxicity within 24 hours (h) of infection in 10 
strains of C. canimorsus tested, including the same strain as in the original study 
(Shin et al., 2007).  However, there seems to be cytotoxicity at later stages of 
infection (48 h post infection) (S. Ittig, personal communication).  Another study 
reported that a very low level of cytokine production was observed in vitro (Frieling 
et al., 1997), which also could not be reproduced (Shin et al., 2007).   
Despite of its classification as a fastidious grower, C. canimorsus exhibits 
robust growth when in direct contact with mammalian cells including phagocytes 
(Mally et al., 2009; Shin et al., 2007).  This property is dependent on a surface 
localized sialidase, which allows the bacterium to use host amino-sugars from 
glycan chains of host cell glycoproteins.  This ability was shown to increase 
virulence in a mouse tissue cage infection model (Mally et al., 2008).   
Furthermore, it has been shown that neither live nor dead C. canimorsus did 
lead to the release of pro-inflammatory signals like interleukin (IL) 1-alpha, IL1-
beta, IL-6, IL-8, macrophage inflammatory protein 1-beta, RANTES and tumor 
necrosis factor-alpha, from either naïve or activated murine macrophage cell line 
or human monocytes.  This could be explained by the absence of Toll-like receptor 
(TLR) 4 activation, presumably due to a hypo-reactive lipopolysaccharide (LPS) 
(Shin et al., 2007).  Even more, one strain isolated from a fatal human case, C. 
canimorsus strain 5 (Cc5), turned out to have a mechanism that actively blocks the 
pro-inflammatory signalling upon stimulation with endotoxic LPS (Shin et al., 
2007).   
The clinical overview of C. canimorsus infections and the previous studies 
suggested that the bacterium might be able to avoid the immune system, at least 
in the early stages of infection.  Nevertheless, it is unknown how C. canimorsus 
interacts with the innate immune system in order to avoid clearance by 
phagocytes, human complement or neutrophil extracellular traps (NETs), which 
might contribute to the establishment of infection.   
In contrast to the high prevalence of C. canimorsus in dogs, there are only very 
little cases of human infections reported.  Even though the patient’s immune 
system probably is an important factor allowing or hindering infection, C. 
canimorsus strains may have some strain diversity, which might discriminate 
virulent and avirulent strains.   
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This thesis describes the findings on the interaction of C. canimorsus with the 
innate immune system, namely with phagocytes, NETs and complement, and 
shows first observations on strain variability in C. canimorsus with respect to 
hypothetical virulence functions.   
1.2. Phagocytosis 
Professional phagocytes such as polymorphonuclear neutrophils (PMNs), 
monocytes and macrophages use phagocytosis to internalize and destroy foreign 
objects, like pathogens.  In addition to clearing of the infectious agent, 
phagocytosis (especially by macrophages and dendritic cells) initiates the process 
of antigen processing and presentation for the development of cellular immune 
responses.   
The surface of phagocytes is adorned with many receptors that are able to 
recognize and decode their cognate ligands expressed on the surface of infectious 
agents and apoptotic cells leading to phagocytosis of the bound particle.  The 
interaction of bacteria with a phagocyte can be direct, through the recognition of 
pathogen-associated molecular patterns (such as surface carbohydrates, 
peptidoglycans, or lipoproteins) by pathogen recognition receptors (PRRs), or 
indirect, through mediation by opsonins, such as immunoglobulin (Ig) G and 
components of the complement cascade like C3b, which attach to the pathogen 
surface where they are recognized by opsonin receptors, such as Fc receptor 
(FcR) gamma and complement receptor (CR) 3.  Although the phagocytosis 
pathways initiated by the different receptors share common steps and lead to the 
destruction of the ingested pathogen, they may also differ depending on the 
particular receptor involved.  While e.g. FcγR engagement is accompanied by a 
respiratory burst and initiation of a pro-inflammatory cascade, CR-mediated 
phagocytosis is not (reviewed by (Rabinovitch, 1995; Stuart and Ezekowitz, 
2005)).   
Emerging from pluripotent hematopoietic stem cells in the bone marrow, 
terminally differentiated PMNs are released into the peripheral blood where they 
circulate for 7-10 h. Upon infection, PMNs migrate into the affected tissues, where 
they have a life span of only a few hours.  In contrast, monocytes that reach  
the extra-vascular compartment generally differentiate into macrophages  
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and – depending on their location in the body and on the functional demands 
placed on them – live for days, weeks, months or even years.   
In addition to their role in phagocytosis, professional phagocytes secrete a 
variety of important immunomodulatory molecules, including cytotoxic radicals of 
oxygen and nitrogen (Nathan, 2003), enzymes that degrade the extracellular 
matrix (Borregaard and Cowland, 1997; Kang et al., 2001; Owen and Campbell, 
1999), and cytokines that can modify the behaviour of phagocytes and several 
other cell types (Bennouna et al., 2003; Wittamer et al., 2005).   
While tissue resident macrophages only rely on the oxidative burst and the 
thereby produced reactive oxygen species (ROS) to kill the phagocytosed 
bacteria, PMNs additionally possess granules filled with antimicrobial peptides 
(AMPs) which constitute a non-oxidative killing mechanism for ingested microbes.  
Hence, we focus here on the events involved in microbial clearance by PMN-
mediated killing.   
1.2.1. Phagocytosis by PMNs 
PMNs are the first immune cells recruited from the blood stream to the site of 
infection, thereby building the first line of defence against invading microorganisms 
such as bacteria, fungi, and protozoa (Kanthack and Hardy, 1895).  In humans, 
roughly 100 billion PMNs enter and leave the circulating blood every day, outlining 
their importance in the immune system.   
Upon contact, PMNs engulf microbes into a phagocytic vacuole, the 
phagosome.  After phagocytosis, the phagosome matures in a series of fusion 
events with cytoplasmic granules to form a phagolysosome, wherein bacteria are 
killed by non-oxidative and oxidative killing mechanisms (reviewed by (Nathan, 
2006; Rabinovitch, 1995; Stuart and Ezekowitz, 2005)).   
Non-oxidative killing 
Non-oxidative killing of invading pathogens is mediated by the fusion of 
neutrophil secretory granules with the phagosome and the subsequent release of 
antimicrobial granule contents into the phagolysosome.  The granules to be 
discharged first are the specific granules (secondary granules) and the gelatinase 
granules (tertiary granules).  Specific granules contain several AMPs including 
lysozyme (Cramer et al., 1985) as well as the transmembrane units of the 
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nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, gp91phox and 
p22phox (comprising flavocytochrome b558) (Borregaard et al., 1983; Jesaitis et al., 
1990).  Gelatinase granules on the contrary contain e.g. the metalloproteases 
gelatinase and leukolysin (Kang et al., 2001; Kjeldsen et al., 1992; Lazarus et al., 
1968).  These metalloproteases are not primarily thought to be important for killing 
of microbes, but to be essential for the degradation of extracellular matrix 
components of the vascular basement membranes during extravasation of PMNs 
(Borregaard and Cowland, 1997; Kang et al., 2001; Owen and Campbell, 1999). 
Next, the azurophilic granules (primary granules) are discharged.  They contain 
α-defensins (Ganz et al., 1985), which kill microorganisms by forming multimeric 
transmembrane pores (Wimley et al., 1994), antibiotic proteases (e.g. cathepsin G, 
proteinase 3 and neutrophil elastase) (Campanelli et al., 1990; Salvesen et al., 
1987; Sinha et al., 1987) and small AMPs, including myeloperoxidase (MPO).  
MPO reacts with hydrogen peroxide (H2O2), formed by the NADPH oxidase, to 
form hypochlorous acid (HOCl), which is highly toxic for microorganisms 
(Klebanoff, 1999), building a link between oxidative and non-oxidative killing.  
Interestingly, azurophilic granules were not only shown to fuse with 
phagolysosomes, but also to be released at the site of contact with antibody (Ab)-
opsonized bacteria even before closure of the phagosomal cup (Tapper et al., 
2002). 
Oxidative killing 
Oxidative killing of microbes depends on the generation of ROS by the NADPH 
oxidase.  In resting cells, the NADPH oxidase is unassembled and inactive, having 
its protein components segregated into membranous and cytosolic parts of the 
cell.  While the subunits p47phox, p67phox, p40phox and the small GTPase Rac2 
reside in the cytosol, flavocytochrome b558 (comprised of gp91
phox and p22phox) is 
bound to the membranes of secondary granules.  Upon activation and recruitment 
of secondary granules and secretory vesicles, flavocytochrome b558 locates to the 
phagolysosomal membrane or the cell surface, depending on the nature of the 
stimulus (DeCoursey and Ligeti, 2005).  Assembly of the cytosolic components 
p67phox, p40phox and p47phox with flavocytochrome b558 at the phagolysosomal 
membrane is triggered by hyperphosphorylation of p47phox (El Benna et al., 1994; 
Inanami et al., 1998) and phosphorylation of p67phox (Dusi and Rossi, 1993; El 
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Benna et al., 1997) via several kinases including protein kinase C (PKC) (Cheng et 
al., 2007; Ding et al., 1993; Majumdar et al., 1993; Nixon and McPhail, 1999; 
Reeves et al., 1999) and Akt (Hoyal et al., 2003).  Upon interaction of p67phox with 
flavocytochrome b558, p67
phox binds to Rac2, which translocates independently to 
the assembling oxidase, where it is required for electron transfer in the active 
complex (Abo et al., 1994; Clark et al., 1990; Heyworth et al., 1994; Iyer et al., 
1994; Park et al., 1992; Quinn et al., 1993). 
After assembly, the NADPH oxidase transfers electrons from cytoplasmic 
NADPH to extracellular or intraphagosomal molecular oxygen (O2), thereby 
generating superoxide (O2
-).  Within the phagosome, O2
- is rapidly converted into 
H2O2 by superoxide dismutase (SOD).  H2O2 further reacts to form other ROS 
such as singlet oxygen and hydroxyl radical (OH●).  Furthermore, MPO can 
catalyze the H2O2-dependent oxidation of halides to form toxic chloramines and 
hypohalous acids, primarily HOCl (Babior, 1995).  The importance of NADPH 
oxidase is highlighted by patients with chronic granulomatous disease, lacking a 
functional oxidase, which suffer from repeated life-threatening bacterial and fungal 
infections (Allen et al., 1999; Curnutte, 1993; Dinauer, 1993).  
Even though the phagocytic capability of macrophages is very efficient, their 
oxidative killing capacity is less marked, primarily because they lack MPO.  
However, it has been shown that concomitant with the uptake of apoptotic PMNs 
by macrophages, granule contents seemed to traffic to early endosomes and to 
co-localize with engulfed bacteria, increasing the killing efficiency of the 
macrophages (Tan et al., 2006).  Therefore, the transfer of AMPs from PMNs to 
macrophages could provide a cooperative defence strategy between innate 
immune cells against intracellular pathogens. 
Bacterial evasion strategies 
Pathogenic bacteria and fungi have evolved efficient strategies to avoid 
clearance by PMNs.  The main strategies can be divided into six groups:  
(i) avoiding contact, (ii) preventing phagocytosis, (iii) inducing host cell death,  
(iv) escape into the cytoplasm, (v) interference with phagosome maturation, and 
(vi) increasing resistance to AMPs and oxidative stress (Figure 1).   
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Figure 1.  Bacterial strategies for evasion of phagocytic killing 
Under normal circumstances, adherent bacteria are phagocytosed, the nascent phagosome 
matures via fusion with granules to form a phagolysosome, and the internalized bacteria are killed 
and degraded.  Pathogens can perturb this system at several points, including avoiding contact or 
recognition by receptors (i), preventing phagocytosis (ii), induction of host cell death (iii), escape 
into the cytoplasm (iv), interference with phagosome maturation (v), or increasing resistance 
against AMPs and oxidative stress (vi).  Adapted from (Allen, 2003). 
 
There are two strategies known to avoid contact with PMNs: pathogens either 
remain in regions inaccessible to phagocytes, as does e.g. Listeria 
monocytogenes, which induces its own uptake into epithelial cells (Gaillard et al., 
1991), or they prevent the recruitment of PMNs to the site of infection by 
interfering with the proinflammatory response, e.g. by secreting chemotactic 
inhibitory protein (Staphylococcus aureus) (de Haas et al., 2004).   
Pathogenic bacteria are known to use three different approaches to prevent 
phagocytosis.  First, they use physical barriers such as polysaccharide or 
polyglutamate capsules (e.g. Porphyromonas gingivalis (Sundqvist et al., 1991), 
Bacillus anthracis (Keppie et al., 1963)), thereby preventing recognition by the 
phagocyte’s PRRs.  Second, they block the phagocyte’s actin cytoskeleton (e.g. 
Yersinia (Persson et al., 2002)).  Third, they interfere with opsonization.  Bacteria 
can either interfere with complement deposition (e.g. Streptococcus pneumoniae 
(Horstmann et al., 1988)), or they evade Ab-opsonization by degrading Abs 
(Streptococcus (Reinholdt et al., 1990)), or by surface antigen variation (e.g. 
Neisseria (Hagblom et al., 1985)), thereby preventing recognition by opsonin 
receptors.   
Some pathogens also induce host cell death to avoid clearance by PMNs by 
secreting lysing toxins (e.g. S. aureus (Menestrina et al., 2001)) or injecting 
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apoptosis inducing proteins (e.g. Yersinia enterocolitica (Ruckdeschel et al., 
1998)). 
Interestingly, many bacteria survive inside PMNs after phagocytosis.  The 
survival strategies range from inhibition or modification of phagosome maturation, 
as done e.g. by Streptococcus pyogenes (Staali et al., 2006), degradation of 
AMPs (e.g. P. gingivalis (Carlisle et al., 2009)) or relocation of NADPH oxidase 
(e.g. Helicobacter pylori (Allen et al., 2005; Allen, 2007)), to the escape into the 
cytoplasm (e.g. S. pyogenes (Medina et al., 2003)).  Transcriptional analyses 
using whole genome microarrays have shown that group A Streptococci (GAS) 
e.g. up-regulate genes crucial for resistance to phagocyte-dependent killing, such 
as SOD, catalases and glutathione peroxidases, if attacked by PMNs (Voyich et 
al., 2003).   
1.3. NETs 
PMNs have recently been shown to possess an alternative, phagocytosis-
independent killing mechanism, called NETs.  Upon activation (e.g. by phorbol 
myristate acetate (PMA), IL-8, LPS, bacteria, fungi, or activated platelets) PMNs 
release granule proteins and DNA that together form an extracellular fibrillar matrix 
that binds and kills Gram-positive and -negative bacteria (Brinkmann et al., 2004; 
Clark et al., 2007; Wartha et al., 2007b).   
The activation pathway leading to the formation of NETs can involve different 
receptors such as TLRs, as well as CRs and FcRs (Brinkmann et al., 2004; Clark 
et al., 2007).  Stimulation of these receptors activates PKC, which initiates a signal 
transduction cascade that induces the assembly and activation of the NADPH 
oxidase complex.  First, the nuclei of PMNs loose their shape and the eu- and 
heterochromatin homogenize and later, the nuclear envelope and the granule 
membranes disintegrate, allowing the mixing of NET components.  Finally, the 
NETs are released as the cell membrane breaks (Fuchs et al., 2007). 
Structurally, NETs consist of smooth fibers with 15-17 nm diameter and 
globular domains of 25-28 nm and are composed of nuclear constituents such as 
chromatin and histones and granular peptides and enzymes, such as neutrophil 
elastase, cathepsin G and MPO, which are normally stored in typical neutrophil 
granules.  In contrast, CD36, a granule membrane protein, the cytoplasmic 
markers annexin, actin and tubulin and various other cytoplasmic proteins were 
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excluded from NETs (Brinkmann et al., 2004).  It can be assumed that granule 
proteins and chromatin together form an extracellular structure that amplifies the 
effectiveness of its antimicrobial substances by ensuring a high local 
concentration.   
Bacterial evasion strategies 
Since NETs have only recently been discovered (Brinkmann et al., 2004), there 
are only few studies addressing the interaction of NETs with pathogens.  While 
Candida albicans has been shown to induce NET-formation and to be susceptible 
to NET-dependent killing (Urban et al., 2006), both, Gram-positive (e.g. S. aureus, 
S. pneumoniae, and GAS) and -negative bacteria (e.g. Salmonella enterica 
serovar Typhimurium and Shigella flexneri) have been shown to be captured 
within NETs (Beiter et al., 2006; Brinkmann et al., 2004; Buchanan et al., 2006).  
Whether viruses and parasites are killed by NETs is not yet known.   
Whereas most bacteria studied so far became killed after being trapped within 
NETs, some bacteria were shown to be able to evade NET-dependent killing.  The 
most studied evasion mechanism is the production of an extracellular DNase, e.g. 
by GAS, to degrade the DNA backbone (Beiter et al., 2006; Buchanan et al., 
2006).  Other possible mechanisms might involve polysaccharide capsules which 
prevent lysis by AMPs (e.g. in Pneumococci) (Wartha et al., 2007a), or the 
secretion of proteases that degrade the NET-associated AMPs.  Alternatively, one 
could also speculate that bacteria inhibiting the oxidative burst could prevent the 
formation of NETs.  
1.4. Complement 
The complement system is the major effector of the humoral branch of the 
immune system.  While the membrane attack complex (MAC) mediates cell lysis, 
other complement components or split products participate in the inflammatory 
response, opsonization of antigen, viral neutralization, and clearance of immune 
complexes.  We will focus here on the direct killing of bacteria by complement. 
Complement-mediated opsonization and killing by MAC insertion depends on 
triggering of the classical, lectin and alternative pathways of complement 
activation.  Complement activation by the classical pathway commonly begins with 
the binding of Abs to antigens, e.g. on a bacterial cell.  The formation of antigen-
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Ab complex induces conformational changes in the Fc portion of the IgM molecule 
that expose a binding site for C1.  Binding and activation of C1 subunits then leads 
to the formation of the C3 convertase C4b2a by cleaving C4 and C2.  The lectin 
pathway is activated by the binding of mannose-binding lectin (MBL) to mannose 
residues of glycoproteins or carbohydrates on the surface of microorganisms.  
Binding of MBL to a surface results in the recruitment of the MBL-associated 
proteases 1 and 2, which cause cleavage of C4 and C2 leading to the formation of 
the C3 convertase C4b2a.  Finally, the alternative pathway contrasts with both the 
classical and the lectin pathway in that it is activated by direct interaction of C3 
with the pathogen surface.  C3, which contains an unstable thioester bond, 
undergoes slow spontaneous hydrolysis and the formed C3b then binds to foreign 
surface antigens or even to the host’s own cells.  Since sialic acids present on the 
membranes of most mammalian cells bind factor H (fH), C3b molecules bound on 
host cells are rapidly inactivated.  Because many foreign antigenic surfaces have 
only low levels of sialic acid, C3b bound to these surfaces remains active for a 
longer time, which leads to the binding of factor B to C3b.  Factor B is thereafter 
cleaved by factor D, leading to the formation of the C3 convertase C3bBb.   
After assembly of a C3 convertase, which builds the major amplification step 
within the complement cascade, all three pathways converge in a single 
downstream process.  First, C3 is cleaved into the small protein C3a and the large 
C3b. C3b can covalently associate with pathogen surfaces, leading to 
opsonization of the pathogens.  Besides its function as opsonin, C3b also 
assembles with the C3 convertases to form a C5 convertase, which then cleaves 
C5 into C5a and C5b.  While C5a is a potent pro-inflammatory molecule, C5b 
binds to the surface of the target cell and provides a binding site for the 
subsequent components of the MAC, C6, C7, C8, and C9 (reviewed by (Muller-
Eberhard, 1988; Walport, 2001a, b)).   
Upon binding of C6 and C7 to C5b, the resulting complex C5b67 undergoes 
structural changes exposing hydrophobic regions, which serve as biding sites for 
phospholipids, allowing the complex to insert into the phospholipid bilayer.  Upon 
insertion of C8 to the C5b67 complex, a small pore is formed in the target cell 
membrane, but only upon binding and oligomerization of C9, the MAC forms a 
large channel through the membrane of the target cell, enabling ions and small 
molecules to diffuse freely across the membrane.  Thereby, the affected cell 
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looses its osmotic stability and is killed by an influx of water and loss of 
electrolytes (Born and Bhakdi, 1986; Muller-Eberhard, 1986) (Figure 2).   
 
 
Figure 2.  Overview of the complement activation pathways 
The classical pathway is initiated when C1 binds to antigen-Ab complexes.  The alternative 
pathway is initiated by binding of spontaneously generated C3b to activating surfaces.  The lectin 
pathway is initiated by binding of the serum protein MBL to the surface of a pathogen.  All three 
pathways generate C3 convertases and C5 convertases.  C5b generated by the C5 convertases 
binds to the target cell membrane and is subsequently converted into a MAC by recruitment of C6, 
C7, C8 and C9.  Adapted from (Goldsby et al., 2003). 
 
Because many elements of the complement system are capable of attacking 
host cells as well as foreign cells and microorganisms, elaborate regulatory 
mechanisms have evolved to restrict complement activity to designated targets.   
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A general mechanism of regulation in all complement pathways is the inclusion of 
highly labile components like C3b that undergo spontaneous inactivation if they 
are not stabilized by reacting with other components.  In addition, a series of 
regulator proteins can inactivate various complement components (e.g. C4 by 
C4b-binding protein (C4BP) and C3b by fH) or can avoid MAC-dependent lysis by 
preventing assembly of poly-C9 (e.g. protectin).   
Bacterial evasion strategies 
Gram-positive bacteria are naturally resistant to complement due to their 
capsules and the thick peptidoglycan layer, which sterically hinders the access of 
complement molecules to the bacterial surface.  Even if the opsonin C3b is 
formed, it may become embedded deep in the capsular network thereby becoming 
inaccessible, which has been most clearly demonstrated with S. aureus (Wilkinson 
et al., 1979).  Some Streptococci were shown to shed lipoteichoic acids, which can 
bind to mammalian cells and not only sensitize them to autologous complement, 
but also redirect complement activation away from the bacterial surface (Beachey 
et al., 1979; Hummell and Winkelstein, 1986). 
Gram-negative bacteria have evolved different strategies to prevent killing by 
complement.  The main strategies can be divided into three groups: (i) binding of 
regulators of the complement cascade, (ii) degradation of complement 
components, and (iii) inhibition of MAC-dependent lysis (Figure 3). 
Many pathogens have been shown to bind complement regulatory proteins.  
Some bacteria decorate themselves with sialic acids to mimic host cells (e.g. 
Meningococci (Mandrell et al., 1990)), as sialic acids were shown to interact with 
fH, a negative regulator of C3 convertases (Meri and Pangburn, 1990).  A classical 
example of a specific factor responsible for complement resistance of a microbe is 
the M protein family of S. pyogenes.  Besides binding fH (Horstmann et al., 1988), 
many members of the M protein family can also bind C4BP, thereby disassembling 
the classical and the lectin pathway C3 convertase (Johnsson et al., 1996;  
Thern et al., 1995). 
 
Introduction 
 
 - 19 - 
 
Figure 3.  Bacterial evasion strategies 
Bacteria interfere with complement activation and complement deposition at different stages.  
Adapted from (Goldsby et al., 2003). 
 
Many bacteria have proteases that can degrade complement proteins or inhibit 
their accumulation on bacterial surfaces.  Some pathogenic P. gingivalis strains 
were shown to express an arginine-specific cysteine protease capable of cleaving 
C5 and C3, whereby C3b does not become bound onto the bacterial surface 
(Chen et al., 1992; Schenkein, 1989).  P. aeruginosa secretes active proteases in 
the form of alkaline protease and elastase that cleave C3b and thus inhibit C3b 
deposition and complement activation at the bacterial surface (Hong and 
Ghebrehiwet, 1992; Schmidtchen et al., 2003).  In addition, LPS variants of  
P. aeruginosa which are expressed at the pathogen surface, interfere with C3b 
deposition (Engels et al., 1985; Schiller and Joiner, 1986).  Alternatively, many 
strains of GAS and group B Streptococci produce a C5a-inactivating C5a-ase and 
Introduction 
 - 20 - 
can therefore inhibit the inflammatory response and opsonophagocytosis 
(Takahashi et al., 1995).   
Some bacteria were also shown to prevent MAC-dependent lysis by either 
preventing insertion of the late complement components into the bacterial 
membrane, or by binding MAC regulators.  Most bacteria interfere with the 
assembly of C9 to the MAC, thereby preventing pore formation and subsequent 
lysis.  While capsular polysaccharides of A. pleuropneumoniae e.g. can limit the 
amount of bound C9 (Ward and Inzana, 1994), some pathogenic Escherichia coli 
strains can bind protectin (Rautemaa et al., 1998), a negative host regulator of C9 
assembly.   
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2.1. Summary 
In this chapter we show that Cc5 is even more resistant to phagocytosis and 
killing by murine macrophages (J774.1) than Y. enterocolitica, which is known as a 
model bacterium for resistance against phagocytosis due to its type 3 secretion 
system (T3SS) (Grosdent et al., 2002).  We observed that upon high multiplicity of 
infection (moi of 50), Cc5 even completely resists phagocytosis and killing.  
Moreover, pre-opsonization with specific Abs only slightly increased phagocytosis 
and killing of Cc5.   
In addition, we demonstrate that Cc5 transposon (Tn) mutant Y1C12, identified 
during a serum sensitivity screen by Ch. Fiechter, has an increased sensitivity to 
phagocytosis and killing by J774.1 macrophages even in the unopsonized state.  
This indicated that not an increased susceptibility for Ab binding, or complement 
deposition led to an increased phagocytosis, but that the outer surface of the 
bacteria is more readily recognized by the macrophages.   
Furthermore, we have observed that upon growth in the presence of cells, Cc5 
releases or modifies factor(s) in the medium, which interact with fresh 
macrophages and block their ability to kill bacteria after phagocytosis.  This 
capacity was found in 6 out of 10 C. canimorsus strains tested.   
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2.2. Publication 
 
Capnocytophaga canimorsus resists phagocytosis by macrophages and 
blocks the ability of macrophages to kill other bacteria 
 
Immunobiology 213 (2008) 805-814 
 
Salome Meyer, Hwain Shin and Guy R. Cornelis 
 
Statement of my work.  My contribution was the data of all figures except Fig. 6.  Phagocytosis 
and killing of bacteria by murine macrophages and blocking of E. coli killing by C. canimorsus. 
Data of Fig. 6 was contributed by H. Shin.  
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2.3. Additional results 
Cc5 glycosyltransferase (gtf) mutant Y1C12 is sensitive to phagocytosis and 
killing by J774.1 macrophages 
During the serum sensitivity screen on our Cc5 Tn mutant library, Ch. Fiechter 
has identified Cc5 Tn mutant Y1C12 to be serum sensitive.  To enlarge our 
knowledge on this mutant, we decided to determine phagocytosis resistance of 
Y1C12 in comparison to Cc5.  We therefore tested phagocytosis and killing of 
Y1C12 by J774.1 mouse macrophages at low and high moi (moi 1 and moi 50, 
respectively).   
 
 
Figure 1.  Phagocytosis and killing of Y1C12 bacteria by J774.1 macrophages 
Infection of macrophages with unopsonized (grey), Ab pre-opsonized (white), or complement  
pre-opsonized (black) Y1C12 was done for 0, 30, 60 and 120 minutes (min).  (A) Infection at an 
moi of 1.  (B) Infection at an moi of 50.  Mean values and standard deviations from at least three 
independent experiments are shown including statistical significance in comparison to Cc5 (Meyer 
et al., 2008) with * p < 0.05, ** p < 0.01 and *** p < 0.001 using two-tailed, unpaired Student’s t test. 
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At an moi of 1 Cc5 bacteria were only phagocytosed and killed by ~40% and 
~25%, respectively (Meyer et al., 2008), while ~65% Y1C12 bacteria were 
phagocytosed within 2 h and ~50% were killed (Figure 1.A).  At an moi of 50, Cc5 
was completely resistant to phagocytosis and killing by murine macrophages 
(Meyer et al., 2008) whereas ~35% Y1C12 bacteria were phagocytosed and ~30% 
were killed (Figure 1.B).  Comparably to Ab pre-opsonization of Cc5 (Meyer et al., 
2008), Abs increased killing of Y1C12 by about 10% at high moi.  In contrast, pre-
opsonization with heat-inactivated (HI) guinea pig complement did neither at low 
nor at high moi significantly increase killing of Y1C12 bacteria compared to killing 
of unopsonized Y1C12 bacteria.  Though, it needs to be noted that HI guinea pig 
complement only leads to opsonization with pre-formed C3b, which strongly 
decreases complement opsonization.   
Overall, these observations show that – compared to Cc5 – Y1C12 mutant 
bacteria have an increased sensitivity against phagocytosis and killing by mouse 
macrophages at low and high moi. 
2.4. Materials and methods 
Bacterial strains and media 
Growth of bacteria and preparation of cRPMI (Gibco) was done as described 
(Meyer et al., 2008). 
Selective agents 
To select for strains or transposons, antibiotics were added at the following 
concentration: 10 µg/ml Em, 20 µg/ml Gm. 
In vitro phagocytosis and killing assay 
The assay was performed as described (Meyer et al., 2008). 
Statistical analysis 
For all experiments, means and standard deviations were calculated.  
Statistical significance was evaluated using two-tailed, unpaired Student’s t test.  
Differences were considered to be significant when p < 0.05 with * p < 0.05,  
** p < 0.01 and *** p < 0.001. 
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2.5. Discussion 
We could demonstrate that Cc5 is even more resistant to phagocytosis and 
killing by murine macrophages than Y. enterocolitica, which is considered a model 
organism for phagocytosis resistance due to its T3SS (Grosdent et al., 2002).  
However a Cc5 Tn mutant discovered in a screening for serum sensitivity, Y1C12, 
was observed to have an increased sensitivity towards phagocytosis and killing by 
murine macrophages at low and high moi (moi 1 and 50, respectively) compared 
to Cc5.  Interestingly, we could observed that Cc5 mutant Y1C12 is more 
susceptible to phagocytosis even in the unopsonized state.  This indicated that not 
an increased susceptibility for Ab binding or complement deposition led to an 
increased phagocytosis, but that the outer surface of the bacteria is more readily 
recognized by the macrophage’s PRRs, leading to an increased phagocytosis and 
therefore to an increased killing of the mutant bacteria.  As the mutant has been 
found in a screen on serum sensitivity (performed by Ch. Fiechter), this further 
indicated that the mutant might be affected in its outer membrane structure.  
More analysis on the gene hit by the Tn in mutant Y1C12 needs to be done to 
understand its increased susceptibility to complement and phagocytosis by murine 
macrophages.  In addition, LPS of Cc5 and Y1C12 should be compared in order to 
verify whether the mutant indeed displays an altered outer membrane structure 
thus explaining increased phagocytosis and serum sensitivity.   
Human PMNs are among the first line of defence bacteria encounter upon 
infection and they are the most efficient professional phagocytes of the human 
immune system.  Therefore, resistance of Cc5 and Y1C12 against phagocytosis 
and killing by human PMNs should be investigated.   
Interestingly, we observed that four out of eight clinical isolates and two out of 
two isolates from healthy dogs were able to block the ability of murine 
macrophages to kill phagocytosed bacteria.  It would thus be interesting to identify 
the mechanisms and the bacterial factor(s) by which C. canimorsus interferes with 
the killing ability of macrophages.  Additionally, determination of the prevalence of 
this capacity within C. canimorsus strains would allow achieving further information 
on the hypothetical contribution of this property to virulence. 
To summarize, we provide evidence that Cc5 is highly resistant to 
phagocytosis and killing by murine macrophages and additionally interferes with 
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the macrophage’s killing ability upon prolonged exposure.  This might be beneficial 
for bacterial survival in its natural environment, the oral cavity of dogs, which is 
naturally enriched by tissue resident macrophages. 
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3.1. Summary 
As we have shown previously that Cc5 blocks the killing ability of macrophages 
(Meyer et al., 2008), we investigate here that Cc5 needs to grow in the presence 
of cells in order to generate conditioned (cond.) medium or cond. bacteria, which 
are then able to block the killing ability of fresh murine macrophages upon 4 h of 
pre-treatment.   
Investigating the mechanism by which Cc5 interferes with the killing ability of 
macrophages, we could demonstrate that Cc5 does neither affect lysosome 
associated protein 1 (LAMP-1) recruitment to phagosomes nor acidification of 
phagolysosomes, indicating that phagosome maturation is not affected by Cc5.  In 
contrast, Cc5 prevents the oxidative burst normally induced upon phagocytosis of 
E. coli.  Whether Cc5 prevents the assembly of the NADPH oxidase, or whether 
Cc5 redirects the oxidase away from the phagolysosomes could not be 
determined yet.   
In another approach, we wanted to identify factor(s) involved in blocking the 
NADPH oxidase activity.  We demonstrate here that protein(s) and divalent cations 
are involved in interfering with the killing ability of macrophages.  S. Ittig has 
prepared medium from uninfected and Cc5 infected HeLa cells and SDS-PAGE 
analysis revealed a band appearing after infection with Cc5.  This band was 
analyzed by mass spectrometry (MS) by S. Ittig and P. Jenö and one of the 
proteins identified corresponded to open reading frame (ORF) 958 (pitrilysin), 
having a predicted metallopeptidase activity and a Zinc-binding motif.  S. Ittig 
thereafter constructed a Cc5 pitrilysin mutant (∆pit) and a complementation 
plasmid (c∆pit).  ∆pit bacteria could not prevent the induction of an oxidative burst 
upon phagocytosis of E. coli, indicating that pitrilysin is indeed involved in the 
mechanism by which Cc5 interferes with the NADPH oxidase.  Further 
investigations on the biochemical properties of pitrilysin are ongoing as well as 
attempts to identify the mechanism by which pitrilysin interacts with macrophages.   
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3.2. Introduction 
As we have shown previously that Cc5 blocks the killing ability in macrophages 
(Meyer et al., 2008), we wanted to determine the underlying mechanism and the 
involved factor(s). 
3.3. Results 
Cc5 needs to grow in the presence of cells to prevent killing of E. coli  
As we observed that – upon growth in the presence of cells – Cc5 released 
secreted factor(s), which prevented killing but not phagocytosis of E. coli by J774.1 
macrophages (Meyer et al., 2008),  we wanted to verify the conditions required to 
observe this block of killing.   
Therefore, we first determined how long cond. bacteria (bacteria grown for 24 h 
in the presence of J774.1) needed to be in contact with macrophages in order to 
interfere with their killing ability.  Thus, fresh macrophages were pre-infected with 
cond. bacteria for different pre-infection times and killing of E. coli (moi 50) by 
macrophages was determined thereafter.  While 2 h pre-infection with cond. Cc5 
did not affect killing of E. coli, 4 h pre-infection with cond. bacteria prevented killing 
of E. coli within 2 h of infection (Figure 1).  As Cc5 resuspended from plate could 
only interfere with the killing ability of macrophages after ~7 h of pre-infection 
(Meyer et al., 2008), this indicated that upon growth in the presence of cells, Cc5 
become more competent to block the killing ability of macrophages.  
In order to exclude that the above findings were due to a mass effect as Cc5 
grows in the presence of macrophages upon 24 h of infection (Shin et al., 2007), 
we determined the OD600 of cond. bacteria before pre-infection of fresh 
macrophages.  Starting from an OD600 of 0.0125, the bacteria had grown up to an 
OD600 of 1.73 ± 0.64 within 24 h.  Thus, fresh Cc5 from plate were prepared at the 
appropriate concentration and fresh macrophages were pre-infected for 4 h before 
infection with E. coli at an moi of 50.  4 h pre-infection with high amounts of fresh 
Cc5 did not block the killing of E. coli within 2 h of infection (Figure 1).  This was in 
contrast to 4 h pre-infection with cond. Cc5, indicating that growth in the presence 
of cells and not the moi is important to make Cc5 capable of blocking the killing 
ability of macrophages (Figure 1).   
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Figure 1. Cc5 needs to grow in the presence of cells to prevent killing of E. coli 
J774.1 macrophages were either left untreated (control) or pre-infected for either 2 or 4 h with 
either conditioned or fresh Cc5.  After pre-infection, macrophages were infected for 2 h with E. coli 
at an moi of 50 and phagocytosis and killing of E. coli were determined by survival plating.  Mean 
values and standard deviations from at least three independent experiments are shown including 
statistical significance comparing to phagocytosis and killing, respectively, by untreated 
macrophages with *** p < 0.001 using two-tailed, unpaired Student’s t test. 
 
As we observed that – upon growth in the presence of murine macrophages – 
Cc5 released or modified factor(s) in the medium, which were able to block the 
killing ability of macrophages in the absence of whole bacteria (Meyer et al., 
2008), we decided to continue working with cond. medium, i.e. medium gained 
after infection of macrophages for 24 h. 
Therefore, we wanted to determine, how long cond. medium needs to be 
applied to fresh cells in order to block the killing ability of macrophages.  Thus, 
J774.1 macrophages were pre-treated for either 2 or 4 h with Cc5 cond. medium 
before infection with E. coli (moi 50).  As already observed for cond. Cc5 (Figure 
1), Cc5 cond. medium had to be added for 4 h to fresh macrophages in order to 
block their killing ability (Figure 2).   
As the bacteria need to be grown for 24 h in the presence of cells to gain cond. 
medium, we wanted to exclude that the age of the medium itself influenced the 
killing ability of the macrophages.  Therefore, fresh macrophages were pre-treated 
for 4 h with old cRPMI (medium which was previously for 24 h in contact with cells) 
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before infection with E. coli (moi 50).  4 h pre-treatment with old cRPMI had no 
influence on the killing ability of the macrophages (Figure 2), indicating that indeed 
Cc5 released or modified factor(s) in the medium upon growth in the presence of 
cells, which interfere with the macrophages.   
As the effect on the killing ability of macrophages was only observed after at 
least 4 h of pre-treatment with either cond. bacteria (Figure 1) or cond. medium 
(Figure 2), we tested whether the concentration of the cond. medium is also 
relevant.  Thus, macrophages were pre-treated for 4 h with Cc5 cond. medium 
diluted 1:2 with fresh cRPMI before infection with E. coli (moi 50).  Interestingly, 
diluted Cc5 cond. medium could not prevent killing of E. coli, suggesting that 
concentration of the factor(s) is critical (Figure 2). 
 
 
Figure 2. Concentration of cond. medium is essential 
J774.1 macrophages were either left untreated (control) or pre-treated as indicated before infection 
with E. coli at an moi of 50.  2 h after infection, phagocytosis and killing of E. coli were determined 
by survival plating.  Mean values from three or more independent experiments and standard 
deviations are shown including statistical significance comparing to phagocytosis and killing, 
respectively, by untreated macrophages with ** p < 0.01 using two-tailed, unpaired Student’s t test. 
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As we observed that Cc5 interfered with the killing ability of murine 
macrophages, we wanted to explore, whether Cc5 could also block the killing 
ability of human PMNs.  Thus, freshly isolated PMNs were either left untreated or 
pre-treated for 4 h with Cc5 cond. medium before infection with E. coli (moi 50).  
As PMNs are very short lived after isolation from human blood, PMNs died before 
the end of the experiment and it therefore could not be determined yet, whether 
Cc5 has an effect on the killing ability of human PMNs. 
Cc5 blocks the oxidative burst 
Upon phagocytosis by macrophages, bacteria are engulfed within 
phagosomes, which mature to acidic phagolysosomes via a series of vesicle 
fusion events (for a review on phagocytosis see (Stuart and Ezekowitz, 2005)).  As 
we have shown that Cc5 blocks the killing ability of macrophages without affecting 
phagocytosis (Meyer et al., 2008), we wanted to determine whether Cc5 interferes 
with the maturation of the phagosomes.   
In a first step we thus used LAMP-1 as a marker for lysosomes and localization 
of E. coli (expressing enhanced green fluorescent protein (eGFP)) within 
phagolysosomes was determined.  Therefore, either fresh (control) or Cc5 cond. 
medium pre-treated macrophages were infected with E. coli (moi 10).  After 2 h of 
infection, cells were fixed and phagosome maturation was determined by 
immunofluorescence.   
We observed that ~70% of the E. coli localized within LAMP-1 positive 
lysosomes after 2 h of infection.  This percentage did not differ whether the 
macrophages were fresh (control) or pre-treated with Cc5 cond. medium  
(Figure 3).   
To exclude that extracellular E. coli interfered with the evaluation of E. coli 
localized in lysosomes, macrophages were additionally pre-treated with 
Cytochalasin (Cyt.) D, which blocks the actin cytoskeleton, thereby preventing 
phagocytosis.  Upon pre-treatment with Cyt. D, less than 15% of the E. coli were 
still found to be localized within LAMP-1 positive lysosomes (Figure 3).  These 
might represent bacteria phagocytosed by macrophages, which were not blocked 
by Cyt. D, or extracellular E. coli which were incorrectly counted to be localized in 
LAMP-1 positive lysosomes due to their localization on the cell.  However, 
treatment of macrophages with Cyt. D strongly and equally reduced the lysosomal 
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localization of E. coli in control as well as in Cc5 cond. medium pre-treated 
macrophages.  This indicated that the ~70% lysosomal localization determined 
previously represented predominantly phagocytosed E. coli localized within  
LAMP-1 positive lysosomes.  These results suggested that Cc5 did not affect 
phagolysosomal maturation until the recruitment of LAMP-1. 
As acidification is the latest step in phagolysosome maturation, we wanted to 
determine whether LAMP-1 stained only acidic lysosomes.  Thus, macrophages 
were pre-treated with Bafilomycin, which prevents acidification of lysosomes.  
Upon pre-treatment with Bafilomycin, LAMP-1 positive lysosomal localization of  
E. coli was reduced from ~70% to ~50% and ~40% in control macrophages and 
Cc5 cond. medium pre-treated macrophages, respectively (Figure 3).  As still 
between 40-50% of the E. coli were localized within LAMP-1 positive lysosomes 
even if acidification was prevented by the addition of Bafilomycin, this indicated 
that LAMP-1 was recruited before acidification of the lysosomes.  Therefore 
LAMP-1 is not a suitable marker to determine acidification of phagolysosomes. 
 
 
Figure 3. Cc5 does not affect LAMP-1 recruitment 
Lysosomal localization of E. coli 2 h after infection of macrophages at an moi of 10.  Lysosomal 
localization of E. coli after phagocytosis by 4 h Cc5 cond. medium pre-treated macrophages is 
shown in white, lysosomal localization after phagocytosis by fresh macrophages (control) is shown 
in black.  Lysosomal localization was determined by calculating the percentage of E. coli found in 
LAMP-1-positive lysosomes (immunofluorescence).  If indicated, macrophages were additionally 
pre-treated with either Cyt. D to block phagocytosis, or with Bafilomycin to prevent acidification of 
the lysosomes.  Mean values and standard deviations from at least three independent experiments 
are shown including statistical significance comparing to lysosomal localization in untreated 
macrophages with * p < 0.05, ** p < 0.01 and *** p < 0.001 using two-tailed, unpaired Student’s t 
test. 
Chapter 3 
 
 - 45 - 
In order to test, whether acidification of the lysosomes still occurred after pre-
treatment with Cc5 cond. medium, we investigated the localization of E. coli within 
acidic lysosomes by lysotracker staining.  Lysotracker is a red fluorescent, cell-
permeant dye, accumulating in acidic environments and organelles.  After infecting 
macrophages for 2 h with E. coli at an moi of 10, ~60% of the E. coli localized 
within lysotracker-stained, acidic lysosomes irrespective of whether the 
macrophages were fresh (control) or pre-treated for 4 h with Cc5 cond. medium 
(Figure 4).  
To exclude that extracellular E. coli interfered with the evaluation of E. coli 
localized in acidic lysosomes, macrophages were pre-treated with Cyt. D.  After 
pre-treatment with Cyt. D, less than 11% of the bacteria were still found to be 
localized within acidic lysosomes (Figure 4).  These might represent E. coli 
phagocytosed by macrophages, which were not blocked by Cyt. D, or extracellular 
E. coli which were incorrectly counted to be localized within acidic lysosomes due 
to their extracellular attachment to the cell.  However, the strong and equal 
reduction in lysosomal localization of E. coli after treatment with Cyt. D in control 
macrophages as well as in Cc5 cond. medium pre-treated macrophages indicated 
that the lysosomal localization in untreated macrophages represented 
phagocytosed E. coli localized within lysotracker-stained lysosomes. 
To determine the specificity of lysotracker for acidic lysosomes, macrophages 
were pre-treated with Bafilomycin.  Upon pre-treatment with Bafilomycin, acidic 
lysosomal localization of E. coli was reduced from ~60% to less than 8% in control 
macrophages and Cc5 cond. medium pre-treated macrophages (Figure 4), 
indicating that lysotracker indeed specifically accumulated in acidic lysosomes and 
therefore suggesting that Cc5 did not affect acidification of lysosomes and thus did 
not affect phagolysosomal maturation. 
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Figure 4. Cc5 does not affect acidification of lysosomes 
Lysosomal localization of E. coli 2 h after infection of macrophages at an moi of 10.  Lysosomal 
localization of E. coli after phagocytosis by 4 h Cc5 cond. medium pre-treated macrophages is 
shown in white, lysosomal localization after phagocytosis by fresh macrophages (control) is shown 
in black.  Lysosomal localization was determined by calculating the percentage of E. coli 
recruitment to lysotracker-positive lysosomes (immunofluorescence).  If indicated, macrophages 
were additionally pre-treated with either Cyt. D to block phagocytosis, or with Bafilomycin to 
prevent acidification of the lysosomes.  Mean values and standard deviations from at least three 
independent experiments are shown including statistical significance comparing to lysosomal 
localization in untreated macrophages with *** p < 0.001 using two-tailed, unpaired Student’s t test. 
 
As we observed that pre-treatment of murine macrophages with Cc5 cond. 
medium blocked the killing ability of macrophages (Meyer et al., 2008), but not the 
maturation of phagolysosomes (Figures 3 and 4), we wanted to examine whether 
Cc5 has an influence on the oxidative burst induced upon activation of the NADPH 
oxidase in the acidified phagolysosome.  We therefore infected either fresh 
(control) or 4 h Cc5 cond. medium pre-treated J774.1 macrophages for 30 min 
with E. coli at an moi of 50.  After addition of the cell permeant dye 
dihydrorhodamine 1.2.3 (DHR), the strength of the oxidative burst was determined 
by measuring the mean fluorescence intensity of the macrophages, as DHR 
becomes fluorescent and membrane-impermeant upon oxidation.   
While infection of fresh macrophages induced an oxidative burst and therefore 
induced oxidation of DHR, macrophages pre-treated for 4 h with Cc5 cond. 
medium were not able to induce an oxidative burst upon infection with E. coli 
(Figure 5).  These results suggested that Cc5 specifically prevented the oxidative 
burst normally induced upon phagocytosis. 
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Figure 5. Cc5 blocks the oxidative burst 
The strength of the oxidative burst induced after 30 min infection with E. coli at an moi of 50 was 
determined either in untreated macrophages (control) or in 4 h Cc5 cond. medium pre-treated 
macrophages.  The oxidative burst was measured by the addition of DHR and the mean 
fluorescence intensity of the macrophages was determined by FACS analysis.  Background 
fluorescence of uninfected macrophages was subtracted.  The values represent means and 
standard deviations of at least three independent experiments.  Statistical significance is shown 
comparing Cc5 cond. medium pre-treated macrophages to control macrophages with *** p < 0.01 
using two-tailed, unpaired Student’s t test. 
 
In a next step, we wanted to examine how Cc5 interfered with the NADPH 
oxidase.  Therefore, we intended to analyze the expression and localization of four 
NADPH oxidase subunits (p22phox, p47phox, p67phox and gp91phox).  Unfortunately, 
determination of NADPH oxidase subunit expression and localization in fresh and 
4 h Cc5 cond. medium pre-treated macrophages before and after infection with E. 
coli at an moi of 50 was not successful, by reasons of experimental limits due to 
the insufficient quality of commercially available Abs. 
Block of the oxidative burst depends on the release of pitrilysin 
After we identified that Cc5 blocked the oxidative burst (Figure 5), we wanted 
to identify the factor(s) involved in this mechanism.   
In a first step, we intended to identify whether protein(s) are essential for 
interfering with the killing ability of macrophages.  Thus, Cc5 cond. medium was 
either HI or treated with proteinase K before addition to fresh macrophages for 4 h.  
Analysis of subsequent E. coli killing revealed that neither HI, nor proteinase K-
treated Cc5 cond. medium could prevent the killing of E. coli by macrophages 
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within 2 h of infection.  This indicated that protein(s) might be important for 
blocking the killing ability of macrophages (Figure 6).   
Next, we were interested whether the binding or translocation of divalent 
cations might be required for interference with the killing ability of macrophages.  
Hence, we supplemented Cc5 cond. medium with 1 mM EDTA before adding it for 
4 h to fresh macrophages.  Interestingly, EDTA supplemented Cc5 cond. medium 
could not block the killing ability of macrophages (Figure 6), indicating that indeed 
divalent cations are important for the mechanism underlying the blocking of the 
macrophage’s killing ability.  
 
 
Figure 6. Chelating divalent cations prevents blocking of the killing ability of macrophages 
J774.1 macrophages were either left untreated (control) or pre-treated for 4 h as indicated before 
infection with E. coli at an moi of 50.  Killing of E. coli after 2 h of infection was determined by 
survival plating.  Mean values and standard deviations from at least three independent experiments 
are shown including statistical significance comparing to killing by untreated macrophages with  
*** p < 0.001 using two-tailed, unpaired Student’s t test. 
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As the previous results indicated that protein(s) might be necessary, we 
wanted to determine the size of the involved protein(s) by applying size exclusion 
centrifugation steps on Cc5 cond. medium.  As the flowthrough of a 10 kilo Dalton 
(kDa) cut off filter still blocked the killing ability of macrophages (Figure 7), we 
applied a second centrifugation step with a 3 kDa cut off filter.  Therefore, Cc5 
cond. medium was passed through a 10 kDa filter and the flowthrough was further 
passed through a 3 kDa filter.  The retention sample of the second filtration step 
still blocked the killing of E. coli (Figure 7).  These findings indicated that factor(s) 
involved in blocking the killing ability of macrophages can pass a 10 kDa filter, but 
are retained by a 3 kDa filter.   
 
 
Figure 7. Size exclusion centrifugation of Cc5 cond. medium 
J774.1 macrophages were either left untreated (control) or pre-treated for 4 h as indicated before 
infection with E. coli at an moi of 50.  Killing of E. coli was determined 2 h after infection by survival 
plating.  Mean values and standard deviations from at least three independent experiments  
are shown including statistical significance comparing to killing by untreated macrophages with  
*** p < 0.001 using two-tailed, unpaired Student’s t test. 
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SDS-PAGE analysis of cond. medium filtered through a 10 kDa filter by S. Ittig 
revealed that filtration did not prevent proteins between 10-50 kDa from passing 
the membrane, but only reduced the amount of higher molecular weight proteins 
(data not shown).  Thus, we concluded that at least one factor involved has a 
molecular size between 3 and 50 kDa. 
S. Ittig prepared medium from Cc5 infected and from untreated HeLa cells and 
compared them by SDS-PAGE followed by silver staining.  He identified a band 
running at ~54 kDa, which was absent in medium from untreated cells, but 
appeared in medium of cells infected with Cc5 (Figure 8).  Upon MS analysis  
(P. Jenö), S. Ittig identified peptides belonging to proteins of 3 ORFs (Table 1) 
based on the Cc5 genome provided by P. Manfredi (unpublished data).  
 
 
Figure 8. Comparison of uninfected and Cc5 infected medium 
Silver staining of an SDS-PA gel.  In the first lane, sDMEM from uninfected HeLa cells was loaded 
(control).  In the second lane, sDMEM from 4 h Cc5 infected HeLa cells was loaded.  The arrow 
indicates a band appearing after infection with Cc5, which was cut for MS analysis. 
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Predicted ORF Predicted size Predicted function Signal peptide 
1890 48 kDa C-terminal: OmpA/MotB like; N-terminal: 
thrombospondin type III repeat 
Yes 
958 50 kDa Metallopeptidase, Zn-binding motif (HXXEH), 
insulinase/pitrilysin 
Yes 
1975 50 kDa Fumarat hydratase, aspartate-ammonia lyase No 
Table 1. ORFs corresponding to MS data 
 
Based on the previous findings that chelating divalent cations in Cc5 cond. 
medium prevented the block of the killing ability in macrophages (Figure 6), we 
decided to knockout ORF #958 (∆pit) and – as control – ORF #1890 (∆1890).  Cc5 
knockouts were generated by S. Ittig.  The two knockouts were subsequently 
tested for their ability to prevent killing of E. coli by murine macrophages.  
Therefore, cond. medium of either mutant was added for 4 h to fresh macrophages 
and macrophages were then infected for 2 h with E. coli at an moi of 50.   
 
 
 
Figure 9. ∆pit cond. medium cannot block the killing ability of macrophages 
J774.1 macrophages were either left untreated (control) or pre-treated for 4 h as indicated before 
infection with E. coli at an moi of 50 for 2 h.  Killing of E. coli was determined by survival plating.  
Mean values and standard deviations from at least three independent experiments are shown 
including statistical significance comparing to killing by untreated macrophages with *** p < 0.001 
using two-tailed, unpaired Student’s t test. 
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Cond. medium from ∆1890 bacteria blocked the killing of E. coli, whereas cond. 
medium of ∆pit bacteria did not (Figure 9).  As complementation of the ∆pit 
mutation by expressing pitrilysin from pSI04 in trans in ∆pit (c∆pit) again prevented 
the killing of E. coli, this indicated that the predicted metallopeptidase pitrilysin 
might be involved in blocking the killing ability of macrophages (Figure 9). 
As the pitrilysin protein seemed to be involved in blocking the killing ability of 
macrophages, we next determined whether pitrilysin is also important for blocking 
the oxidative burst.  Therefore either fresh (control) or ∆pit cond. medium pre-
treated J774.1 macrophages were infected for 30 min with E. coli at an moi of 50.  
After addition of DHR, the strength of the oxidative burst was determined by 
measuring the mean fluorescence intensity of the macrophages, as DHR becomes 
fluorescent upon oxidation.   
 
 
Figure 10. ∆pit cond. medium cannot block the oxidative burst 
The strength of the oxidative burst induced after 30 min infection with E. coli at an moi of 50 was 
determined either in untreated macrophages (control) or in macrophages pre-treated for 4 h as 
indicated.  The oxidative burst was measured by the addition of DHR and the mean fluorescence 
intensity of the macrophages was determined by FACS analysis.  Background fluorescence of 
uninfected macrophages was subtracted.  The values represent means and standard deviations of 
at least three independent experiments.  Statistical significance is shown in comparison to control 
macrophages with *** p < 0.01 using two-tailed, unpaired Student’s t test. 
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While macrophages pre-treated with Cc5 cond. medium were not able to 
induce an oxidative burst upon infection with E. coli, infection of untreated 
macrophages induced an oxidative burst and thus induced oxidation of DHR.  Pre-
treatment of macrophages with ∆pit cond. medium did not prevent the oxidative 
burst induced upon infection with E. coli.  In contrast, cond. medium from a ∆pit 
mutant expressing pitrilysin in trans (c∆pit) again blocked the oxidative burst 
(Figure 10).  These results suggested that Cc5 specifically prevented the oxidative 
burst induced upon phagocytosis dependent on the release of pitrilysin into the 
medium. 
3.4. Materials and methods 
Bacterial strains and media 
Growth of bacteria and preparation of cRPMI (Gibco) was done as described 
(Meyer et al., 2008).  HeLa type Kyoto cells were grown in DMEM (Gibco) 
supplemented with 2% glutamine (Gibco) and 10% fetal calf serum (FCS) 
(cDMEM).  For infection with bacteria, medium was replaced with DMEM (Gibco) 
supplemented with 2% glutamine (Gibco) and Hepes (10 mM, Gibco) (sDMEM).   
Selective agents 
To select for strains, plasmids or transposons, antibiotics were added at the 
following concentration: 10 µg/ml Cf, 10 µg/ml Em, 20 µg/ml Gm and 10 µg/ml Sm. 
Phagocytosis and killing by pre-infected macrophages 
The assay was performed as described (Meyer et al., 2008). 
Conditioning of bacteria 
2 h after seeding J774.1 macrophages (105 cells/well in a 24-well plate, 
Falcon), cells were infected for 24 h with C. canimorsus at an moi of 50.  The 
supernatant was thoroughly mixed to detach C. canimorsus bacteria and removed 
from cells.  The supernatant was centrifuged (2 min, 13000 rounds per minute 
(rpm), room temperature (RT)) and the pellet was resuspended in 100 µl PBS.  
Cond. bacteria were then added to fresh J774.1 cells, which had been seeded  
24 h prior (105 cells/well in a 24-well plate, Falcon).  J774.1 macrophages were 
incubated for indicated times at 37 °C and 5% CO2 with the cond. bacteria, 
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washed once and supplemented with fresh cRPMI medium before infection with 
Sm-resistant E. coli at an moi of 50.  The phagocytosis assay was then continued 
as described (Meyer et al., 2008). 
Conditioning of the medium 
Cond. medium was generated as described (Meyer et al., 2008). 
Manipulation of cond. medium 
Cond. medium was generated as described (Meyer et al., 2008) and 
manipulated as indicated.  Heat-inactivation was done for 1 h at 56 °C.  Proteinase 
K (0.1 mg/ml, Roche) was added for 2 h at 37°C.  Divalent cations were chelated 
by incubation of cond. medium for 30 min at 37°C with 1 mM EDTA.  Filtration via 
a 10 kDa cut off filter (Amicon Ultra) was done by centrifugation (19 min, 4000 g, 
RT).  The cond. medium filtered through a 10 kDa filter (10 kDa flowthrough) was 
then loaded on a 3 kDa filter (Amicon Ultra) if indicated and centrifuged again  
(30 min, 4000 g, RT).  The retained medium from the 3 kDa filter was re-diluted to 
the loading volume with fresh cRPMI and then used for pre-treatment of fresh 
macrophages. 
Isolation of human PMNs 
Human PMNs were isolated from healthy volunteers using the dextran-Percoll 
protocol, adapted with modifications described previously (Jepsen and Skottun, 
1982).  Contaminating erythrocytes were removed by hypotonic lysis with “aqua ad 
iniectabilia” (Bichsel). 
Phagocytosis and killing by pre-treated PMNs 
Freshly isolated human PMNs were resuspended at 107 ml-1 in D-PBS (Gibco) 
supplemented with 10% Ab-depleted HI NHS (Scipac Ltd.) and pre-treated for 4 h 
with Cc5 cond. medium. After pre-treatment, PMNs were infected with E. coli at an 
moi of 50.  As control, untreated PMNs were infected.  Samples were analyzed 2 h 
after infection.  To distinguish between phagocytosis and killing, an aliquot was 
incubated with “aqua ad iniectabilia” (Bichsel) for 1 min in order to lyse the PMNs.  
Aliquots from untreated and lysed samples were then plated at different dilutions 
to count the surviving bacteria.  Samples from bacteria incubated without cells 
were plated in parallel as a reference.  Counts from lysed samples gave the total 
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number of surviving bacteria, whereas counts from untreated cell samples gave 
the numbers of non-phagocytosed, non-adhering, extracellular bacteria.  Numbers 
of phagocytosed and killed bacteria were calculated by subtracting the counts of 
extracellular or surviving bacteria, respectively, from the counts of the bacteria 
grown without cells (reference sample).   
Localization of E. coli in LAMP-1 positive lysosomes 
All samples were prepared in triplicates.  J774.1 macrophages were seeded in 
96 well black-clear TC-treated plates (approx. 2x 104 cells/well in 200 µl cRPMI, 
Costar) and incubated overnight (o/n) at 37 °C and 5% CO2 in a humidified 
incubator.  24 h after seeding, the medium was replaced with 200 µl Cc5 cond. 
medium if indicated and incubated another 4 h.  If indicated, cells were pre-treated 
with either Cyt. D (10 µg/ml, Sigma) for 20 min or with Bafilomycin (20 nM, Sigma) 
for 30 min before infection with eGFP expressing E. coli at an moi of 10.  To 
synchronize the infection, plates were centrifuged (5 min, 1000 rpm, 37 °C).  
Plates were incubated for 2 h at 37 °C and 5% CO2 in a humidified incubator.  To 
stop the infection, cells were washed 2x with pre-warmed PBS and fixed by the 
addition of 200 µl pre-warmed PFA (3%) for 13 min at 37 °C.  After fixation, cells 
were washed 2x with PBS and permeabilized with 0.1% Saponin supplemented 
with 2% bovine serum albumin (Saponin/BSA) for 30 min at RT.  After 
permeabilization, cells were incubated 40 min at RT with α-1D4B (α-LAMP-1 Ab, 
rat monoclonal, 1:200, gift from J. Pieters) diluted in Saponin/BSA.  After washing 
4x with Saponin/BSA, cells were incubated for 30 min at RT with Cy3-conjugated 
Affini Pure goat anti-rat IgG (1:100, Jackson Immuno Research, gift from Ch. 
Dehio) diluted in Saponin/BSA.  After washing 3x with PBS, DNA was stained by 
the addition of Hoechst (1:10000, Sigma) for 30 min at RT.  Cells were washed 
again 3x with PBS and stored at 4 °C in the dark until use.  The plates were 
analyzed using an automated microscope ImageXpressMICRO (Molecular 
Devices Corporation).  Pictures were taken at 12 sites/well using filters for DAPI 
(10 ms), Texas Red (1500 ms) and GFP (400 ms).  Mean inner LAMP-1 
fluorescence was recorded at the same position as eGFP signals. Mean outer 
LAMP-1 fluorescence was recorded within a 5 µm circle around eGFP signals.  
Data was analyzed using MetaXpress 2.0.1.18.  E. coli were determined to be 
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localized within LAMP-1 positive lysosomes if the average of the mean outer 
fluorescence divided by the mean inner fluorescence was < 0.5.   
Localization of E. coli in acidified lysosomes (lysotracker staining) 
All samples were prepared in triplicates.  J774.1 macrophages were seeded in 
96 well black-clear TC-treated plates (approx. 2x 104 cells/well in 200 µl cRPMI, 
Costar) and incubated o/n at 37 °C and 5% CO2 in a humidified incubator.  24 h 
after seeding, the medium was replaced with 200 µl Cc5 cond. medium if indicated 
and incubated another 4 h.  Thereafter, the medium was replaced by 200 µl 
cRPMI supplemented with 60 nM lysotracker red.  After 30 min incubation, cells 
were pre-treated if indicated with either Cyt. D (10 µg/ml, Sigma) for 20 min or with 
Bafilomycin (20 nM, Sigma) for 30 min before infection with eGFP expressing E. 
coli at an moi of 10.  To synchronize the infection, plates were centrifuged (5 min, 
1000 rpm, 37 °C).  Plates were incubated for 2 h at 37 °C and 5% CO2 in a 
humidified incubator.  To stop the infection, cells were washed 2x with pre-warmed 
PBS and fixed by the addition of 200 µl pre-warmed PFA (3%) for 13 min at 37 °C.  
After fixation, cells were washed 1x with PBS and DNA was stained by the 
addition of Hoechst (1:10000, Sigma) for 30 min at RT.  Cells were washed again 
3x with PBS and stored at 4 °C in the dark until use.  The plates were analyzed as 
described for LAMP-1 staining.   
Western blot analysis of NADPH oxidase subunits 
J774.1 murine macrophages were seeded into 6 well plates (6x 105 cells/well in 
2 ml cRPMI, Falcon) and incubated for 24 h at 37 °C and 5% CO2 in a humidified 
incubator.  If needed, cells were pre-treated for 4 h with Cc5 cond. medium and 
subsequently infected with E. coli at an moi of 50.  To synchronize the infection, 
plates were centrifuged (5 min, 1000 rpm, 37 °C) and then incubated for 30 min at 
37 °C and 5% CO2 in a humidified incubator.  To stop the infection, the cells were 
washed with PBS and the well plate was cooled on ice.  After washing the cells 
with ice-cold PBS, the cells were scraped and transferred into an Eppendorf tube.  
After centrifugation (10 min, max. speed, 4 °C), the cells were lysed by the 
addition of 100 µl RIPA buffer supplemented with 1% Triton X-100 and complete 
protease inhibitors Mini mix (Roche).  To allow complete lysis, the cells were 
incubated for 30 min on ice and mixed repeatedly.  To trash the cell debris, the 
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samples were centrifuged (5 min, max. speed, 4 °C) and the supernatant was 
transferred into a fresh Eppendorf tube and mixed with 25 µl 5x SDS-PAGE buffer. 
Samples were boiled 5 min at 99 °C and stored at -20 °C until use.  To detect 
expression of NADPH oxidase subunits, samples were loaded onto 12% SDS-
PAGE gels and separated (15 min at 125 V, followed by 75 min at 195 V).  
Proteins were transferred onto a nitrocellulose membrane (HybondTM, Amershan 
Biosciences) by semi-dry Western blotting (90 min, 25 V) and the membrane was 
blocked o/n at 4 °C with PBS/Tween (0.2% Tween) supplemented with  
5% skimmed milk.  Next, the blot was washed 4x with PBS/Tween followed by 1 h 
incubation at RT with the primary Ab diluted in PBS/Tween.  After washing 6x with 
PBS/Tween, the membrane was incubated another h at RT with the corresponding 
secondary Ab diluted in PBS/Tween.  The membranes were again washed 6x with 
PBS/Tween and developed for 1 min by the addition of ECL (GE Healthcare).  
Primary Abs used were α-p22phox (rabbit), α-p47phox (goat), α-p67phox (goat) and  
α-gp91phox (goat) (used at various dilutions ranging from 1:200 to 1:10000,  
Santa Cruz) and secondary Abs used were swine anti-rabbit Ig/HRP and rabbit 
anti-goat Ig/HRP (1:5000, DAKO). 
Localization of NADPH oxidase subunits by immunofluorescence 
J774.1 macrophages were seeded in 8 well chamber slides (104 cells/well in 
200 µl cRPMI, Falcon) and incubated 24 h at 37 °C and 5% CO2 in a humidified 
incubator.  If needed, cells were pre-treated for 4 h with Cc5 cond. medium and 
subsequently infected with E. coli at an moi of 50.  To synchronize the infection, 
plates were centrifuged (5 min, 1000 rpm, 37 °C) and then incubated for 2 h at  
37 °C and 5% CO2 in a humidified incubator. To stop the infection, cells were fixed 
by the addition of 3% PFA.  After fixation, cells were washed 2x with PBS and 
permeabilized with 0.1% Saponin supplemented with 2% BSA (Saponin/BSA) for 
40 min at RT.  After permeabilization, cells were incubated 60 min at RT with the 
primary Ab diluted in Saponin/BSA.  After washing 4x with Saponin/BSA, the cells 
were incubated for 30 min at RT with the corresponding secondary Ab diluted in 
Saponin/BSA.  After washing 3x with PBS, Hoechst was added (1:10000, Sigma) 
and the cells were incubated for another 20 min at RT.  After washing 3x with PBS 
and 1x with ddH2O, the chambers were removed and the slide was mounted using 
VectaShield Hard Cover Mounting Medium (Vector).  Slides were analyzed on an 
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Olympus IX81F-3 microscope mounted with a high speed Yokogawa spinning 
head and pictures were analyzed using AndorIQ software.  Primary Abs used were 
α-p22phox (rabbit), α-p47phox (goat), α-p67phox (goat) and α-gp91phox (goat) (used at 
various dilutions ranging from 1:100 to 1:500, Santa Cruz) and secondary Abs 
used were rabbit anti-goat Ig/FITC (1:200, SBA) and goat anti-rabbit Ig/FITC 
(1:200, Santa Cruz) respectively. 
Measurement of NADPH oxidase activity 
NADPH oxidase activity was determined by measuring oxidation of DHR 
(Molecular Probes), a cell permeant dye which becomes fluorescent and cell 
impermeant upon oxidation.  Therefore, murine macrophage J774.1 cells were 
seeded in a 24-well plate (105 cells/well in 1 ml cRPMI, Falcon) and incubated 24 h 
at 37 °C and 5% CO2 in a humidified incubator.  If needed, cells were pre-treated 
for 4 h with cond. medium and subsequently infected with E. coli at an moi of 50.  
To synchronize the infection, plates were centrifuged (5 min, 1000 rpm, 37 °C) and 
then incubated for 30 min at 37 °C and 5% CO2 in a humidified incubator.  After  
30 min of infection, DHR (2 µM) was added for 15 min to the cells.  Thereafter, 
cells were washed 3x with PBS containing 2% FCS.  Cells were scraped and 
FACS analysis was performed determining the mean fluorescence intensity of 
macrophages.  The oxidative burst was determined after subtraction of the 
background values (uninfected macrophages). 
Preparation of culture medium samples for SDS-PAGE  
HeLa type Kyoto cells were seeded in a 6-well plate (2x 105 cells/well in 2 ml 
cDMEM, Falcon) and incubated 24 h at 37°C and 5% CO2 in a humidified 
incubator.  After incubation, cells were washed once with sDMEM and 2 ml 
sDMEM were added to the cells.  HeLa cells were either left uninfected, or infected 
for 4 h with Cc5 at an moi of 50.  To synchronize the infection, plates were 
centrifuged (5 min, 1000 rpm, 37 °C).  After infection, the supernatant was 
collected and centrifuged (10 min, 14000 rpm, 4 °C).  The supernatant was 
transferred into a fresh Eppendorf tube and proteins were precipitated o/n at 4 °C 
by the addition of 10% TCA.  After centrifugation (60 min, 14000 rpm, 4 °C), the 
pellet was resuspended in 300 µl ice-cold acetone and incubated 2 min at RT.  
After another step of centrifugation (60 min, 14000 rpm, 4 °C), the acetone was 
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removed and the pellet was air dried.  For SDS-PAGE analysis, the pellet was 
resuspended in 60 µl Tris/HCl (pH 8.0) and 15 µl 5x SDS-PAGE loading dye.  
Samples were boiled (10 min, 99 °C) and after cooling to RT, 2 µl 0.5 M 
iodoacetamide in Tris/HCl (pH 8.0) (gift from P. Jenö) were added. 35 µl of each 
sample were loaded onto 15% SDS-PA gels for analysis. 
Silver periodic acid staining 
SDS-PA gels were fixed for 10 min in 40% EtOH, 10% acetic acid.   
After rinsing with water for 10 min, the gels were sensibilized with  
0.05% glutaraldehyde, 0.01% formaldehyde and 40% EtOH for 5 min.  After 
rinsing 20 min with 40% EtOH, gels were rinsed for 20 min with water and were 
sensibilized for 1 min with 0.02% sodium-thiosulfate.  After rinsing 2x with water, 
gels were coloured with 0.1% silver nitrate for 20 min in the dark.  After rinsing with 
water, gels were developed by the addition of 2.5% sodium-carbonate, 0.04% 
formaldehyde and the colour reaction was stopped by replacing the solution with 
5% acetic acid. 
Directed gene replacement by allelic exchange 
Directed gene replacement by allelic exchange was performed as described 
(Mally and Cornelis, 2008).  The ermF resistance cassette was amplified from 
pEP4351 as template and the upstream and downstream flanking regions of 
genes 1890 and pitrilysin were amplified from 100 ng Cc5 genomic DNA  as 
template.  Genomic DNA from Cc5 was isolated with the GenElute bacterial 
genomic DNA kit (Sigma) following the manufacturers instructions.  For generating 
upstream and downstream flanking regions and the ermF resistance cassette 
containing homologous extensions for ∆1890, primer pairs 5094+9095, 
5096+5097 and 5098+5099 were used.  The final PCR product was generated 
using primers 5094+5099 and was digested with PstI and SpeI for cloning into the 
appropriate sites of C. canimorsus suicide vector pMM25 giving pSI03.  For 
generating upstream and downstream flanking regions and the ermF resistance 
cassette containing homologous extensions for ∆pit, primer pairs 5100+9101, 
5102+5103 and 5104+5105 were used.  The final PCR product was generated 
using primers 5100+5105 and was digested with PstI and SpeI for cloning into the 
appropriate sites of C. canimorsus suicide vector pMM25 giving pSI02.  The 
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resulting plasmids were transferred by conjugative transfer into Cc5 (Mally and 
Cornelis, 2008). 
Electroporation 
Electroporation of C. canimorsus was done as described (Mally and Cornelis, 
2008). 
Statistical analysis 
For all experiments, means and standard deviations were calculated.  
Statistical significance was evaluated using two-tailed, unpaired Student’s t test.  
Differences were considered to be significant when p < 0.05 with * p < 0.05,  
** p < 0.01 and *** p < 0.001. 
3.5. Discussion 
We could show that upon growth in the presence of cells, Cc5 releases soluble 
factor(s) into the supernatant, which interfere with the oxidative burst in murine 
macrophages, thereby preventing the killing of phagocytosed bacteria.  As only  
10 strains have been tested so far for their ability to interfere with the killing ability 
of macrophages (Meyer et al., 2008), the prevalence of this ability should be 
analyzed on a collection of C. canimorsus strains derived not only from human 
cases, but also isolated from healthy dogs in order to determine the prevalence of 
this capacity in C. canimorsus and the potential relevance for virulence.   
Most cell types use their NADPH oxidase to produce ROS for signalling 
purposes.  However, NADPH oxidase of phagocytes plays a crucial role in host 
defence by producing ROS that are intended to kill invading microbes.  As we 
observed that Cc5 blocks the oxidative burst in macrophages, we thus tried to 
investigate how Cc5 interacts with the NADPH oxidase of murine macrophages.  
In a resting phagocyte, the NADPH oxidase complex is disassembled, with its 
components segregated into different parts of the cell.  To activate the NADPH 
oxidase, the following events must occur: (i) Agonists (e.g. bacteria) bind their 
plasma membrane receptor.  (ii) Protein kinases – including PKC – phosphorylate 
activating components, the most critical and extensively phosphorylated being 
p47phox, which unfolds from an autoinhibitory conformation.  (iii) Phospholipase A2 
is activated and generates arachidonic acid, which activates NADPH oxidase.   
(iv) The four cytosolic components comprising the heterotrimer of p67phox, p47phox 
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and p40phox, as well as Rac2, translocate to the phagosome or plasma membrane 
where flavocytochrome b558 is located and NADPH binds to the assembled 
complex.  (v) Proton channels are converted to readily open “active” state, 
perhaps by arachidonic acid or by phosphorylation of PKC, or tyrosine kinase 
(DeCoursey and Ligeti, 2005; Lee et al., 2003).   
Some bacteria like Francisella tularensis have been shown to prevent the 
accumulation of both membraneous and soluble NADPH oxidase components on 
the phagosomal membrane (McCaffrey and Allen, 2006), and others like H. pylori 
redirect the majority of NADPH oxidase complexes to the plasma membrane, 
whereby ROS are released into the extracellular milieu (Allen et al., 2005).  
Interestingly, N. gonorrhoeae have been shown to suppress the oxidative burst in 
PMNs, but the mechanism remains unknown (Criss and Seifert, 2008).  
Once the NADPH oxidase is assembled, control over the rate of enzyme 
activity could be exerted at a number of points: (i) NADPH biosynthesis, (ii), 
NADPH binding to the reactive site on gp91phox, (iii) NADP+ release, (iv) electron 
transfer from NADPH to O2, (v) O2 binding to its pocket, (vi) O2
- release and  
(vii) dismutation of O2
- to H2O2, which might prevent reversed electron flow.  It 
should be noted that NADPH must be regenerated continuously during the 
respiratory burst, which is believed to occur mainly via the hexose monophosphate 
shunt in PMNs, but for sure from intracellular glycogen breakdown (DeCoursey 
and Ligeti, 2005; Lee et al., 2003).   
In order to examine how Cc5 interferes with the oxidative burst in murine 
macrophages, it is noteworthy that cond. medium needs to be in contact with fresh 
macrophages for at least 4 h to block the oxidative burst.  This could eventually 
suggest that Cc5 reduces the expression of single NADPH oxidase subunits, the 
level of free NADPH in the cells, or that Cc5 interferes with the signalling cascade.  
Cc5 has been shown to feed on aminosugars present on cell surfaces (Mally et al., 
2008) and there are indications that Cc5 deglycosylates TLR4 (S. Ittig, personal 
communication).  These observations might be further indications, that Cc5 
possibly degrades receptors involved in the signalling cascade normally leading to 
the activation of the NADPH oxidase subunits, thereby preventing the assembly of 
the NADPH oxidase.  
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On the other hand, it is also possible that Cc5 interferes with signalling without 
preventing the assembly of the NADPH oxidase, but rather redirecting the 
localization of the NADPH oxidase away from the phagolysosomes towards the 
outer membrane.  Since Cc5 itself is highly resistant against phagocytosis by 
murine macrophages, it remains questionable whether release of ROS into the 
extracellular milieu would indeed be beneficial for the survival of C. canimorsus.   
By analyzing Cc5 cond. medium, we could demonstrate that one of the factors 
involved in preventing the oxidative burst is pitrilysin, a putative metallopeptidase 
containing an inverted zinc-binding motif.   
Zinc-containing metalloproteases are widely distributed from prokaryotes to 
eukaryotes and bacterial metalloproteases may fall into three families: thermolysin, 
serralysin and neurotoxin families of which prototype enzymes are produced by 
Bacillus thermoproteolytics, Serratia marcescens, or Clostridium tetani 
respectively (Miyoshi and Shinoda, 2000).  The majority of these zinc binding 
enzymes catalyze hydrolysis or closely related transfer reactions.  In a protein 
environment, tetrahedral or 5-coordinated Zn2+ is ideally suited to activate 
coordinated water or hydroxide as a nucleophile for attacking the carbonyl carbon 
of a peptide bond, the carbon CO2 or the phosphorus of a phosphate ester 
(Coleman, 1998).   
Pitrilysin from C. canimorsus belongs to one of the at least four families of zinc 
proteases that do not contain the classical HEXXH motif.  Besides the so-called 
pitrilysin family, these include the carboxypeptidase A family, the zinc D-Ala-D-Ala 
carboxypeptidases, and the aminopeptidases (Coleman, 1998).   
The periplasmic zinc oligopeptidase pitrilysin from E. coli (previously also 
called protease III and protease Pi, among others) is the founding member of this 
family (Roth, 2004; Swamy and Goldberg, 1982).  These proteases contain an 
inverted zinc-metalloprotease core motif (HXXEH) that is typically located within 
200 residues of the N-terminal, as well as a pair of glutamate residues that are 
located 70 and 77 aa distal to the core motif.  The conserved residues of this 
extended metalloprotease motif (HXXEHX69EX6E) are either catalytic or 
coordinate the enzyme’s catalytic zinc ion and are essential for activity (Becker 
and Roth, 1992).   
Pitrilysin from E. coli is the only protease of this family whose structure has 
been determined (PDB ID 1Q2L).  This revealed that the enzyme has two nearly 
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identically sized concave domains that are tethered by a linker region of 20-30 
residues (Maskos et al., 2005).  In vitro studies have demonstrated that pitrilysin 
from E. coli is a non-essential enzyme which cleaves insulin, glucagons, Aβ 
peptide, β-galactosidase fragments and certain short synthetic peptides (Alper et 
al., 2006; Cornista et al., 2004; Roth, 2004).  However, these substrates have 
been used as surrogate substrates for pitrilysin since its physiological targets are 
unknown.   
We could show so far that upon growth of Cc5 in the presence of cells, 
pitrilysin is released into the supernatant and cond. medium from a ∆pit mutant 
can no longer block the oxidative burst induced upon infection with E. coli, 
indicating that pitrilysin is involved in blocking the NADPH oxidase.  Biochemical 
characterization of pitrilysin from Cc5 is needed to understand its properties in 
vitro and purification of active pitrilysin could help identifying its interaction partners 
thereby giving hints on the mechanism how Cc5 blocks the oxidative burst.   
If pitrilysin can be purified, it might also be possible to analyze the effect of 
pitrilysin on human PMNs in order to understand whether Cc5 can also interfere 
with the oxidative burst in human PMNs.  However, it should be noted that in 
contrast to tissue resident macrophages, PMNs also contain granules filled with 
AMPs, which contribute to a non-oxidative killing of phagocytosed bacteria.  But as 
C. canimorsus encounters rather tissue resident macrophages than PMNs in its 
natural habitat, it might be of more importance for C. canimorsus to interfere with 
the oxidative burst.   
  
 
 
 
 
 
 
 
 
 
 
Chapter 4  
Interaction of C. canimorsus with 
human complement and PMNs 
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4.1. Summary 
We show here that Cc5 is resistant to phagocytosis and killing by human and 
dog PMNs and to killing by human and dog complement.  We furthermore 
demonstrate that complement resistance seems to be due to prevention of MAC 
deposition even though Cc5 becomes opsonized by C3b.   
Additionally, Ch. Fiechter isolated Y1C12, a Cc5 Tn mutant that is 
hypersensitive to killing by complement via the Ab-dependent classical pathway.  
The mutation inactivated a putative gtf gene, suggesting that the Y1C12 mutant is 
affected at the level of a capsular polysaccharide or LPS structure.  Indeed, M. 
Mally and U. Zaehringer could show that Cc5 appeared to have several 
polysaccharidic structures, one being altered in Y1C12.   
We here provide evidence that increased serum sensitivity of Y1C12 bacteria 
might be due to an increased deposition of MAC.  Besides, we also show that 
Y1C12 bacteria are more sensitive to phagocytosis and killing by human PMNs 
than Cc5 wild-type (wt) bacteria, thereby strengthening the observations that the 
mutant is affected in the outer membrane structure of the bacteria.   
Even if Cc5 was found to be completely resistant to phagocytosis by human 
PMNs at an moi of 50, Cc5 could not prevent the phagocytosis and killing of  
Y. enterocolitica ∆YscN bacteria upon co-infection of human PMNs.  This indicated 
that resistance observed at high moi is not due to a general interference with the 
phagocytosis ability of the cells.   
We demonstrate in addition that Cc5 induces the formation of NETs upon 
infection of human PMNs in vitro and that Cc5 is trapped and killed within NETs, 
indicating sensitivity of Cc5 towards AMPs present in PMN granules, which 
become embedded in NETs. 
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4.3. Additional results 
Cc5 does not interfere with phagocytosis of Y. enterocolitica ∆YscN 
bacteria upon co-infection 
As we have observed that Cc5 completely resists phagocytosis at high moi 
(moi of 50), but is phagocytosed up to ~40% at low moi (moi of 1) (Meyer et al., 
2008; Shin et al., 2009), we intended to determine, whether Cc5 also interferes 
with phagocytosis of other bacteria upon co-infection of human PMNs.  We thus 
co-infected freshly isolated human PMNs with Y. enterocolitica ∆YscN, a 
phagocytosis-sensitive strain due to inactivation of its T3SS (Meyer et al., 2008; 
Woestyn et al., 1994), at an moi of 1 and either Cc5 (moi of 50) or – as a  
control – E. coli (moi of 50).  As rates of phagocytosis and killing of bacteria can 
depend on the moi, we additionally infected PMNs with Y. enterocolitica ∆YscN 
bacteria at an moi of 50.   
 
 
Figure 1. Cc5 does not interfere with phagocytosis of ∆YscN bacteria upon co-infection 
Freshly isolated human PMNs were infected with Y. enterocolitica ∆YscN bacteria at either an moi 
of 1 or an moi of 50.  In addition, PMNs were co-infected with either Cc5 or E. coli at an moi of 50 if 
indicated.  Phagocytosis and killing of Y. enterocolitica ∆YscN was determined by survival plating  
2 h after infection.  Means and standard deviations of three independent experiments are shown. 
 
Upon 2 h of infection at an moi of 1, ~65 % Y. enterocolitica ∆YscN bacteria 
were phagocytosed and ~60% were killed by human PMNs.  At an moi of 50, rates 
of phagocytosis and killing were with ~60% and ~50%, respectively, slightly lower 
but not significantly different.  Phagocytosis and killing of ∆YscN bacteria was 
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neither significantly affected if PMNs were co-infected with Cc5 at an moi of 50, 
nor if PMNs were co-infected with E. coli at an moi of 50 (Figure 1).  This indicated 
that Cc5 can prevent its own phagocytosis at high moi (Meyer et al., 2008; Shin et 
al., 2009), but not phagocytosis of other bacteria.   
Cc5 resists phagocytosis and killing by dog PMNs 
We have shown previously, that Cc5 is even more resistant to phagocytosis 
and killing by human PMNs than Y. enterocolitica, and that phagocytosis 
resistance is increased at increasing moi (Shin et al., 2009).  We were therefore 
interested, whether Cc5 is also resistant to phagocytosis and killing by dog PMNs.  
Thus, we infected freshly isolated dog PMNs at low and high moi (1 and 50, 
respectively) and determined phagocytosis and killing of Cc5 within 2 h of infection 
by survival plating. 
 
 
Figure 2. Cc5 is resistant to phagocytosis and killing by dog PMNs at high moi 
Freshly isolated dog PMNs were infected with Cc5 at the indicated moi.  2 h after infection, 
phagocytosis and killing were determined by survival plating.  Means and standard deviations of 
four independent experiments are shown.   
 
Comparably to phagocytosis and killing by human PMNs (Shin et al., 2009), 
~33% Cc5 bacteria were phagocytosed and ~22% were killed within 2 h of 
infection at low moi, whereas Cc5 bacteria were completely resistant to 
phagocytosis and killing by dog PMNs at high moi (Figure 2).  These findings 
suggested that Cc5 also resist phagocytosis by PMNs in their natural habitat, the 
oral cavity of dogs, which may help the bacteria to reside inside the dog’s mouth. 
Chapter 4 
 
 - 79 - 
Cc5 is sensitive to NET-dependent killing 
As it has been shown recently that PMNs form NETs upon infection, which trap 
and kill extracellular bacteria (Brinkmann et al., 2004), we were interested whether 
Cc5 also resists killing by NETs.   
In order to test if we can artificially induce NET formation, we triggered NET 
formation by the addition of PMA and observed DNA release by staining with 
Sytox, a cell impermeant green fluorescent DNA binding dye.  Analysis of DNA 
release with a fluorescent plate reader showed that PMNs indeed released DNA 
upon PMA stimulation (Figure 3.A).   
In a next step, we wanted to see, whether the released DNA formed NETs.  
We thus analyzed untreated and PMA treated PMNs either by 
immunofluorescence, staining DNA with Hoechst, or by scanning electron 
microscopy (SEM) and we could thereby observe formation of NETs upon PMA 
stimulation (Figure 3.B-E).   
As we could artificially induce NET formation, we wanted to examine whether 
Cc5 and the Cc5 Tn mutant Y1C12 induced NET formation upon infection.  Thus, 
we infected human PMNs at an moi of 1 with either Cc5 or Y1C12 bacteria. As 
negative control, we used untreated PMNs and as positive control, PMNs were 
treated with PMA.  Infection of PMNs for 3 h with either Cc5 or Y1C12 bacteria 
strongly induced DNA release as observed by Sytox staining of extracellular DNA 
(Figure 4.A).  In a next step, we wanted to know, whether the release of DNA upon 
infection with Cc5 or Y1C12 is only triggered by viable bacteria, or whether HI 
bacteria also induce DNA release.  Analysis of DNA release after infection of 
PMNs for 3 h at an moi of 1 with HI bacteria revealed that both, HI Cc5 as well as 
HI Y1C12 bacteria induced the release of DNA (Figure 4.A), suggesting that  
C. canimorsus passively induced NET formation upon infection of human PMNs.   
We thus analyzed by SEM, whether the observed DNA release upon infection 
with C. canimorsus corresponded to NET formation.  Hence, we infected human 
PMNs for 2 h with either Cc5 or Y1C12 bacteria at an moi of 1.  We observed that 
Cc5 and Y1C12 both induced the formation of NETs (Figure 4.B-C).  As bacteria 
were found to be covered within NETs, this indicated that the bacteria might be 
bound by NETs and therefore might be in contact with the AMPs bound to the NET 
DNA backbone. 
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Figure 3. PMNs form NETs upon stimulation with PMA 
(A) DNA release was quantified by Sytox staining of untreated PMNs and PMA treated PMNs.  
Mean values from three independent experiments and standard deviation are shown including 
statistical significance in comparison to untreated PMNs with ** p < 0.01 using unpaired, two-tailed 
Student’s t test.  (B) Untreated PMNs were stained with Hoechst and analyzed on a Leica Dmire2 
microscope.  (C) PMA-treated PMNs were stained and analyzed as in (B).  (D) Untreated PMNs 
analyzed by SEM.  (E) PMA treated PMNs analyzed by SEM. 
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Figure 4. Cc5 and Y1C12 induce NET formation in vitro 
(A) PMNs were infected for 3 h with Cc5 or Y1C12 bacteria at an moi of 1.  DNA release was 
quantified by Sytox staining.  Untreated PMNs were used as negative control and NET formation 
was induced by PMA as positive control.  Mean values from three independent experiments and 
standard deviations are shown including statistical significance in comparison to untreated PMNs 
with ** p < 0.01 and *** p < 0.001 using unpaired, two-tailed Student’s t test.  (B) Human PMNs 
were infected for 2 h with Cc5 at an moi of 1 and analyzed by SEM.  Right panel shows a 
magnified detail of left panel.  (C) Human PMNs were infected for 2 h with Y1C12 at an moi of 1 
and analyzed by SEM.  Right panel shows a magnified detail of left panel.   
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In order to analyze whether Cc5 and Y1C12 bacteria were sensitive to NET-
dependent killing, we infected PMA stimulated and Cyt. D treated (block of the 
actin cytoskeleton, thereby preventing phagocytosis) human PMNs for 2 h with 
bacteria at an moi of 1 and determined extracellular killing by survival plating.  In 
order to prevent NET degradation by human serum, we reduced the serum 
concentration from 10% to 2% compared to normal phagocytosis assays.  We 
observed that ~30% Cc5 and ~40% Y1C12 bacteria were killed within 2 h.  To 
exclude that extracellular killing of the bacteria was NET-independent, we 
additionally pre-treated PMNs with DNase to degrade NETs, which completely 
prevented killing of bacteria. This suggested that bacteria were killed by NETs 
upon infection of PMA and Cyt. D treated PMNs (Figure 5).   
 
 
Figure 5. Cc5 and Y1C12 are sensitive to NET-dependent killing 
Extracellular killing of bacteria was determined 2 h after infection at an moi of 1 by survival plating.  
NET formation was stimulated by pre-treatment of PMNs with PMA and phagocytosis was 
prevented by the addition of Cyt. D (black).  As control, NETs were degraded by the addition of 
DNase before infection (white).  Mean values from three or more independent experiments and 
standard deviation are shown.  Statistical significance compared to Cc5 is shown with ** p < 0.01 
using two-tailed, unpaired Student’s t test. 
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4.4. Materials and methods 
Bacterial strains and growth conditions 
Bacteria were grown as described (Meyer et al., 2008).   
Selective agents 
To select for strains and transposons, antibiotics were added at the following 
concentration: 10 µg/ml Em, 20 µg/ml Gm, 3.5 µg/ml Na and 10 µg/ml Sm. 
Isolation of PMNs 
Human or dog PMNs were isolated from healthy donors using the dextran-
Percoll protocol, adapted with modifications described previously (Jepsen and 
Skottun, 1982).  Contaminating erythrocytes were removed by hypotonic lysis with 
“aqua ad iniectabilia” (Bichsel). 
Co-infection of human PMNs 
Freshly isolated human PMNs were resuspended at 107 ml-1 in D-PBS (Gibco) 
supplemented with 10% Ab-depleted HI NHS (Scipac Ltd.) and infected with 
bacteria as indicated.  In vitro phagocytosis and killing assay was continued as 
described (Shin et al., 2009). 
In vitro phagocytosis and killing assay with dog PMNs 
Freshly isolated dog PMNs were resuspended at 107 ml-1 in D-PBS (Gibco) 
supplemented with 10% Ab-depleted HI NHS (Scipac Ltd.) and in vitro 
phagocytosis and killing assay was continued as described (Shin et al., 2009). 
Quantification of DNA released by activated PMNs 
The assay was adapted from (Gupta et al., 2005).  Briefly, freshly isolated 
human PMNs were resuspended in D-PBS (Gibco) supplemented with  
2% Ab-depledet HI NHS (Scipac Ltd.).  The cells were seeded into 96-well 
microtiter plates (2 x 105 cells/well, Falcon) and either stimulated with PMA (25 
nM, Sigma) for 30 min, or infected with bacteria at an moi of 1 for 3 h at 37 °C and 
5% CO2 in a humidified incubator.  After incubation, Sytox green (10 µM, Molecular 
Probes), a cell impermeant DNA binding dye, was added to the cells to detect 
extracellular DNA.  Untreated PMNs were used as control.  Fluorescence was 
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determined at 485 nm and detected with a Wallac Victor2 1420 Multilabel counter 
(Perkin Elmer).   
Immunofluorescence analysis of DNA release 
Falcon culture slides (Becton Dickinson) were coated with poly-D-lysine.  
Freshly isolated human PMNs were prepared in RPMI 1640 (Invitrogen) 
supplemented with 2% Ab-depleted HI NHS (Scipac Ltd.) and 2 mM L-glutamine 
(hRPMI) at a concentration of 106 ml-1.  Slides were washed 3x with D-PBS 
(Gibco).  500 µl of the PMN suspension were added to the slides and incubated for 
1 h at 37 °C and 5% CO2 in a humidified incubator.  If necessary, PMNs were 
thereafter incubated for 30 min with 25 nM PMA (Sigma) to induce NET formation.  
Slides were fixed with 4% PFA for 1 h at 37 °C.  Slides were then washed 2x with 
D-PBS and blocked o/n at 4 °C with PBS containing 3% BSA.  DNA was labelled 
by incubation with Hoechst (1:10000, Sigma) for 30 min at RT in the dark.  Slides 
were washed 3x with PBS and once with ddH2O before mounting with VectaShield 
Hard Cover Mounting Medium (Vector).  Slides were analyzed by use of a Leica 
Dmire2 microscope at 40x magnification.  Pictures were taken with a digital 
camera (Hamatsu Photonics) and OpenLab software (version 3.1.2). 
SEM analysis of NET formation 
SEM analysis of NET formation was adapted from (Gupta et al., 2005).  In 
brief, freshly isolated human PMNs were resuspended in D-PBS (Gibco) 
supplemented with 2% Ab-depledet HI NHS (Scipac Ltd.).  The cells were seeded 
on 12 mm 0.001% poly-D-lysine coated coverslips in 24-well microtiter plates  
(106 cells/well, Falcon).  The medium was replaced with hRPMI and bacteria were 
added at an moi of 1.  After 2 h of infection at 37 °C and 5% CO2, samples were 
fixed with 2.5% glutaraldehyde and dehydrated with graded ethanol series  
(30%, 50%, 70%, and 100%).  After dehydration and critical-point drying, the 
specimens were coated with 2 nm platinum-film and analyzed on a Philips XL-30 
ESEM scanning electron microscope at the ZMB, Biozentrum, University of Basel. 
In vitro analysis of NET-dependent killing 
The protocol was adapted from (Urban et al., 2006).  Freshly isolated human 
PMNs were resuspended at 106 ml-1 in D-PBS (Gibco) supplemented with  
2% Ab-depleted HI NHS (Scipac Ltd.).  To induce NET formation, PMNs were 
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incubated for 30 min with 25 nM PMA (Sigma) at 37 °C and 5% CO2.  Cyt. D  
(10 µg/ml, Sigma) was added for 20 min before infection to block phagocytosis.  
Bacteria were added at an moi of 1 to PMNs.  To determine killing, samples were 
taken at 2 h after infection, diluted in ddH2O and plated.  As control, NETs were 
degraded by incubation with 50 U/ml of RNase-free and protease-free DNase-1 
(Worthington) prior to the addition of bacteria.  To determine reference values, an 
equal number of bacteria was incubated without PMNs.  The survival rate was 
calculated by reference to the sample without PMNs.   
Statistical analysis 
For all experiments, means and standard deviations were calculated.  
Statistical significance was evaluated using two-tailed, unpaired Student’s t test.  
Differences were considered to be significant when p < 0.05 with * p < 0.05,  
** p < 0.01 and *** p < 0.001. 
4.5. Discussion 
We could demonstrate that Cc5 is even more resistant to phagocytosis and 
killing by human PMNs than Y. enterocolitica, which is considered a model 
organism for phagocytosis resistance due to its T3SS (Grosdent et al., 2002).  
This resistance of Cc5 was decreased upon disruption of a putative gtf gene by a 
Tn in Cc5 mutant Y1C12, which led to an altered outer membrane structure.  
These findings go in line with the observation that Cc5 is highly resistant to 
phagocytosis and killing by murine macrophages (Meyer et al., 2008), whereas 
Y1C12 is not.  In addition, we observed that Cc5 also resists phagocytosis and 
killing by dog PMNs, which suggests, that Cc5 also resists phagocytosis in its 
natural habitat, the oral cavity of dogs. 
We also show that Cc5 is highly resistant to killing by human complement, as 
the bacteria prevent the deposition of MAC by virtue of their LPS.  This was 
supported by the observation that Y1C12 mutant bacteria were serum sensitive 
due to an increased MAC deposition.  All these findings suggest that Cc5 has a 
highly protective outer membrane structure shielding the bacteria not only from 
MAC deposition, but also preventing phagocytosis by professional phagocytes.  
Thereby the bacteria maybe not only promote their survival within their natural 
habitat, but also within patients.   
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Complement resistance of C. canimorsus was analyzed so far for strains Cc5, 
Cc11 and Cc12 and all of them displayed a high serum resistance.  This was in 
contrast to an old study on the serum sensitivity of oral Capnocytophaga spp. 
isolates, which indicated that these bacteria might be sensitive to the classical 
complement pathway (Wilson et al., 1985).  However, in a following study, oral and 
blood derived Capnocytophaga strains were tested for their serum sensitivity and 
an increased serum-resistance was observed in blood derived strains. This 
observation correlated with different electrophoretic mobilities of the examined 
LPS, indicating that serum resistance might be a virulence trait (Wilson et al., 
1987).  As the three C. canimorsus strains tested here were all derived from 
human cases, further analysis should be done on human case strains in 
comparison to strains isolated from healthy dogs.  Comparison of the outer 
membrane structure composition and the prevalence of serum resistance in case 
strains and in dog isolates could eventually reveal more information about this 
potential virulence trait in C. canimorsus.   
As we observed that Cc5 displays an increasing resistance to phagocytosis by 
either murine macrophages (Meyer et al., 2008) or human PMNs with increasing 
moi, we suggested that Cc5 might interfere with the phagocytosis ability of the 
phagocytes.  We therefore co-infected human PMNs with Cc5 (moi of 50) and  
Y. enterocolitica ∆YscN bacteria (moi of 1), but this did not affect phagocytosis and 
killing of ∆YscN bacteria.  This suggested that Cc5 actively prevents its own 
phagocytosis, but does not generally interfere with phagocytosis.  This result is in 
good agreement with the previous observation that upon prolonged infection of 
murine macrophages with Cc5 (moi of 50), killing, but not phagocytosis of E. coli 
bacteria, is prevented (Meyer et al., 2008).   
All together, our findings implicate that Cc5 possesses at least three 
mechanisms by which the bacteria interfere with phagocytosis by professional 
phagocytes.  First, Cc5 seems to have an unreactive outer membrane structure, 
which is not readily recognized by PRRs on phagocytes, as unopsonized Cc5 are 
highly resistant to phagocytosis and killing by professional phagocytes.  Second, 
we observed that Cc5 bacteria display an increased phagocytosis resistance at 
increasing moi, but do not prevent phagocytosis of other bacteria.  This 
implements that Cc5 bacteria actively interfere with their own uptake in a dose-
dependent manner, but do not generally interfere with the ability of phagocytes to 
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engulf bacteria.  And third, we demonstrated that Cc5 can interfere with the killing 
ability of murine macrophages (Meyer et al., 2008) by blocking the oxidative burst 
normally induced upon phagocytosis.  This capacity does not affect phagocytosis 
of other bacteria and was found to be dependent on the release of the putative 
metallopeptidase pitrilysin. 
Interestingly, not only Y1C12 mutant bacteria, but also Cc5 was found to 
induce the formation of NETs upon infection of human PMNs at an moi of 1 in 
vitro.  Both strains were observed to be sensitive to NET-dependent killing, even if 
Y1C12 mutant bacteria displayed an increased sensitivity compared to Cc5 
bacteria. This might be due to the altered outer membrane structure of Y1C12 
bacteria, rendering the bacteria more accessible and therefore more sensitive to 
the antimicrobial activity of AMPs bound to NETs.   
As we have shown that Cc5 bacteria are sensitive to trapping and killing by 
NETs, these findings indicated that the bacteria display some sensitivity against 
AMPs.  These results are in good agreement with another study where  
C. sputigena ATCC 33123, C. gingivalis ATCC 33124 and C. ochracea  
ATCC 27872 were shown to be sensitive to the bactericidal activity of synthetic  
LL-37, a cathelicidin, indicating sensitivity of Capnocytophaga spp. to AMPs 
(Tanaka et al., 2000). 
However, it has been shown recently that formation of NETs requires the 
production of ROS in vivo (Fuchs et al., 2007).  As we have discovered that Cc5 
can block the NADPH oxidase in murine macrophages upon prolonged infection in 
vitro, it might be interesting to examine whether Cc5 can also block the oxidative 
burst in human PMNs and whether the bacteria thereby also prevent the formation 
of NETs.  This could help C. canimorsus establishing a systemic infection in 
humans and might thus contribute to virulence.  As examination of this mechanism 
still requires a 4 h pre-treatment of the macrophages with Cc5 cond. medium, 
these questions could so far not be addressed as human PMNs quickly die after 
isolation.  A study on the prevalence of the capability of blocking the killing ability 
of macrophages could give further hints on whether this mechanism might 
contribute to virulence in humans and should therefore be conducted.   
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5.1. Summary 
In this chapter we provide evidence that C. canimorsus strains have strain 
variability with respect to hypothetical virulence functions.  A collection of 69 
strains (8 human case isolates and 61 dog isolates) were analyzed in collaboration 
with L. Soussoula for their ability to prevent killing of E. coli by murine 
macrophages.  59% of the strains (50% of case strains, 61% of dog isolates) 
displayed this phenotype.  As the 2 C. cynodegmi control strains also had this 
property, this indicated that this capability might rather be a species trait than a 
capacity uniquely linked to virulence.   
M. Mally determined sialidase activity and found this to be present in all strains 
outlining the importance of sialidase for the survival of the bacteria in their natural 
habitat.  Additionally, M. Mally provided evidence that thorough sequence analysis 
is needed in order to correctly distinguish C. canimorsus from C. cynodegmi 
strains as they share high sequence similarity and she revealed the existence of a 
new clade of C. canimorsus.  Furthermore, M. Mally demonstrated that analysis of 
carbohydrate fermentation as a tool for species identification is unreliable.  H. Shin 
demonstrated that the ability to suppress NO release in macrophages is a rare 
property.   
Screening of the C. canimorsus library for serum resistance in collaboration 
with C. Paroz revealed that 60% of the strains were highly serum resistant (100% 
of case strains, 54% of dog isolates), indicating that serum resistance is 
widespread among C. canimorsus strains, but necessary for establishing an 
infection in humans.   
As we have shown that serum resistance is linked to a polysaccharidic 
structure in Cc5, we were interested whether there is a specific structure in  
C. canimorsus, which might be responsible for serum resistance.  Analysis of the 
polysaccharidic structures of all strains in collaboration with C. Paroz showed a 
high strain heterogeneity which did not obviously correlate with serum resistance.   
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5.2. Publication 
 
Prevalence of Capnocytophaga canimorsus in dogs and occurrence of 
potential virulence factors 
 
Microbes and Infection 11 (2009) 509-514 
 
Manuela Mally*, Cécile Paroz*, Hwain Shin*, Salome Meyer*, Lavinia Soussoula, 
Ueli Schmiediger, Caroline Saillen-Paroz and Guy R. Cornelis 
 
* Contributed equally to this work 
 
Statement of my work.  My contribution was the data on the ability of the C. canimorsus strains to 
block the killing of E. coli by J774.1 macrophages (summarized in Table 1).   
Data on suppression of the killing ability was generated in collaboration with L. Soussoula. 
Data on 16srDNA sequence, carbohydrate fermentation and sialidase activity was contributed by 
M. Mally in collaboration with C. Paroz.  Data on suppression of NO release was contributed by  
H. Shin in collaboration with C. Paroz.  Strains were collected by U. Schmiediger and C. Saillen-
Paroz.  
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5.3. Additional results 
Serum resistance varies in C. canimorsus strains 
As we have shown previously that the three human case isolates Cc5, Cc11 
and Cc12 are highly resistant to killing by human complement (Shin et al., 2009), 
we wanted to examine whether this is a species property, or whether complement 
resistance might be a virulence determinant. 
Hence, C. Paroz incubated C. canimorsus case isolates (Cc) and  
C. canimorsus dog strains (CcD) with either HI NHS or NHS and compared colony 
forming units (cfu) after 3 h of infection.  We observed that 100% of the human 
case strains (8/8) and 54% of the dog isolates (33/61) were highly resistant to 
killing by human complement (reduced by less than 1 log10) (Table 1).  These 
findings indicated that serum resistance might indeed be an important virulence 
determinant. 
C. canimorsus strains display outer membrane structure heterogeneity 
As we have shown evidence that serum resistance of Cc5 is linked to the 
polysaccharidic structure of the bacteria (Shin et al., 2009), we were interested 
whether there is a specific polysaccharidic structure in C. canimorsus, which is 
linked to serum resistance.  C. Paroz therefore analyzed proteinase K-treated 
samples of all C. canimorsus strains by tricine SDS-PAGE and either periodic 
acid/silver staining (Figure 1) or immunoblotting with α-Cc5 Ab (data not shown).   
It has been previously shown that Cc5 comprises 4 polysaccharidic structures 
purified by proteinase K digest (Shin et al., 2009).  As bands A and B were not 
present in an LPS purification, this suggested that those two polysaccharidic 
structures probably do not represent LPS, but maybe a capsule.  Bands C and D 
were identified in an LPS purification indicating that these two bands might 
represent two LPS structures of Cc5 (Shin et al., 2009).  Even though serum 
sensitivity of Cc5 gtf mutant Y1C12 could be linked to band C (Shin et al., 2009), 
C. canimorsus strains displayed a high polysaccharide structure heterogeneity 
(Figure 1) which did not obviously correspond to serum resistance (Table 1). 
 
 
Chapter 5 
 - 98 - 
Strain Serum sensitivity 
a
 Strain Serum sensitivity 
a
 
CcD88 
CcD103 
CcD79 
CcD85 
CcD50 
CcD46 
CcD71 
CcD82 
CcD102 
CcD1 
CcD75 
CcD11 
CcD36 
CcD64 
CcD4 
Cc9 
b
 
CcD95 
CcD94 
CcD97 
CcD76 
CcD63 
CcD34 
CcD38 
CcD89 
Cc5 
b
 
CcD7 
CcD66 
CcD43 
CcD53 
Cc2 
b
 
Cc3 
b
 
CcD16 
CcD96 
CcD68 
Cc7 
b
 
-0.267 ± 0.549 
0.073 ± 0.136 
0.077 ± 0.028 
0.088 ± 0.217 
0.096 ± 0.024 
0.130 ± 0.091 
0.136 ± 0.087 
0.147 ± 0.048 
0.159 ± 0.159 
0.167 ± 0.114 
0.208 ± 0.135 
0.212 ± 0.162 
0.216 ± 0.194 
0.235 ± 0.295 
0.246 ± 0.019 
0.296 ± 0.076 
0.301 ± 0.124 
0.303 ± 0.142 
0.339 ± 0.064 
0.372 ± 0.117 
0.391 ± 0.109 
0.393 ± 0.181 
0.416 ± 0.162 
0.437 ± 0.132 
0.439 ± 0.140 
0.502 ± 0.139 
0.512 ± 0.253 
0.530 ± 0.101 
0.569 ± 0.258 
0.589 ± 0.156 
0.636 ± 0.059 
0.662 ± 0.126 
0.808 ± 0.221 
0.833 ± 0.247 
0.853 ± 0.124 
CcD35 
Cc10 
b
 
Cc11 
b
 
CcD93 
CcD77 
Cc12 
b
 
CcD33 
CcD80 
CcD5 
CcD18 
CcD51 
CcD54 
CcD57 
CcD84 
CcD39 
CcD40 
CcD81 
CcD104 
CcD106 
CcD10 
CcD101 
CcD3 
CcD105 
CcD13 
CcD58 
CcD37 
CcD25 
CcD69 
CcD73 
CcD52 
CcD6 
CcD44 
CcD20 
CcD47 
 
0.863 ± 0.289 
0.877 ± 0.120 
0.880 ± 0.162 
0.885 ± 0.230 
0.952 ± 0.068 
0.971 ± 0.063 
1.101 ± 0.206 
1.185 ± 0.156 
1.202 ± 0.451 
1.245 ± 0.163 
1.297 ± 0.267 
1.361 ± 0.149 
1.406 ± 0.240 
1.449 ± 0.261 
1.466 ± 0.211 
1.694 ± 0.215 
1.823 ± 0.089 
1.924 ± 0.038 
1.926 ± 0.087 
1.969 ± 0.188 
1.970 ± 0.166 
2.063 ± 0.096 
2.136 ± 0.219 
2.205 ± 0.520 
2.209 ± 0.227 
2.243 ± 0.073 
2.243 ± 0.278 
2.272 ± 0.467 
2.321 ± 1.175 
2.366 ± 0.324 
2.514 ± 0.166 
2.736 ± 0.321 
2.801 ± 0.176 
3.042 ± 0.309 
 
Table 1. Serum sensitivity of C. canimorsus strains 
a  
Log10 reduction and standard deviations analyzed after 3 h of incubation with NHS.   
b
  Human case strains are highlighted in yellow.   
Strains reduced by less than 1 log10 were considered to be serum resistant.  Means and standard deviations 
of at least three independent experiments are shown. 
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Figure 1. C. canimorsus strain heterogeneity in outer membrane structure  
Silver periodic acid staining analysis of Tricine gel electrophoresis of proteinase K-treated  
C. canimorsus strains.  
 
5.4. Materials and methods 
Bacterial strains and media 
Bacteria were grown as described (Shin et al., 2007). 
Selective agents 
To select for C. canimorsus strains, Gm was added to a concentration of 20 
µg/ml. 
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Serum sensitivity 
Serum sensitivity was determined as published (Shin et al., 2009).  Means and 
standard deviations of at least three independent experiments are shown. 
Preparation of proteinase K-resistant samples 
Samples were prepared as described (Shin et al., 2009) and loaded onto a 
16% Tricine-SDS-PA gel.  Analysis was done by immunoblotting with α-Cc5 Ab 
(Shin et al., 2009) or silver-periodic acid staining (Tsai and Frasch, 1982). 
5.5. Discussion 
As we observed that Cc5 resists killing by human complement (Shin et al., 
2009), we were interested whether serum resistance is a common trait in  
C. canimorsus or whether this capacity is linked to virulence.  Previous studies on 
the serum sensitivity of oral Capnocytophaga spp. isolates indicated that these 
bacteria might be sensitive to the classical complement pathway (Wilson et al., 
1985).  Additionally, it has been shown that blood derived strains displayed a 
higher serum resistance compared to oral isolates, coming along with different 
electrophoretic mobility of LPS (Wilson et al., 1987).  This suggested that indeed 
serum resistance might be a virulence trait in Capnocytophaga spp..  We observed 
that 100% of the human case strains, but only 54% of the dog isolates were highly 
resistant to killing by human complement.  These findings indicated that even if 
serum resistance is widespread among C. canimorsus strains, it is necessary for 
establishing an infection in humans.  As our findings are in good agreement with a 
previous study on blood-derived Capnocytophaga spp. strains (Wilson et al., 
1987), this suggested that serum resistance is not necessary for survival of 
Capnocytophaga spp. in their natural habitat, but is an important virulence trait.   
Gram-negative bacteria, including closely related P. gingivalis (Slaney et al., 
2006), are well known to prevent killing by human complement by virtue of their 
polysaccharidic structures, either by steric hindrance of MAC deposition or by 
binding fH, eventually through decoration with sialic acid residues (Frank et al., 
1987; Rautemaa and Meri, 1999).  As our data suggested that Cc5 rather sterically 
prevents MAC deposition (Shin et al., 2009), we analyzed the polysaccharidic 
outer structures of C. canimorsus human case strains and isolates from healthy 
dogs by silver periodic acid staining and immunoblotting of proteinase K-treated 
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samples.  Interestingly, C. canimorsus strains displayed a high polysaccharidic 
outer structure heterogeneity, which did not obviously correlate with serum 
resistance.  More detailed analysis of operons involved in LPS or capsule 
formation and hypothetical sialic acid decoration is therefore needed to clarify the 
origin of serum resistance in C. canimorsus.   
  
 
 
 
 
 
 
 
 
 
 
Chapter 6  
Addendum: 
YadA confers NET sensitivity to Y. enterocolitica 
Chapter 6 
 
 - 103 - 
6.1. Summary 
Studying the interaction of Cc5 with NETs, we also observed that  
Y. enterocolitica wt bacteria were readily trapped and killed within NETs, whereas 
Y. enterocolitica ∆YadA bacteria were neither trapped nor killed by NETs, even if 
both bacteria induced formation of NETs in vitro.  Binding of Y. enterocolitica to 
NETs was found to be dependent on the collagen binding sites of Yersinia adhesin 
A (YadA).  In addition, we could provide evidence for the presence of collagen 
within or closely associated to NET structures.  These findings indicated that 
binding to NETs is essential for rendering the bacteria accessible to AMPs present 
on the DNA backbone of the NETs.  As it has been discovered previously that 
YadA only exists as a pseudogene in Yersinia pestis, which increased the 
virulence of these bacteria (Rosqvist et al., 1988), we determined NET-sensitivity 
of Y. pestis.  Interestingly, Y. pestis EV76 bacteria were resistant to killing by 
NETs but became sensitive upon the expression of yadA in trans.  These 
observations provide an example that virulence factors may always have a cost for 
the pathogen, thereby displaying the close evolutionary relation between 
pathogens and their virulence factors on side and the human immune system on 
the other side. 
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6.2. Manuscript in preparation 
 
Oligomeric coiled-coil adhesin YadA is a double-edged sword 
 
Manuscript in preparation 
 
Salome Casutt-Meyer and Guy R. Cornelis 
 
Statement of my work.  My contribution included all data; In vitro induction of NET formation upon 
infection of human PMNs and sensitivity of bacteria to NET-dependent killing.  In addition,  
I analyzed the presence of collagen in NETs and the serum resistance of the different strains. 
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Abstract 
YadA (Yersinia adhesin A) is an important virulence factor for the food-borne 
pathogens Yersinia enterocolitica and Yersinia pseudotuberculosis.  
Surprisingly, yadA is a pseudogene in Yersinia pestis.  Even more intriguing, 
the introduction of a functional yadA gene correlates with a decrease of the 
virulence of Y. pestis.  Here we show that YadA makes Yersinia sensitive to 
killing by the neutrophil extracellular traps (NETs) produced by leukocytes.  
By providing an explanation as for why evolution selected for the 
inactivation of yadA in Y. pestis, this observation clarifies an old enigma.  It 
also illustrates the complexity of host-pathogen interactions. 
 
Adhesins are adherence factors essential to the virulence of many pathogenic 
bacteria (1).  YadA (Yersinia adhesin A) from the food-borne pathogens Yersinia 
enterocolitica and Yersinia pseudotuberculosis is the archetype of a family of 
coiled-coil oligomeric protein adhesins also encountered in Neisseria (NadA), 
Moraxella (UspAs), Haemophilus (Hia) and Bartonella (BadA) (2).  It is encoded on 
the same virulence plasmid as the type-III secretion system (T3SS) and its 
expression is co-regulated with that of the T3SS, suggesting an important role in 
pathogenesis (3).  Indeed, YadA promotes docking to animal cells and hence 
facilitates T3S.  It also confers adherence to extracellular matrix components, the 
capacity to invade non-phagocytic cells, resistance to phagocytosis by 
polymorphonuclear leukocytes (PMNs) and resistance to complement (4).  It thus 
came as a surprise that yadA is a pseudogene in the flea-borne Yersinia pestis, 
the causative agent of plague (5, 6).  Even more intriguing, the introduction of a 
functional yadA gene (originally called yopA) correlates with a decrease of the 
virulence of Y. pestis in a mouse model (5).  These results imply that YadA 
imposes a cost to Yersinia in the host, which led to its disappearance by natural 
selection.  The cost of this was however, not known so far.   
Here we show that YadA makes Yersinia sensitive to killing by neutrophil 
extracellular traps (NETs) (7).  Upon contact with human PMNs, Y. enterocolitica 
E40 bacteria induced the formation of NETs (Fig. 1A and S1A) and became 
trapped in fibers (Fig. 1A).  In agreement with this, ~40% of bacteria were killed 
(Fig. 1C).  yadA knockout (∆YadA) Y. enterocolitica E40 bacteria also induced the 
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formation of NETs (Fig. 1B and S1A) but in contrast to wt bacteria, they were 
neither trapped (Fig. 1B) nor killed (Fig. 1C).  This experiment revealed, for the 
first time, that YadA has some negative effect for the pathogen.  To test whether 
this negative effect could help explaining why yadA is a pseudogene in Y. pestis 
EV76, we set out to test if the original YadA from Y. pestis had this property.  We 
expressed YadA from a Y. pseudotuberculosis strain (94% similar to frame-shift 
corrected YadA from Y. pestis EV76) (YadAΨtb) in ∆YadA Y. enterocolitica and 
found that indeed, ∆YadA Y. enterocolitica E40 bacteria expressing YadAΨtb 
regained the sensitivity to NETs (Fig. 1C).  Consistently, wt Y. pestis EV76 were 
resistant to attachment (Fig. S1B) and killing by NETs but they became sensitive 
upon introduction of the functional yadA gene from Y. enterocolitica E40 (yadAE40) 
or from Y. pseudotuberculosis (yadAΨtb) (Fig. 1C).  Since the scanning electron 
micrographs (Fig. 1A, B) suggested that sensitivity to NETs correlates with 
attachment, we investigated whether NETs contain substrates to which YadA is 
known to bind.  We found that NETs contain collagen (Fig. 1D), and to test 
whether collagen was responsible for the attachment of YadA to NETs, we 
substituted from YadAE40 six of the eight NSVAIG-S sites required for collagen 
binding (8).  Substitution of these sites did not affect folding and insertion into the 
outer membrane since ∆YadA Y. enterocolitica expressing the modified YadA 
proteins were resistant to killing by human serum (Fig. S1D).  Likewise, in an 
electrophoretic analysis, the modified YadA proteins behaved like the wt YadA 
multimers (not shown).  However, none of the truncated adhesins conferred NET 
sensitivity, indicating a strong correlation between the ability of YadA to bind to 
collagen and to promote sensitivity to NETs (Fig. 1C). 
In conclusion, these observations demonstrate that adherence to collagen has 
a cost, which may explain why yadA is a pseudogene in Y. pestis.  They also show 
that virulence factors can be double-edged swords, illustrating the complexity of 
host-pathogen interactions.   
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Legend to Fig. 1 
YadA renders Y. enterocolitica and Y. pestis sensitive to NET-dependent 
killing.  (A) Scanning electron micrograph (SEM) of Y. enterocolitica E40 wt 
bacteria (expressing YadA) trapped in NETs after 120 min infection at an moi of 1.  
(B) Y. enterocolitica E40 ∆YadA bacteria induce NET formation but are not 
trapped (same conditions as in A) (SEM).  (C) % of Y. enterocolitica E40 and Y. 
pestis EV76, expressing YadAE40, YadAE40 depleted from one of the eight 
NSVAIG-S motifs (M1, M3, M4, M6, M7, M8) or YadAΨtb, killed by PMA-triggered 
NETs (120 min infection at an moi of 1).  Phagocytosis was prevented by the 
addition of Cytochalasin D.  Mean values from three or more experiments and 
standard deviations are shown.  Statistical significance is shown with *** p < 0.001 
using one-way ANOVA.  Statistical significance is shown in comparison to wt Y. 
enterocolitica for all Y. enterocolitica strains and in comparison to wt Y. pestis for 
all Y. pestis strains.  (D) Immunofluorescence analysis of NETs formed upon 
infection of PMNs with Y. enterocolitica E40 (120 min at an moi of 1).  DNA (blue) 
and collagen (green). 
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Legend to Fig. S1 
(A) Y. enterocolitica induces DNA release upon infection of PMNs.  PMNs were 
infected for 120 min with Y. enterocolitica E40 wt or ∆YadA at an moi of 1.  DNA 
release was quantified by Sytox staining.  Untreated PMNs were used as negative 
control and NET formation was induced by PMA as positive control.  Mean values 
from three or more experiments and standard deviation are shown including 
statistical significance in comparison to untreated PMNs with ** p < 0.01 and * p < 
0.05 using one-way ANOVA.  (B) Y. pestis EV76 wt bacteria (do not express 
YadA) induce NET formation but are not trapped (SEM, same conditions as in A).  
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(C) Y. pestis EV76 bacteria expressing YadAE40 from Y. enterocolitica E40 trapped 
in NETs (same conditions as in B).  (D) YadA confers serum resistance to Y. 
enterocolitica E40 even if one of the collagen-binding sites is removed.  Y. pestis 
resists complement without YadA.  Total cfu present after incubation of bacteria 
with either NHS (white) or heat-inactivated NHS (black) for 180 min. 
 
Materials and Methods 
Bacterial strains and media.  Bacterial strains are listed in Table S1a. Y. 
enterocolitica and Y. pestis were grown as in ref (1).  Expression of YadA was 
induced with 0.2% arabinose for 60 min at 37°C before infection of PMNs. 
Site-directed mutagenesis of NSVAIG-S motifs of YadA from Y. 
enterocolitica was performed by PCR at sites indicated in ref (2).  Primers are 
given in Table S1b.   
Human PMNs were isolated from healthy volunteers using the Dextran-Percoll 
protocol, adapted with modifications from ref (3).  
NET-dependent attachment and killing was adapted from ref (4).  
Quantification of DNA released by activated neutrophils was adapted from ref 
(5).  
Scanning electron microscopy was adapted from ref (5).  
Immunofluorescence.  Freshly isolated human PMNs were resuspended in RPMI 
1640 (Gibco) supplemented with 2% Ab-depleted pooled human serum (Scipac 
Ltd.) and 2% L-glutamine (Gibco) and seeded on FalconTM culture slides (Becton 
Dickinson) coated with 0.001% poly-D-lysine (5 x 105 cells/well). PMNs were 
infected for 120 min with Y. enterocolitica wt bacteria at an moi of 1, washed with 
D-PBS (Gibco), fixed with 4% paraformaldehyde for 60 min at 37°C and then 
blocked overnight at 4°C with D-PBS containing 3% BSA.  Collagen was labelled 
with mouse anti-human collagen type I antibody (1:1000; Sigma). FITC-conjugated 
secondary antibody (1:200; Southern Biotech) and Hoechst DNA staining dye 
(1:10000; Sigma) were added and slides were incubated for 30 min at RT,  
washed 4 times with D-PBS, mounted with antifade reagent (Vector Laboratories) 
and analyzed on an Olympus IX81F-3 microscope mounted with a high speed 
Yokogawa spinning head.  
Serum sensitivity was determined as in ref (6).    
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TABLE S1a:  Bacterial strains and plasmids used in this study.  
Bacterial strain or plasmid Description Reference 
Y. enterocolitica 
E40 
∆YadA 
 
Y. pestis EV76 
Y. pseudotuberculosis 
 
Serotype O:9, wt 
isogenic knockout mutant (pLJM4029, yadA::pLJM31), 
Sm
R 
pla
+
, caf1
+
, pCD1
+
 (70-kb virulence plasmid), ∆pgm 
Serotype 1B wt, isolated from a hare 
 
(Sory and Cornelis, 1994) 
(Mota et al., 2005) 
 
(Rosqvist et al., 1988) 
G Wauters 13215/72 
 
Expression plasmids 
pMA1 
 
pSAM16 
 
 
pSAM17 
 
pSAM18 
 
pSAM19 
 
pSAM20 
 
pSAM21 
 
pSAM22 
 
 
 
Full-length yadA from Y. enterocolitica W227 cloned into 
pBAD digested with NcoI and EcoRI, Ara
I
, Amp
R
 
Full-length yadA from Y. pseudotuberculosis, cloned into 
pBAD digested with NcoI and EcoRI, Ara
I
, Amp
R
 
pBAD expressing full-length YadA from Y. enterocolitica 
W227 including mutation M1, Ara
I
, Amp
R
 
pBAD expressing full-length YadA from Y. enterocolitica 
W227 including mutation M3, Ara
I
, Amp
R
 
pBAD expressing full-length YadA from Y. enterocolitica 
W227 including mutation M4, Ara
I
, Amp
R
 
pBAD expressing full-length YadA from Y. enterocolitica 
W227 including mutation M6, Ara
I
, Amp
R
 
pBAD expressing full-length YadA from Y. enterocolitica 
W227 including mutation M7, Ara
I
, Amp
R
 
pBAD expressing full-length YadA from Y. enterocolitica 
W227 including mutation M8, Ara
I
, Amp
R
 
 
 
This study 
 
This study 
 
 
This study 
 
This study 
 
This study 
 
This study 
 
This study 
 
This study 
 
 
TABLE S1b:  Oligonucleotides used in this study 
Oligonucleotide 5’-3’ sequence, mutated codons in bold Purpose Plasmid 
5114 GGAATTCTTACCACTCGATATTAAATGATGCGT PCR, cloning pSAM16 
5115 GACCATGGCCACTAAAGATTTTAAGATCAGTGTCTC PCR, cloning pMA1, pSAM16-
pSAM22 
5116 ACCTTCGTCTTCGTCATGGATACCCTTAGCGCTACA mutator M1 
5117 CATGACGAAGACGAAGGTGCTACTGCTGAAGCAGCG mutator M1 
5118 ACCCTCATCATCATCATTAACGCCTGTTGCAATTGAACC mutator M3 
5119 AATGATGATGATGAAGGTCCTTTAAGTAAGGCATTG mutator M3 
5120 ACCCACATCATCTCCATCTTTCTGGGCGGTACT mutator M4 
5121 GATGGAGATGATGAGGGTGCGAGAGCATCAACTTCA mutator M4 
5122 TCCTTCGTCATCAGAGTTTTTTGCATCAGCTTT mutator M6 
5123 AACTCTGATGACGAAGGACACTCTAGTCACGTTGCG mutator M6 
5124 CCCTTCATCTTCTGAATAACCATGATTTGCCGC mutator M7 
5125 TATTCAGAAGATGAAGGGGATCGTTCTAAAACTGAC mutator M7 
5126 ACCTTCGGAATCACTATTTTCTCGGTCAGTTTT   mutator M8 
5127 AATAGTGATTCCGAAGGTCATGAAAGCCTTAATCGC mutator M8 
4561 GGAATTCTTACCACTCGATATTAAATGATGCAT PCR, cloning pMA1, pSAM17-
pSAM22 
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Abbreviations 
Antibody Ab 
Antimicrobial peptide AMP 
Ampicillin resistance AmpR 
Arabinose inducible AraI 
Bovine serum albumin BSA 
C4b-binding protein C4BP 
Capnocytophaga canimorsus C. canimorsus 
Capnocytophaga canimorsus 5 Cc5 
Capnocytophaga canimorsus 5 ∆pitrilysin ∆pit 
Capnocytophaga canimorsus 5 ∆pitrilysin complemented c∆pit 
Capnocytophaga canimorsus dog isolate CcD 
Capnocytophaga canimorsus human case isolate Cc 
Capnocytophaga cynodegmi C. cynodegmi 
Capnocytophaga gingivalis C. gingivalis 
Capnocytophaga ochracea C. ochracea 
Capnocytophaga sputigena C. sputigena 
Cefoxitine resistance CfR 
Chloramphenicol resistance CmR 
Colony forming unit cfu 
Complement receptor CR 
Conditioned cond. 
Cytochalasin D Cyt. D 
Dihydrorhodamine 1.2.3 DHR 
Dysogenic fermenter DF 
Enhanced green fluorescence protein eGFP 
Erythromycin resistance EmR 
Escherichia coli E. coli 
Factor H fH 
Fc receptor FcR 
Fetal calf serum FCS 
Gentamicin resistance GmR 
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Glycosyltransferase gtf 
Group A Streptococci GAS 
Heat-inactivated HI 
Helicobacter pylori H. pylori 
Hour(s) h 
Hydrogen peroxide H2O2 
Hypochlorous acid HOCl 
Immunoglobulin Ig 
Interleukin IL 
Kanamycin resistant KanR 
Kilo Dalton kDa 
Lipopolysaccharide LPS 
Lysosome associated protein 1 LAMP-1 
Mannose-binding lectin MBL 
Mass spectrometry MS 
Membrane attack complex MAC 
Minute(s) min 
Molecular oxygen O2 
Multiplicity of infection moi 
Myeloperoxidase MPO 
Nalidixic acid resistance NaR 
Neomycin resistant NeoR 
Neutrophil extracellular trap NET 
Nicotinamide adenine dinucleotide phosphate (reduced) NADPH 
Open reading frame ORF 
Overnight o/n 
Paraformaldehyde PFA 
Pattern recognition receptor PRR 
Phorbol myristate acetate PMA 
Polymorphonuclear neutrophil PMN 
Pooled normal human serum NHS 
Porphyromonas gingivalis P. gingivalis 
Protein kinase C PKC 
Room temperature RT 
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Rounds per minute rpm 
Salmonella enterica S. enterica 
Scanning electron microscopy SEM 
Staphylococcus aureus S. aureus  
Streptococcus pneumoniae S. pneumoniae 
Streptococcus pyogenes S. pyogenes 
Streptomycin resistance SmR 
Superoxide O2
- 
Superoxide dismutase SOD 
Tetracycline resistance TetR 
Toll-like receptor TLR 
Transposon Tn 
Wild-type wt 
Yersinia adhesin A YadA 
Yersinia enterocolitica Y. enterocolitica 
Yersinia pestis Y. pestis 
Yersinia pseudotuberculosis Y. pseudotuberculosis 
Strains and Plasmids 
Table 1. Strains 
Bacterial strain Genotype or description Reference or source 
E. coli   
Top10 F- mcrA ∆(mrr-hsdRMS-mcrBC) ϕlacZ∆M15 
∆lacX74 recA1 araD139 ∆(ara leu)7697 galU 
galK rpsL (Sm
R
) endA1 nupG 
Invitrogen 
C. canimorsus   
Cc2 
Cc3 
 
Cc5 
Cc5 Y1C12 
Cc5 ∆1980 
Cc5 ∆pit 
Cc7 
Cc9 
Cc10 
Cc11 
Human fatal septicaemia after dog bite 1989 
Human septicaemia 
 
Human fatal septicaemia after dog bite 1995 
Cc5 Tn mutant, Tn inserted into gtf gene 
Cc5 knockout mutant of ORF #1890 
Cc5 knockout mutant of ORF #958 (pitrilysin) 
Human septicaemia 1998 
Human septicaemia 1965 
Human septicaemia after dog bite 
Human septicaemia (BCCM/LMG 11551  
(Hantson et al., 1991) 
(Vanhonsebrouck et al., 
1991) 
(Shin et al., 2007) 
(Shin et al., 2009) 
This study 
This study 
(Shin et al., 2007) 
(Vandamme et al., 1996) 
(Vandamme et al., 1996) 
A. von Graevenitz, Univ.  
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Cc12 
CcD1 
CcD3 
CcD4 
CcD5 
CcD6 
CcD7 
CcD10 
CcD11 
CcD13 
CcD16 
CcD18 
CcD20 
CcD25 
CcD33 
CcD34 
CcD35 
CcD36 
CcD37 
CcD38 
CcD39 
CcD40 
CcD43 
CcD44 
CcD46 
CcD47 
CcD50 
CcD51 
CcD52 
CcD53 
CcD54 
CcD57 
CcD58 
CcD63 
CcD64 
CcD66 
CcD68 
CcD69 
CcD71 
CcD73 
CcD75 
CcD76 
CcD77 
CcD79 
MCCM 01373) 
Human septicaemia after dog bite  
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Zurich, Switzerland 
ATCC 35979, CDC 7120 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
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CcD80 
CcD81 
CcD82 
CcD84 
CcD85 
CcD88 
CcD89 
CcD93 
CcD94 
CcD95 
CcD96 
CcD97 
CcD101 
CcD103 
CcD104 
 
CcD105 
 
CcD106 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate from healthy dog’s saliva; formerly 
known as Cc13 
Isolate from healthy dog’s saliva; formerly 
known as Cc14 
Isolate form healthy dog’s saliva 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Shin et al., 2007) 
 
(Shin et al., 2007) 
 
(Mally et al., 2009) 
C. cynodegmi   
Ccy19 
Ccy46 
Ccy74 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
Isolate form healthy dog’s saliva 
(Mally et al., 2009) 
(Mally et al., 2009) 
(Mally et al., 2009) 
S. enterica   
wt 
 
∆rfaG 
Serovar Typhimurium, strain SL1344, aroA 
 
Serovar Typhimurium, strain SL1344, aroA, 
rfaG 
(Hoiseth and Stocker, 
1981) 
(Shin et al., 2009) 
Y. enterocolitica   
E40 
 
∆YadA 
 
∆YscN 
Serotype O:9, wt 
 
Isogenic knockout mutant (pLJM4029, 
yadA::pLJM31), Sm
R 
Deletion mutant YscN∆
169-177
 
(Sory and Cornelis, 
1994) 
(Mota et al., 2005) 
 
(Woestyn et al., 1994) 
Y. pestis   
EV76 pla
+
, caf1
+
, pCCD1
+
 (70-kb virulence 
plasmid), ∆pgm 
(Rosqvist et al., 1988) 
Y. pseudotuberculosis   
Clinical isolate Serotype 1B wt, isolated from a hare G. Wauters 13215/72 
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Table 2. Plasmids 
Plasmid Description Reference or 
source 
pBAD 
peGFP-N1 
pEP4351 
 
pYVe227 
pMA1 
 
 
pMM13 
 
pMM25 
 
pMM47 
 
pSAM16 
 
 
pSAM17 
 
 
 
pSAM18 
 
 
 
pSAM19 
 
 
 
pSAM20 
 
 
 
pSAM21 
 
 
 
pSAM22 
 
 
 
Expression vector; Ara
I
, Amp
R
; Myc and HisA tags 
Expression vector for eGFP; Kan
R
, Neo
R 
pir requiring R6K oriV; RP4 oriT; Cm
R
, Tet
R
, Em
R 
 
Wt virulence plasmid from strain Y. enterocolitica W22703 
YadA from Y. enterocolitica pYVe227;  4560 + 4561 amplified gene 
cut with NcoI and EcoRI and inserted into the corresponding sites 
of pBAD
 
ColE1 ori; Amp
R 
(Em
R
) 
 
ColE1 ori; Km
R 
(Cf
R
); Suicide vector for C. canimorsus.  
 
ColE1 ori (pCC7 ori); Amp
R
 (Cf
R
); E. coli – C. canimorsus 
expression shuttle plasmid 
YadA from Y. pseudotuberculosis; 5113 + 5114 amplified gene cut 
with NcoI and EcoRI and inserted into the corresponding sites of 
pBAD
 
YadA from Y. enterocolitica pYVe227 including mutation M1; 
amplified by overlapping PCR using primer pairs 5115 + 5116 and 
5117 + 4561, followed by 5115 + 4561; amplified gene cut with 
NcoI and EcoRI and inserted into the corresponding sites of pBAD  
YadA from Y. enterocolitica pYVe227 including mutation M3; 
amplified by overlapping PCR using primer pairs 5115 + 5118 and 
5119 + 4561, followed by 5115 + 4561; amplified gene cut with 
NcoI and EcoRI and inserted into the corresponding sites of pBAD  
YadA from Y. enterocolitica pYVe227 including mutation M4; 
amplified by overlapping PCR using primer pairs 5115 + 5120 and 
5121 + 4561, followed by 5115 + 4561; amplified gene cut with 
NcoI and EcoRI and inserted into the corresponding sites of pBAD  
YadA from Y. enterocolitica pYVe227 including mutation M6; 
amplified by overlapping PCR using primer pairs 5115 + 5122 and 
5123 + 4561, followed by 5115 + 4561; amplified gene cut with 
NcoI and EcoRI and inserted into the corresponding sites of pBAD  
YadA from Y. enterocolitica pYVe227 including mutation M7; 
amplified by overlapping PCR using primer pairs 5115 + 5124 and 
5125 + 4561, followed by 5115 + 4561; amplified gene cut with 
NcoI and EcoRI and inserted into the corresponding sites of pBAD  
YadA from Y. enterocolitica pYVe227 including mutation M8; 
amplified by overlapping PCR using primer pairs 5115 + 5126 and 
5127 + 4561, followed by 5115 + 4561; amplified gene cut with 
NcoI and EcoRI and inserted into the corresponding sites of pBAD  
Invitrogen 
Clonetech 
(Cooper et al., 
1997) 
NC_002120 
This study 
 
 
(Mally and 
Cornelis, 2008) 
(Mally and 
Cornelis, 2008) 
(Mally and 
Cornelis, 2008) 
This study 
 
 
This study 
 
 
 
This study 
 
 
 
This study 
 
 
 
This study 
 
 
 
This study 
 
 
 
This study 
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pSI02 
 
 
 
 
 
pSI03 
 
 
 
 
 
pSI04 
 
ColE1 ori; Km
R 
(Cf
R
); To create a pit::ermF three initial PCR 
products were amplified with 5100+5101 and 5102+5103 from Cc5 
chromosomal DNA and 5104+5105 from pMM13.  pit::ermF was 
then amplified by overlapping PCR using external primers 
5100+5105, cut with PstI and SpeI and inserted into corresponding 
sites of pMM25 
ColE1 ori; Km
R 
(Cf
R
); To create a 1980::ermF three initial PCR 
products were amplified with 5094+5095 and 5096+5097 from Cc5 
chromosomal DNA and 5098+5099 from pMM13.  1980::ermF was 
then amplified by overlapping PCR using external primers 
5094+5099, cut with PstI and SpeI and inserted into corresponding 
sites of pMM25 
Pitrilysin gene from Cc5 (ORF #958) amplified using primer pair 
5213 + 5214 and cut with NcoI and XbaI, inserted into the 
corresponding sites of pMM47 
This study 
 
 
 
 
 
This study 
 
 
 
 
 
This study 
 
Oligonucleotides 
Table 2. Oligonucleotides 
MIPA # Sequence 
5’-3’ sequence, mutated codons in bold 
Reference 
5094 
5095 
5096 
 
5097 
 
5098 
5099 
5100 
5101 
5102 
 
5103 
 
5104 
5105 
5114 
5115 
5116 
5117 
5118 
5119 
CACTGCAGGCTTCTGCGGTAACAGTAGG 
GAGTAGATAAAAGCACTGTTCAATGCTTGCGTAACCTAC 
CACAAGCAGGTGTAGGTTACGCAAGCATTGAACAGTGCTTTTATCTACT
CCGATAGCTTC 
CATCATTGTCTCTGTCTCTGTGAGGACAACCCTACGAAGGATGAAATTTT
TCAGGGACAAC 
AAAAATTTCATCCTTCGTAGGGTTGTCCTCACAGAGACAG 
CAACTAGTCAAGTTGATTTCAACACGACGG 
CACTGCAGGAAGGGACATTTATTAACTGC 
GAGTAGATAAAAGCACTGTTGTACGTGTAGGGTCTTCGTC 
TGGGGCAAAAGACGAAGACCCTACACGTACAACAGTGCTTTTATCTACT
CCGATAGCTTC 
GTTTTATAGGCTCTTCTTGAATATCCACTCCTACGAAGGATGAAATTTTT
CAGGGACAAC 
AAAAATTTCATCCTTCGTAGGAGTGGATATTCAAGAAGAG 
CAACTAGTCTGGCAAGTAATCCAAATCC 
GGAATTCTTACCACTCGATATTAAATGATGCGT 
GACCATGGCCACTAAAGATTTTAAGATCAGTGTCTC 
ACCTTCGTCTTCGTCATGGATACCCTTAGCGCTACA 
CATGACGAAGACGAAGGTGCTACTGCTGAAGCAGCG 
ACCCTCATCATCATCATTAACGCCTGTTGCAATTGAACC 
AATGATGATGATGAAGGTCCTTTAAGTAAGGCATTG 
This study 
This study 
This study 
 
This study 
 
This study 
This study 
This study 
This study 
This study 
 
This study 
 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
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5120 
5121 
5122 
5123 
5124 
5125 
5126 
5127 
4560 
4561 
ACCCACATCATCTCCATCTTTCTGGGCGGTACT 
GATGGAGATGATGAGGGTGCGAGAGCATCAACTTCA  
TCCTTCGTCATCAGAGTTTTTTGCATCAGCTTT 
AACTCTGATGACGAAGGACACTCTAGTCACGTTGCG 
CCCTTCATCTTCTGAATAACCATGATTTGCCGC 
TATTCAGAAGATGAAGGGGATCGTTCTAAAACTGAC 
ACCTTCGGAATCACTATTTTCTCGGTCAGTTTT 
AATAGTGATTCCGAAGGTCATGAAAGCCTTAATCGC 
GATCATGGCCACTAAAGATTTTAAGATCAGTGTCTC 
GGAATTCTTACCACTCGATATTAAATGATGCAT 
 This study 
 This study  
 This study 
 This study 
 This study 
 This study 
 This study 
 This study 
 This study 
 This study 
 
Antibodies 
Table 3. Antisera 
MIPA 
# 
Name Antigen Origin Source 
 
 
 
 
 
 
 
161 
164 
168 
215 
243 
246 
247 
248 
249 
640 
α-1D4B 
 
AffiniPure α-rat IgG/Cy3 conjugated 
 
 
Lysotracker red 
 
α-rabbit IgG/FITC conjugated 
α-goat IgG/HRP conjugated 
α-rabbit IgG/HRP conjugated 
α-Cc5 
α-goat IgG/FITC conjugated 
α-p22
phox
 
α-p47
phox
 
α-p67
phox
 
α-gp91
phox 
Hoechst 
LAMP-1 
 
Rat IgG 
 
 
Acidic regions 
 
Rabbit IgG 
Goat IgG 
Rabbit IgG 
HK Cc5 
Goat IgG 
p22
phox 
p47
phox 
p67
phox 
gp91
phox 
DNA 
Rat 
 
Goat 
 
 
 
 
Goat 
Rabbit 
Swine 
Rabbit 
Rabbit 
Rabbit 
Goat 
Goat 
Goat 
 
Homemade, gift from J. 
Pieters 
Jackson Immuno 
Research, gift from Ch. 
Dehio 
Invitrogen, gift from J. 
Pieters 
SBA 
DAKO 
DAKO 
Homemade 
Santa Cruz  
Santa Cruz 
Santa Cruz 
Santa Cruz 
Santa Cruz 
Sigma, 10 mg/ml 
 
  
 
 
 
 
 
 
 
 
 
 
References 
 
References 
 - 122 - 
Abo, A., Webb, M.R., Grogan, A., and Segal, A.W. (1994) Activation of NADPH 
oxidase involves the dissociation of p21rac from its inhibitory GDP/GTP 
exchange protein (rhoGDI) followed by its translocation to the plasma 
membrane. Biochem J 298 Pt 3: 585-591. 
Allen, L.-A.H., DeLeo, F.R., Gallois, A., Toyoshima, S., Suzuki, K., and Nauseef, 
W.M. (1999) Transient association of the nicotinamide adenine dinucleotide 
phosphate oxidase subunits p47phox and p67phox with phagosomes in 
neutrophils from patients with X-linked chronic granulomatous disease. 
Blood 93: 3521-3530. 
Allen, L.-A.H. (2003) Mechanisms of pathogenesis: evasion of killing by 
polymorphonuclear leukocytes. Microbes Infect 5: 1329-1335. 
Allen, L.-A.H., Beecher, B.R., Lynch, J.T., Rohner, O.V., and Wittine, L.M. (2005) 
Helicobacter pylori disrupts NADPH oxidase targeting in human neutrophils 
to induce extracellular superoxide release. J Immunol 174: 3658-3667. 
Allen, L.-A.H. (2007) Immunofluorescence and confocal microscopy of neutrophils. 
Methods Mol Biol 412: 273-287. 
Alper, B.J., Nienow, T.E., and Schmidt, W.K. (2006) A common genetic system for 
functional studies of pitrilysin and related M16A proteases. Biochem J 398: 
145-152. 
Babior, B.M. (1995) The respiratory burst oxidase. Curr Opin Hematol 2: 55-60. 
Bailie, W.E., Stowe, E.C., and Schmitt, A.M. (1978) Aerobic bacterial flora of oral 
and nasal fluids of canines with reference to bacteria associated with bites. 
J Clin Microbiol 7: 223-231. 
Beachey, E.H., Dale, J.B., Simpson, W.A., Evans, J.D., Knox, K.W., Ofek, I., and 
Wicken, A.J. (1979) Erythrocyte binding properties of streptococcal 
lipoteichoic acids. Infect Immun 23: 618-625. 
Becker, A.B., and Roth, R.A. (1992) An unusual active site identified in a family of 
zinc metalloendopeptidases. PNAS 89: 3835-3839. 
Beebe, J.L., and Koneman, E.W. (1995) Recovery of uncommon bacteria from 
blood: association with neoplastic disease. Clin Microbiol Rev 8: 336-356. 
Beiter, K., Wartha, F., Albiger, B., Normark, S., Zychlinsky, A., and Henriques-
Normark, B. (2006) An endonuclease allows Streptococcus pneumoniae to 
escape from neutrophil extracellular traps. Current Biology 16: 401-407. 
References 
 
 - 123 - 
Bennouna, S., Bliss, S.K., Curiel, T.J., and Denkers, E.Y. (2003) Cross-talk in the 
innate immune system: neutrophils instruct recruitment and activation of 
dendritic cells during microbial infection. J Immunol 171: 6052-6058. 
Blanche, P., Bloch, E., and Sicard, D. (1998) Capnocytophaga canimorsus in the 
oral flora of dogs and cats. J Infection 36: 134. 
Bobo, R.A., and Newton, E.J. (1976) A previously undescribed gram-negative 
bacillus causing septicemia and meningitis. Am J Clin Pathol 65: 564-569. 
Born, J., and Bhakdi, S. (1986) Does complement kill E. coli by producing 
transmural pores? Immunology 59: 139-145. 
Borregaard, N., Heiple, J.M., Simons, E.R., and Clark, R.A. (1983) Subcellular 
localization of the b-cytochrome component of the human neutrophil 
microbicidal oxidase: translocation during activation. J Cell Biol 97: 52-61. 
Borregaard, N., and Cowland, J.B. (1997) Granules of the human neutrophilic 
polymorphonuclear leukocyte. Blood 89: 3503-3521. 
Brenner, D.J., Hollis, D.G., Fanning, G.R., and Weaver, R.E. (1989) 
Capnocytophaga canimorsus sp. nov. (formerly CDC group DF-2), a cause 
of septicemia following dog bite, and C. cynodegmi sp. nov., a cause of 
localized wound infection following dog bite. J Clin Microbiol 27: 231-235. 
Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, 
D.S., Weinrauch, Y., and Zychlinsky, A. (2004) Neutrophil extracellular 
traps kill bacteria. Science 303: 1532-1535. 
Buchanan, J.T., Simpson, A.J., Aziz, R.K., Liu, G.Y., Kristian, S.A., Kotb, M., 
Feramisco, J., and Nizet, V. (2006) DNase expression allows the pathogen 
group A Streptococcus to escape killing in neutrophil extracellular traps. 
Curr Biol 16: 396-400. 
Buu-Hoi, A.Y., Joundy, S., and Acar, J.F. (1988) Endocarditis caused by 
Capnocytophaga ochracea. J Clin Microbiol 26: 1061-1062. 
Campanelli, D., Melchior, M., Fu, Y., Nakata, M., Shuman, H., Nathan, C., and 
Gabay, J.E. (1990) Cloning of cDNA for proteinase 3: a serine protease, 
antibiotic, and autoantigen from human neutrophils. J Exp Med 172: 1709-
1715. 
Campbell, J.R., and Edwards, M.S. (1991) Capnocytophaga species infections in 
children. Pediatr Infect Dis J 10: 944-948. 
References 
 - 124 - 
Carlisle, M.D., Srikantha, R.N., and Brogden, K.A. (2009) Degradation of α- and β-
defensins by culture supernatants of Porphyromonas gingivalis strain 381. 
Antimicrob Agents Ch 52: 638-642. 
Chambers, G.W., and Westblom, T.U. (1992) Pleural infection caused by 
Capnocytophaga canimorsus, formerly CDC group DF-2. Clin Infect Dis 15: 
325-326. 
Chen, Z., Potempa, J., Polanowski, A., Wikstrom, M., and Travis, J. (1992) 
Purification and characterization of a 50-kDa cysteine proteinase (gingipain) 
from Porphyromonas gingivalis. J Biol Chem 267: 18896-18901. 
Cheng, N., He, R., Tian, J., Dinauer, M.C., and Ye, R.D. (2007) A critical role of 
protein kinase C delta activation loop phosphorylation in formyl-methionyl-
leucyl-phenylalanine-induced phosphorylation of p47(phox) and rapid 
activation of nicotinamide adenine dinucleotide phosphate oxidase. J 
Immunol 179: 7720-7728. 
Clark, R.A., Volpp, B.D., Leidal, K.G., and Nauseef, W.M. (1990) Two cytosolic 
components of the human neutrophil respiratory burst oxidase translocate 
to the plasma membrane during cell activation. J Clin Invest 85: 714-721. 
Clark, S.R., Ma, A.C., Tavener, S.A., McDonald, B., Zahra, G., Kelly, M.M., Patel, 
K.D., Chakrabarti, S., McAvoy, E., Sinclair, G.D., Keys, E.M., Allen-Vercoe, 
E., DeVinney, R., Doig, C.J., Green, F.H., and Kubes, P. (2007) Platelet 
TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic 
blood. Nat Med 13: 463-469. 
Coleman, J.E. (1998) Zinc enzymes. Curr Opin Chem Biol 2: 222-234. 
Conrads, G., Mutters, R., Seyfarth, I., and Pelz, K. (1997) DNA-probes for the 
differentiation of Capnocytophaga species. Mol Cell Probe 11: 323-328. 
Cooper, A.J., Kalinowski, A.P., Shoemaker, N.B., and Salyers, A.A. (1997) 
Construction and characterization of a Bacteroides thetaiotaomicron recA 
mutant: transfer of Bacteroides integrated conjugative elements is RecA 
independent. J Bacteriol 179: 6221-6227. 
Cornista, J., Ikeuchi, S., Haruki, M., Kohara, A., Takano, K., Morikawa, M., and 
Kanaya, S. (2004) Cleavage of various peptides with pitrilysin from 
Escherichia coli: kinetic analyses using beta-endorphin and its derivatives. 
Biosci Biotechnol Biochem 68: 2128-2137. 
References 
 
 - 125 - 
Cramer, E., Pryzwansky, K.B., Villeval, J.L., Testa, U., and Breton-Gorius, J. 
(1985) Ultrastructural localization of lactoferrin and myeloperoxidase in 
human neutrophils by immunogold. Blood 65: 423-432. 
Criss, A.K., and Seifert, H.S. (2008) Neisseria gonorrhoeae suppresses the 
oxidative burst of human polymorphonuclear leukocytes. Cell Microbiol. 
Curnutte, J.T. (1993) Chronic granulomatous disease: the solving of a clinical 
riddle at the molecular level. Clin Immunol Immunopathol 67: S2-15. 
de Boer, M.G., Lambregts, P.C., van Dam, A.P., and van't Wout, J.W. (2007) 
Meningitis caused by Capnocytophaga canimorsus: when to expect the 
unexpected. Clin Neurol Neurosurg 109: 393-398. 
de Haas, C.J., Veldkamp, K.E., Peschel, A., Weerkamp, F., Van Wamel, W.J., 
Heezius, E.C., Poppelier, M.J., Van Kessel, K.P., and van Strijp, J.A. (2004) 
Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial 
antiinflammatory agent. J Exp Med 199: 687-695. 
DeCoursey, T.E., and Ligeti, E. (2005) Regulation and termination of NADPH 
oxidase activity. Cell Mol Life Sci 62: 2173-2193. 
Dinauer, M.C. (1993) The respiratory burst oxidase and the molecular genetics of 
chronic granulomatous disease. Crit Rev Clin Lab Sci 30: 329-369. 
Ding, J., Badwey, J.A., Erickson, R.W., Balazovich, K.J., and Curnutte, J.T. (1993) 
Protein kinases potentially capable of catalyzing the phosphorylation of 
p47-phox in normal neutrophils and neutrophils of patients with chronic 
granulomatous disease. Blood 82: 940-947. 
Dire, D.J., Hogan, D.E., and Riggs, M.W. (1994) A prospective evaluation of risk 
factors for infections from dog-bite wounds. Acad Emerg Med 1: 258-266. 
Dusi, S., and Rossi, F. (1993) Activation of NADPH oxidase of human neutrophils 
involves the phosphorylation and the translocation of cytosolic p67phox. 
Biochem J 296 (Pt 2): 367-371. 
El Benna, J., Faust, L.P., and Babior, B.M. (1994) The phosphorylation of the 
respiratory burst oxidase component p47phox during neutrophil activation. 
Phosphorylation of sites recognized by protein kinase C and by proline-
directed kinases. J Biol Chem 269: 23431-23436. 
El Benna, J., Dang, P.M.-C., Gaudry, M., Fay, M., Morel, F., Hakim, J., and 
Gougerot-Pocidalo, M.-A. (1997) Phosphorylation of the respiratory burst 
References 
 - 126 - 
oxidase subunit p67phox during human neutrophil activation. J Biol Chem 
272: 17204-17208. 
Engels, W., Endert, J., and Van Boven, C.P. (1985) A quantitative method for 
assessing the third complement factor (C3) attached to the surface of 
opsonized Pseudomonas aeruginosa: interrelationship between C3 fixation, 
phagocytosis and complement consumption. J Immunol Methods 81: 43-53. 
Esteban, J., Albalate, M., Caramelo, C., Reyero, A., Carriazo, M.A., Hernandez, J., 
Ortiz, A., and Soriano, F. (1995) Peritonitis involving a Capnocytophaga sp. 
in a patient undergoing continuous ambulatory peritoneal dialysis. J Clin 
Microbiol 33: 2471-2472. 
Fischer, L.J., Weyant, R.S., White, E.H., and Quinn, F.D. (1995) Intracellular 
multiplication and toxic destruction of cultured macrophages by 
Capnocytophaga canimorsus. Infect Immun 63: 3484-3490. 
Font, R.L., Jay, V., Misra, R.P., Jones, D.B., and Wilhelmus, K.R. (1994) 
Capnocytophaga keratitis. A clinicopathologic study of three patients, 
including electron microscopic observations. Ophthalmology 101: 1929-
1934. 
Frank, M.M., Joiner, K., and Hammer, C. (1987) The function of antibody and 
complement in the lysis of bacteria. Rev Infect Dis 9 Suppl 5: S537-545. 
Frey, E., Pressler, B., Guy, J., Pitulle, C., and Breitschwerdt, E. (2003) 
Capnocytophaga sp. isolated from a cat with chronic sinusitis and rhinitis. J 
Clin Microbiol 41: 5321-5324. 
Frieling, J.T.M., Mulder, J.A., Hedriks, T., Curfs, J.H., van der Linden, C. J., and 
Sauerwein, R.W. (1997) Differential induction of pro- and anti-inflammatory 
cytokines in whole blood by bacteria: effects on antibiotic treatment. 
Antimicrobial Agents Ch 41: 1439-1443. 
Fuchs, T.A., Abed, U., Goosmann, C., Hurwitz, R., Schulze, I., Wahn, V., 
Weinrauch, Y., Brinkmann, V., and Zychlinsky, A. (2007) Novel cell death 
program leads to neutrophil extracellular traps. J Cell Biol 176: 231-241. 
Gaastra, W., and Lipman, L.J. (2009) Capnocytophaga canimorsus. Vet Microbiol. 
Gaillard, J.L., Berche, P., Frehel, C., Gouin, E., and Cossart, P. (1991) Entry of L. 
monocytogenes into cells is mediated by internalin, a repeat protein 
reminiscent of surface antigens from gram-positive cocci. Cell 65: 1127-
1141. 
References 
 
 - 127 - 
Ganz, T., Selsted, M.E., Szklarek, D., Harwig, S.S., Daher, K., Bainton, D.F., and 
Lehrer, R.I. (1985) Defensins. Natural peptide antibiotics of human 
neutrophils. J Clin Invest 76: 1427-1435. 
Goldsby, R.A., Kindt, T.J., Osborne, B.A., and Kuby, J. (2003) Immunology, 5th 
edition. New York. 
Griego, R.D., Rosen, T., Orengo, I.F., and Wolf, J.E. (1995) Dog, cat, and human 
bites: a review. J Am Acad Dermatol 33: 1019-1029. 
Grosdent, N., Maridonneau-Parini, I., Sory, M.-P., and Cornelis, G.R. (2002) Role 
of Yops and adhesins in resistance of Yersinia enterocolitica to 
phagocytosis. Infect Immun 70: 4165-4176. 
Gupta, A.K., Hasler, P., Holzgreve, W., Gebhardt, S., and Hahn, S. (2005) 
Induction of neutrophil extracellular DNA lattices by placental microparticles 
and IL-8 and their presence in preeclampsia. Human Immunology 66: 1146-
1154. 
Hagblom, P., Segal, E., Billyard, E., and So, M. (1985) Intragenic recombination 
leads to pilus antigenic variation in Neisseria gonorrhoeae. Nature 315: 
156-158. 
Hantson, P., Gautier, P.E., Vekemans, M.C., Fievez, P., Evrard, P., Wauters, G., 
and Mahieu, P. (1991) Fatal Capnocytophaga canimorsus septicemia in a 
previously healthy woman. Ann Emerg Med 20: 93-94. 
Hermann, C.K., Hansen, P.B., Bangsborg, J.M., and Pers, C. (1998) Bacterial 
infections as complications of dog bites. Ugeskr Laeger 160: 4860-4863. 
Heyworth, P.G., Bohl, B.P., Bokoch, G.M., and Curnutte, J.T. (1994) Rac 
translocates independently of the neutrophil NADPH oxidase components 
p47phox and p67phox. Evidence for its interaction with flavocytochrome b558. J 
Biol Chem 269: 30749-30752. 
Hoiseth, S.K., and Stocker, B.A. (1981) Aromatic-dependent Salmonella 
typhimurium are non-virulent and effective as live vaccines. Nature 291: 
238-239. 
Hong, Y.Q., and Ghebrehiwet, B. (1992) Effect of Pseudomonas aeruginosa 
elastase and alkaline protease on serum complement and isolated 
components C1q and C3. Clin Immunol Immunopathol 62: 133-138. 
References 
 - 128 - 
Horstmann, R.D., Sievertsen, H.J., Knobloch, J., and Fischetti, V.A. (1988) 
Antiphagocytic activity of streptococcal M protein: selective binding of 
complement control protein factor H. PNAS 85: 1657-1661. 
Hoyal, C.R., Gutierrez, A., Young, B.M., Catz, S.D., Lin, J.-H., Tsichlis, P.N., and 
Babior, B.M. (2003) Modulation of p47phox activity by site-specific 
phosphorylation: Akt-dependent activation of the NADPH oxidase. PNAS 
100: 5130-5135. 
Hummell, D.S., and Winkelstein, J.A. (1986) Bacterial lipoteichoic acid sensitizes 
host cells for destruction by autologous complement. J Clin Invest 77: 1533-
1538. 
Inanami, O., Johnson, J.L., McAdara, J.K., Benna, J.E., Faust, L.R.P., Newburger, 
P.E., and Babior, B.M. (1998) Activation of the leukocyte NADPH oxidase 
by phorbol ester requires the phosphorylation of p47phox on serine 303 or 
304. J Biol Chem 273: 9539-9543. 
Iyer, S.S., Pearson, D.W., Nauseef, W.M., and Clark, R.A. (1994) Evidence for a 
readily dissociable complex of p47phox and p67phox in cytosol of unstimulated 
human neutrophils. J Biol Chem 269: 22405-22411. 
Janda, J.M., Graves, M.H., Lindquist, D., and Probert, W.S. (2006) Diagnosing 
Capnocytophaga canimorsus infections. Emerg Infect Dis 12: 340-342. 
Jepsen, L.V., and Skottun, T. (1982) A rapid one-step method for the isolation of 
human granulocytes from whole blood. Scand J Clin Lab Inv 42: 325-328. 
Jesaitis, A.J., Buescher, E.S., Harrison, D., Quinn, M.T., Parkos, C.A., Livesey, S., 
and Linner, J. (1990) Ultrastructural localization of cytochrome b in the 
membranes of resting and phagocytosing human granulocytes. J Clin 
Invest 85: 821-835. 
Johnsson, E., Thern, A., Dahlback, B., Heden, L.O., Wikstrom, M., and Lindahl, G. 
(1996) A highly variable region in members of the streptococcal M protein 
family binds the human complement regulator C4BP. J Immunol 157: 3021-
3029. 
Jolivet-Gougeon, A., Sixou, J.-L., Tamanai-Shacoori, Z., and Bonnaure-Mallet, M. 
(2007) Antimicrobial treatment of Capnocytophaga infections. Int J 
Antimicrobial Ag 29: 367-373. 
Kang, T., Yi, J., Guo, A., Wang, X., Overall, C.M., Jiang, W., Elde, R., Borregaard, 
N., and Pei, D. (2001) Subcellular distribution and cytokine- and 
References 
 
 - 129 - 
chemokine-regulated secretion of leukolysin/MT6-MMP/MMP-25 in 
neutrophils. J Biol Chem 276: 21960-21968. 
Kanthack, A., and Hardy, W.B. (1895) The morphology and distribution of the 
wandering cells of mammalia. Journal of Physiology 18: 80.81-119. 
Keppie, J., Harris-Smith, P.W., and Smith, H. (1963) The chemical basis of the 
virulence of Bacillus anthracis. Ix. Its aggressins and their mode of action. 
Br J Exp Pathol 44: 446-453. 
Kjeldsen, L., Bjerrum, O.W., Askaa, J., and Borregaard, N. (1992) Subcellular 
localization and release of human neutrophil gelatinase, confirming the 
existence of separate gelatinase-containing granules. Biochem J 287 (Pt 2): 
603-610. 
Klebanoff, S.J. (1999) Myeloperoxidase. Proc Assoc Am Physicians 111: 383-389. 
Lazarus, G.S., Brown, R.S., Daniels, J.R., and Fullmer, H.M. (1968) Human 
granulocyte collagenase. Science 159: 1483-1485. 
le Moal, G., Landron, C., Grollier, G., Robert, R., and Burucoa, C. (2003) 
Meningitis due to Capnocytophaga canimorsus after receipt of a dog bite: 
case report and review of the literature. Clin Infect Dis 36: e42-46. 
Lee, W.L., Harrison, R.E., and Grinstein, S. (2003) Phagocytosis by neutrophils. 
Microbes Infect 5: 1299-1306. 
Lion, C., Escande, F., and Burdin, J.C. (1996) Capnocytophaga canimorsus 
infections in human: review of the literature and cases report. Eur J 
Epidemiol 12: 521-533. 
Macrea, M.M., McNamee, M., and Martin, T.J. (2008) Acute onset of fever, chills, 
and lethargy in a 36-year-old woman. Chest 133: 1505-1507. 
Majumdar, S., Kane, L.H., Rossi, M.W., Volpp, B.D., Nauseef, W.M., and Korchak, 
H.M. (1993) Protein kinase C isotypes and signal-transduction in human 
neutrophils: selective substrate specificity of calcium-dependent beta-PKC 
and novel calcium-independent nPKC. Biochim Biophys Acta 1176: 276-
286. 
Mally, M., and Cornelis, G.R. (2008) Genetic tools for studying Capnocytophaga 
canimorsus. Appl Environ Microbiol 74: 6369-6377. 
References 
 - 130 - 
Mally, M., Shin, H., Paroz, C., Landmann, R., and Cornelis, G.R. (2008) 
Capnocytophaga canimorsus: a human pathogen feeding at the surface of 
epithelial cells and phagocytes. PLoS Pathog 4: e1000164. 
Mally, M., Paroz, C., Shin, H., Meyer, S., Soussoula, L.V., Schmiediger, U., 
Saillen-Paroz, C., and Cornelis, G.R. (2009) Prevalence of 
Capnocytophaga canimorsus in dogs and occurrence of potential virulence 
factors. Microbes Infect 11: 509-514. 
Mandrell, R.E., Lesse, A.J., Sugai, J.V., Shero, M., Griffiss, J.M., Cole, J.A., 
Parsons, N.J., Smith, H., Morse, S.A., and Apicella, M.A. (1990) In vitro and 
in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope 
structure by sialylation. J Exp Med 171: 1649-1664. 
Maskos, K., Jozic, D., and Fernandez-Catalan, C. (2005) Cyrstal structure of 
pitrilysin, the prototype of insulin-degrading enzymes. RCSB Protein Data 
Bank, Accession no. 1Q2L. 
McCaffrey, R.L., and Allen, L.-A.H. (2006) Francisella tularensis LVS evades 
killing by human neutrophils via inhibition of the respiratory burst and 
phagosome escape. J Leukoc Biol 80: 1224-1230. 
Medina, E., Rohde, M., and Chhatwal, G.S. (2003) Intracellular survival of 
Streptococcus pyogenes in polymorphonuclear cells results in increased 
bacterial virulence. Infect Immun 71: 5376-5380. 
Menestrina, G., Serra, M.D., and Prevost, G. (2001) Mode of action of beta-barrel 
pore-forming toxins of the staphylococcal alpha-hemolysin family. Toxicon 
39: 1661-1672. 
Meri, S., and Pangburn, M.K. (1990) A mechanism of activation of the alternative 
complement pathway by the classical pathway: protection of C3b from 
inactivation by covalent attachment to C4b. Eur J Immunol 20: 2555-2561. 
Meybeck, A., Aoun, N., Granados, D., Pease, S., and Yeni, P. (2006) Meningitis 
due to Capnocytophaga canimorsus: contribution of 16S RNA ribosomal 
sequencing for species identification. Scand J Infect Dis 38: 375-377. 
Meyer, S., Shin, H., and Cornelis, G.R. (2008) Capnocytophaga canimorsus 
resists phagocytosis by macrophages and blocks the ability of 
macrophages to kill other bacteria. Immunobiology 213: 805-814. 
References 
 
 - 131 - 
Meyers, B., Schoeman, J.P., Goddard, A., and Picard, J. (2007) The bacteriology 
and antimicrobial susceptibility of infected and non-infected dog bite 
wounds: fifty cases. Vet Microbiol 127: 360-368. 
Mirza, I., Wolk, J., Toth, L., Rostenberg, P., Kranwinkel, R., and Sieber, S.C. 
(2000) Waterhouse-Friderichsen syndrome secondary to Capnocytophaga 
canimorsus septicemia and demonstration of bacteremia by peripheral 
blood smear. Arch Pathol Lab Med 124: 859-864. 
Miyoshi, S., and Shinoda, S. (2000) Microbial metalloproteases and pathogenesis. 
Microbes Infect 2: 91-98. 
Mota, L.J., Journet, L., Sorg, I., Agrain, C., and Cornelis, G.R. (2005) Bacterial 
injectisomes: needle length does matter. Science 307: 1278. 
Mulder, A.H., Gerlag, P.G., Verhoef, L.H., and van den Wall Bake, A.W. (2001) 
Hemolytic uremic syndrome after Capnocytophaga canimorsus (DF-2) 
septicemia. Clin Nephrol 55: 167-170. 
Muller-Eberhard, H.J. (1986) The membrane attack complex of complement. Annu 
Rev Immunol 4: 503-528. 
Muller-Eberhard, H.J. (1988) Molecular organization and function of the 
complement system. Annu Rev Biochem 57: 321-347. 
Nathan, C. (2003) Specificity of a third kind: reactive oxygen and nitrogen 
intermediates in cell signaling. J Clin Invest 111: 769-778. 
Nathan, C. (2006) Neutrophils and immunity: challenges and opportunities. Nat 
Rev Immunol 6: 173-182. 
Nixon, J.B., and McPhail, L.C. (1999) Protein kinase C (PKC) isoforms translocate 
to Triton-insoluble fractions in stimulated human neutrophils: correlation of 
conventional PKC with activation of NADPH oxidase. J Immunol 163: 4574-
4582. 
Owen, C.A., and Campbell, E.J. (1999) The cell biology of leukocyte-mediated 
proteolysis. J Leukoc Biol 65: 137-150. 
Parenti, D.M., and Snydman, D.R. (1985) Capnocytophaga species: infections in 
nonimmunocompromised and immunocompromised hosts. J Infect Dis 151: 
140-147. 
Park, J.W., Ma, M., Ruedi, J.M., Smith, R.M., and Babior, B.M. (1992) The 
cytosolic components of the respiratory burst oxidase exist as a M(r) 
References 
 - 132 - 
approximately 240,000 complex that acquires a membrane-binding site 
during activation of the oxidase in a cell-free system. J Biol Chem 267: 
17327-17332. 
Pers, C., Gahrn-Hansen, B., and Frederiksen, W. (1996) Capnocytophaga 
canimorsus septicemia in Denmark, 1982-1995: review of 39 cases. Clin 
Infect Dis 23: 71-75. 
Persson, C., Nordfelth, R., Andersson, K., Forsberg, A., Wolf-Watz, H., and 
Fällman, M. (2002) Localization of the Yersinia PTPase to focal complexes 
in an important virulence mechanism. Mol Microbiol 33: 828-838. 
Quinn, M.T., Evans, T., Loetterle, L.R., Jesaitis, A.J., and Bokoch, G.M. (1993) 
Translocation of Rac correlates with NADPH oxidase activation. Evidence 
for equimolar translocation of oxidase components. J Biol Chem 268: 
20983-20987. 
Rabinovitch, M. (1995) Professional and non-professional phagocytes: an 
introduction. Trends Cell Biol 5: 85-87. 
Rautemaa, R., Jarvis, G.A., Marnila, P., and Meri, S. (1998) Acquired resistance of 
Escherichia coli to complement lysis by binding of glycophosphoinositol-
anchored protectin (CD59). Infect Immun 66: 1928-1933. 
Rautemaa, R., and Meri, S. (1999) Complement-resistance mechanisms of 
bacteria. Microbes Infect 1: 785-794. 
Reeves, E.P., Dekker, L.V., Forbes, L.V., Wientjes, F.B., Grogan, A., Pappin, D.J., 
and Segal, A.W. (1999) Direct interaction between p47phox and protein 
kinase C: evidence for targeting of protein kinase C by p47phox in 
neutrophils. Biochem J 344 Pt 3: 859-866. 
Reinholdt, J., Tomana, M., Mortensen, S.B., and Kilian, M. (1990) Molecular 
aspects of immunoglobulin A1 degradation by oral Streptococci. Infect 
Immun 58: 1186-1194. 
Risi, G.F., Jr., and Spangler, C.A. (2006) Capnocytophaga canimorsus meningitis 
after routine myelography: a sentinel event identifies multiple opportunities 
for improvement of standard practices in radiology. Am J Infect Control 34: 
540-542. 
Rosqvist, R., Skurnik, M., and Wolf-Watz, H. (1988) Increased virulence of 
Yersinia pseudotuberculosis by two independent mutations. Nature 334: 
522-524. 
References 
 
 - 133 - 
Roth, R.A. (2004) Insulysin. In Handbook of Proteolytic Enzymes. Barret, A.J., 
Rawlings, N.D. and Woessner, J.F. (eds): Elsevier Academic Press, 
London, pp. 871-876. 
Rubsamen, P.E., McLeish, W.M., Pflugfelder, S., and Miller, D. (1993) 
Capnocytophaga endophthalmitis. Ophthalmology 100: 456-459. 
Ruckdeschel, K., Harb, S., Roggenkamp, A., Hornef, M.W., Zumbihl, R., Köhler, 
S., Heesemann, J., and Rouot, B. (1998) Yersinia enterocolitica impairs 
activation of transcription factor NF-κB: Involvement in the induction of 
programmed cell death and in the suppression of the macrophage tumor 
necrosis factor α production. J Exp Med 187: 1069-1079. 
Salvesen, G., Farley, D., Shuman, J., Przybyla, A., Reilly, C., and Travis, J. (1987) 
Molecular cloning of human cathepsin G: structural similarity to mast cell 
and cytotoxic T lymphocyte proteinases. Biochemistry 26: 2289-2293. 
Sandoe, J.A.T. (2004) Capnocytophaga canimorsus endocarditis. J Med Microbiol 
53: 245-248. 
Schenkein, H.A. (1989) Failure of Bacteroides gingivalis W83 to accumulate 
bound C3 following opsonization with serum. J Periodontal Res 24: 20-27. 
Schiller, N.L., and Joiner, K.A. (1986) Interaction of complement with serum-
sensitive and serum-resistant strains of Pseudomonas aeruginosa. Infect 
Immun 54: 689-694. 
Schmidtchen, A., Holst, E., Tapper, H., and Bjorck, L. (2003) Elastase-producing 
Pseudomonas aeruginosa degrade plasma proteins and extracellular 
products of human skin and fibroblasts, and inhibit fibroblast growth. Microb 
Pathog 34: 47-55. 
Shin, H., Mally, M., Kuhn, M., Paroz, C., and Cornelis, G.R. (2007) Escape from 
immune surveillance by Capnocytophaga canimorsus. J Infect Dis 195: 
375-386. 
Shin, H., Mally, M., Meyer, S., Fiechter, C., Paroz, C., Zaehringer, U., and 
Cornelis, G.R. (2009) Resistance of Capnocytophaga canimorsus to killing 
by human complement and polymorphonuclear leukocytes. Infect Immun 
77: 2262-2271. 
Sinha, S., Watorek, W., Karr, S., Giles, J., Bode, W., and Travis, J. (1987) Primary 
structure of human neutrophil elastase. PNAS 84: 2228-2232. 
References 
 - 134 - 
Slaney, J.M., Gallagher, A., Aduse-Opoku, J., Pell, K., and Curtis, M.A. (2006) 
Mechanisms of resistance of Porphyromonas gingivalis to killing by serum 
complement. Infect Immun 74: 5352-5361. 
Sory, M.P., and Cornelis, G.R. (1994) Translocation of a hybrid YopE-adenylate 
cyclase from Yersinia enterocolitica into HeLa cells. Mol Microbiol 14: 583-
594. 
Staali, L., Bauer, S., Morgelin, M., Bjorck, L., and Tapper, H. (2006) Streptococcus 
pyogenes bacteria modulate membrane traffic in human neutrophils and 
selectively inhibit azurophilic granule fusion with phagosomes. Cell 
Microbiol 8: 690-703. 
Stuart, L.M., and Ezekowitz, R.A.B. (2005) Phagocytosis: elegant complexity. 
Immunity 22: 539-550. 
Sundqvist, G., Figdor, D., Hänström, L., Sörlin, S., and Sandström, G. (1991) 
Phagocytosis and virulence of different strains of Porphyromonas gingivalis. 
Scand J Dent Res 99: 117-129. 
Swamy, K.H., and Goldberg, A.L. (1982) Subcellular distribution of various 
proteases in Escherichia coli. J Bacteriol 149: 1027-1033. 
Takahashi, S., Nagano, Y., Nagano, N., Hayashi, O., Taguchi, F., and Okuwaki, Y. 
(1995) Role of C5a-ase in group B streptococcal resistance to 
opsonophagocytic killing. Infect Immun 63: 4764-4769. 
Tan, B.H., Meinken, C., Bastian, M., Bruns, H., Legaspi, A., Ochoa, M.T., Krutzik, 
S.R., Bloom, B.R., Ganz, T., Modlin, R.L., and Stenger, S. (2006) 
Macrophages acquire neutrophil granules for antimicrobial activity against 
intracellular pathogens. J Immunol 177: 1864-1871. 
Tanaka, D., Miyasaki, K.T., and Lehrer, R.I. (2000) Sensitivity of Actinobacillus 
actinomycetemcomitans and Capnocytophaga spp. to the bactericidal 
action of LL-37: a cathelicidin found in human leukocytes and epithelium. 
Oral Microbiol Immunol 15: 226-231. 
Tapper, H., Furuya, W., and Grinstein, S. (2002) Localized exocytosis of primary 
(lysosomal) granules during phagocytosis: role of Ca2+-dependent tyrosine 
phosphorylation and microtubules. J Immunol 168: 5287-5296. 
Thern, A., Stenberg, L., Dahlback, B., and Lindahl, G. (1995) Ig-binding surface 
proteins of Streptococcus pyogenes also bind human C4b-binding protein 
References 
 
 - 135 - 
(C4BP), a regulatory component of the complement system. J Immunol 
154: 375-386. 
Tierney, D.M., Strauss, L.P., and Sanchez, J.L. (2006) Capnocytophaga 
canimorsus mycotic abdominal aortic aneurysm: why the mailman is afraid 
of dogs. J Clin Microbiol 44: 649-651. 
Tobé, T.J., Franssen, C.F., Zijlstra, J.G., de Jong, P.E., and Stegeman, C.A. 
(1999) Hemolytic uremic syndrome due to Capnocytophaga canimorsus 
bacteremia after a dog bite. Am J Kidney Dis 33: e5. 
Tsai, C.M., and Frasch, C.E. (1982) A sensitive silver stain for detecting 
lipopolysaccharides in polyacrylamide gels. Anal Biochem 119: 115-119. 
Urban, C.F., Reichard, U., Brinkmann, V., and Zychlinsky, A. (2006) Neutrophil 
extracellular traps capture and kill Candida albicans yeast and hyphal 
forms. Cell Microbiol 8: 668-676. 
van Duijkeren, E., van Mourik, C., Broekhuizen, M., Leuven, M., Gaastra, W., and 
Houwers, D. (2006) First documented Capnocytophaga canimorsus 
infection in a species other than humans. Vet Microbiol 118: 148-150. 
Vandamme, P., Vancanneyt, M., van Belkum, A., Segers, P., Quint, W.G.V., 
Kersters, K., Paster, B.J., and Dewhirst, F.E. (1996) Polyphasic analysis of 
strains of the genus Capnocytophaga and Centers for Disease Control 
group DF-3. Int J Syst Bacteriol 46: 782-791. 
Vanhonsebrouck, A.Y., Gordts, B., Wauters, G., and van Landhuyt, H.W. (1991) 
Fatal septicemia with Capnocytophaga canimorsus in a compromised host. 
A case report with review of the literature. Acta Clin Belg 46: 364-370. 
Voyich, J.M., Sturdevant, D.E., Braughton, K.R., Kobayashi, S.D., Lei, B., 
Virtaneva, K., Dorward, D.W., Musser, J.M., and DeLeo, F.R. (2003) 
Genome-wide protective response used by group A Streptococcus to evade 
destruction by human polymorphonuclear leukocytes. PNAS 100: 1996-
2001. 
Walport, M.J. (2001a) Complement. First of two parts. N Engl J Med 344: 1058-
1066. 
Walport, M.J. (2001b) Complement. Second of two parts. N Engl J Med 344: 1140-
1144. 
References 
 - 136 - 
Ward, C.K., and Inzana, T.J. (1994) Resistance of Actinobacillus 
pleuropneumoniae to bactericidal antibody and complement is mediated by 
capsular polysaccharide and blocking antibody specific for 
lipopolysaccharide. J Immunol 153: 2110-2121. 
Wartha, F., Beiter, K., Albiger, B., Normark, S., Zychlinsky, A., and Henriques-
Normark, B. (2007a) Capsule and D-alanylated lipoteichoic acids protect 
Streptococcus pneumoniae against neutrophil extracellular traps. Cell 
Microbiol 9: 1162-1171. 
Wartha, F., Beiter, K., Normark, S., and Henriques-Normark, B. (2007b) Neutrophil 
extracellular traps: casting NET over pathogenesis. Curr Opin Microbiol 10: 
52-56. 
Weinberg, E.D. (2000) Microbial pathogens with impaired ability to acquire host 
iron. Biometals 13: 85-89. 
Westwell, A.J., Kerr, K., Spencer, M.B., and Hutchinson, D.N. (1989) DF-2 
infection. Bmj 298: 116-117. 
Wilkinson, B.J., Sisson, S.P., Kim, Y., and Peterson, P.K. (1979) Localization of 
the third component of complement on the cell wall of encapsulated 
Staphylococcus aureus M: implications for the mechanism of resistance to 
phagocytosis. Infect Immun 26: 1159-1163. 
Wilson, M.E., Burstein, R., Jonak-Urbanczyk, J.T., and Genco, R.J. (1985) 
Sensitivity of Capnocytophaga species to bactericidal properties of human 
serum. Infect Immun 50: 123-129. 
Wilson, M.E., Jonak-Urbanczyk, J.T., Bronson, P.M., Dudas, K.C., Apicella, M.A., 
and Genco, R.J. (1987) Capnocytophaga species: increased resistance of 
clinical isolates to serum bactericidal action. J Infect Dis 156: 99-106. 
Wimley, W.C., Selsted, M.E., and White, S.H. (1994) Interactions between human 
defensins and lipid bilayers: evidence for formation of multimeric pores. 
Protein Sci 3: 1362-1373. 
Wittamer, V., Bondue, B., Guillabert, A., Vassart, G., Parmentier, M., and 
Communi, D. (2005) Neutrophil-mediated maturation of chemerin: a link 
between innate and adaptive immunity. J Immunol 175: 487-493. 
Woestyn, S., Allaoui, A., Wattiau, P., and Cornelis, G.R. (1994) YscN, the putative 
energizer of the Yersinia Yop secretion machinery. J Bacteriol 176: 1561-
1569. 
References 
 
 - 137 - 
Yaqub, S., Bjørnholt, J.V., Hellum, K.B., Steinbakk, M., and Enger, A.E. (2004) 
Bite wound infections. Tidsskr Norske Laege 124: 3194-3196. 
 
  
 
 
 
 
 
 
 
 
 
 
Acknowledgements 
 
Acknowledgements 
 
 - 139 - 
First of all, I am extremely grateful to my Ph.D. mentor Prof. Dr. Guy R. Cornelis, who supported 
me throughout my time here with guidance, input, criticism, advice and faith in my capabilities.  
Thank you very much for your professional and personal support, no matter whether it was about 
my projects, my concerns, or my future career.   
 
I am especially grateful to Simon Ittig, who was joining the C. canimorsus team two years ago and 
will go on with the pitrilysin story.  Thank you for our discussions (the professional ones as well as 
the private ones), your suggestions, your creativity and your commitment.  Working with you was a 
pleasure and I wish you all the best for your future! 
 
I am greatly thankful to Cécile Pfaff-Paroz who helped me with her outstanding technical 
assistance on many projects.  Without you, I would have never managedd 
 
I would like to thank Dr. Hwain K. Shin who was not only a pioneer in the C. canimorsus project, 
but raised my interest in and introduced me to Cc.  You were always an invaluable source for all 
kind of information on Cc.  I thank you for your advice, your tips and tricks and your support!   
 
I would also like to thank Dr. Manuela Mally for many discussions and uncounted suggestions for 
my projects, technically as well as theoretically.  You were my office neighbour for such a long 
timed I enjoyed discussing with you, not only Cc but also our hopes and wishes.  Playing squash 
with you was an excellent break to clear my mind and was lots of fun!   
 
I thank Andreas Diepold, my office and lab neighbour, for so many hours of more or less scientific 
discussions.  You kept on putting the finger on the weak side of a story, which re-opened my eyes 
for missing controls or unanswered questions. 
 
I am greatly thankful to Marina Kuhn, my good spirit.  For your tips and help on so many technical 
aspects, but most of all for your personal support in all situations! 
 
A big “thank you” goes to the whole Cornelis lab!  Thanks for all your suggestions, support, 
assistance and the enjoyable time we had together.  First of all, I’d like to thank the Cc team: Pablo 
Manfredi, for taking care of the Cc genome and for discussions; Chantal Fiechter, for the 
discovery of Y1C12 and the fun we had together; Dr. Francesco Renzi, for your curiosity and your 
humor; Giacomo Golfieri, for purifying pitrilysin and for taking the efforts needed; Lavinia V. 
Soussoula, for screening the library and for introducing me to the fun of supervision.  I’d also like 
to thank the other members of the team: Dr. Catherine Müller, for being a friend in and out of the 
lab and for many discussions; Dr. Isabel Sorg, for advice, protocols and coffee chats; Stefanie 
Wagner, for company; Marlise Amstutz, for organising and ordering many things; Dr. Caroline 
Montagner, for suggestions; Lisa Metzger, for office discussions; Cédric Cattin, for your curiosity; 
Dr. Petr Broz, for starting help; Dr. Gottfried Eisner, for lab chats; Dr. Michel Letzelter, for the 
work we did together; Yaniv Cohen, for your interest. 
 
Acknowledgements 
 - 140 - 
I am especially thankful to Prof. Dr. Regine Landmann, for her constant support and input; Dr. 
Mathias Schmaler for discussions and help on animal experiments and Dr. Naja Jann for so 
many invaluable lunch discussions, support and help on animal experiments, and mostly for your 
friendship. 
 
There are numerous people from the Biozentrum I would like to acknowledge: Prof. Dr. Christoph 
Dehio, for support during my Ph.D.; Michaela Hanisch, for helping out in every situation with a 
smile; Roger Sauder, for your endless pool of useful things; Roland Gut, for preparing uncounted 
amounts of plates, which made my lab life so much easier; Prof. Dr. Cécile Arrieumerlou and her 
team, especially Harry Wischnewski, Christoph Kasper and Dr. Gregory Melroe for help, 
suggestions and tips for handling different microscopes; Evi Bieler for the excellent technical 
support on scanning electron microscopy; Maxime Québatte for FACS help; Dr. Rajesh 
Jayachandran for protocols and discussions; Dr. Nadine Cybulski, for company and chats; 
Samuel Steiner, Dr. Jake Malone and Dr. Tina Jäger, for playing badminton; Prof. Dr. Dirk 
Buman, for tips and Salmonella strains; Dr. Alain Mazé for help with frozen spleens; Dr. Alex 
Böhm, for tips, Vesna Olivieri and Ursula Sauder for transmission electron microscopy; all past 
and present members of the 4
th
 floor, for the excellent atmosphere, their help, the barbecues and 
the film evenings. 
 
I would like to thank Prof. Dr. Joachim Frey and Dr. Paola Pilo for putting so much effort in the 
verification of EV76.   
 
I am deeply grateful to my (WIN-) mentor Janice Branson.  Thank you for accompanying me with 
care, passion and friendship!   
 
Ein besonderer Dank gilt meinen Eltern, Heidi und Fritz Meyer.  Eure Unterstützung und Eure 
liebevolle Begleitung haben mir die Kraft und die Zuversicht gegeben meine Träume zu 
verwirklichen. 
 
Auch meinen Schwiegereltern, Myrtha und Otto Casutt, möchte ich von Herzen für Ihre 
Unterstützung und Ihr Verständnis danken.  
 
Words cannot express how grateful I am to my husband, Marco Casutt.  It is for knowing you at 
my side that I can spread my wings. 
  
 
 
 
 
 
 
 
 
 
 
Curriculum Vitae 
 
Curriculum Vitae Salome Casutt-Meyer 
 - 142 - 
Salome Casutt-Meyer   
Private address: Work address: 
In den Ziegelhöfen 181 Klingelbergstrasse 70 
CH-4054 Basel CH-4056 Basel 
Phone: +41 (0)79 378 51 69 Phone: +41 (0)61 267 21 27 
 
E-mail: Salome.Meyer@unibas.ch 
 
Date of Birth: August 7
th
 1981 
Nationality: Swiss 
 
Education & Experience   
Biozentrum, Infectious Diseases,  PhD with honours (Magna cum laude) in Microbiology 
University of Basel, CH Group of Prof. Guy R. Cornelis 
12/05 – 11/09 “Capnocytophaga canimorsus: Interaction with the innate 
immune system”  
Analysis of host - pathogen interactions with a focus on the 
innate immune system using in vitro infection, microscopy, 
FACS, and molecular biological, biochemical, and 
immunological techniques.  
 
ETH Zurich Diploma in Microbiology  
Zurich, CH Dipl. Natw. ETH, grade 5.75 (6 = best, 1= worst) 
12/00-11/05 Majors: microbiology, cell biology, virology, parasitology, 
immunology, gene technology, and enzyme technology. 
Minors: organic chemistry, anorganic chemistry, physical  
chemistry, analytical chemistry, plant biology, and 
biochemistry. 
 
Institute of Virology Diploma Thesis & Semester Work 
University of Zurich, CH grade 6 (6 = best, 1 = worst) 
03/04 – 04/05 Group of Prof. Mathias Ackermann 
“The ovine herpesvirus-2 ORF68 protein targets the Golgi 
complex and is incorporated into heterologous herpesvirus 
particles”  
Analysis of protein function by cloning, expression, and 
purification of recombinant proteins by in vitro transfections 
and microscopic analysis of protein localization and function. 
 
Gymnasium Leonhard School leaving examination 
Basel, CH  Matura Type “B” (Latin) 
08/92 – 07/00 
 
Training   
Women into Industries Selected mentee and member of the mentee-organizing  
Novartis and University of Basel, CH committee.  Mentor: Janice Branson (CIS – BIOS ECD,  
04/06 – 04/07 Novartis Pharma AG, janice.branson@novartis.com). 
  
Microscopy Course  Introduction and knowledge broadening in light microscopy,  
University of Basel, CH  fluorescence microscopy, and electron microscopy. 
08/06  
 
Didactics Seminar  Introduction into scientific presentation, held in Rathen, GE. 
Institute of Virology,  
University of Zurich, CH 
07/05 
 
Social Practical Course  Care of physically and mentally disabled children, as well as  
Kindergarten Montessori, Basel, CH  foreign-language children (English). 
06/99 
Curriculum Vitae Salome Casutt-Meyer 
 
 - 143 - 
Awards   
BioValley Industry Poster Award For my poster Capnocytophaga canimorsus interferes with 
10/08 macrophages” presented at the Roche BioValley Symposium,  
 Basel, CH. 
 
Young Investigator Award From the European Macrophage and Dendritic Cell Society 
for my speech 09/07  “Capnocytophaga canimorsus prevents  
phagocytosis & killing by macrophages” held at the society 
meeting in Innsbruck, AU.  
 
Scientific Publications   
2009 Casutt-Meyer S. and G. R. Cornelis 
 “Yersinia adhesin YadA is a double-edged sword” 
Manuscript in preparation.   
 My contribution to this paper includes the design, 
performance and evaluation of all experiments 
demonstrating a new function of the Yersinia adhesin A in 
host interaction and I am contributing to the writing of the 
paper. 
 
06/09 Shin H.*, Mally M.*, Meyer S.*, Fiechter C.*, Paroz C., 
Zaehringer U., and G. R. Cornelis (* contributed equally to 
this work) 
 “Resistance of Capnocytophaga canimorsus to killing by 
human complement and polymorphonuclear leukocytes” 
Infection and Immunity, 77, 2262 – 2271 (2009). 
 My contribution to this publication included the design, 
performance and evaluation of the experiments shown in 
fig.1A, 1B, 1D, 2, 3, 4C, and 5 and I contributed to the writing 
of the paper. 
 
04/09 Mally M.*, Paroz C.*, Shin H.*, Meyer S.*, Soussoula L. V., 
Schmiediger U., Saillen-Paroz C., and G. R. Cornelis  
(* contributed equally to this work) 
 “Prevalence of Capnocytophaga canimorsus in dogs and 
occurrence of potential virulence factors” Microbes and 
Infection, 11, 509 – 514 (2009). 
 My contributions to this publication included the design, 
performance and evaluation of the experiments on the 
capability of C. canimorsus to block the killing ability of 
macrophages and I contributed to the writing of the paper. 
 
03/08 Meyer S., Shin H, and G. R. Cornelis  
 “Capnocytophaga canimorsus resists phagocytosis by 
macrophages and blocks the ability of macrophages to kill 
other bacteria” Immunobiology, 213, 805 – 814 (2008). 
 My contribution to this publication included the design, 
performance and evaluation of all experiments except fig. 7 
and I contributed to the writing of the paper.  
 
07/06 Letzelter M., Sorg I., Mota L. J., Meyer S., Stalder J., 
Feldman M., Kuhn M., Callebaut I., and G. R. Cornelis  
 "The discovery of SycO highlights a new function for type III 
secretion effector chaperones” EMBO, 25, 3223 – 3233 
(2006).  
 My contribution to this publication included construction of 
expression vectors, in vitro transfection of human cell line 
and protein localization by confocal microscopy (especially 
fig.7). 
Curriculum Vitae Salome Casutt-Meyer 
 - 144 - 
Scientific Presentations   
Poster Casutt-Meyer S. and G. R. Cornelis 
09/09 “YadA is a double-edged sword rendering Yersinia sensitive 
to neutrophil extracellular trap-dependent killing” 
 Microbial Pathogens & Host Interactions Meeting, Cold 
Spring Harbor Laboratory, New York, United States of 
America. 
 
Speech Meyer S. and G R. Cornelis 
06/09 “Why binding can be obstructive to survival: the Yersinia Yad 
story” 
 1
st
 Biozentrum PhD Retreat, Engelberg, Switzerland. 
 
Poster Meyer S.*, Ittig S.*, and G. R. Cornelis (* contributed equally 
to this work) 
10/08 “Capnocytophaga canimorsus interferes with the oxidative 
burst in macrophages”  
 Roche BioValley Symposium, Basel, Switzerland. 
 
Poster Meyer S.*, Ittig S.*, and G. R. Cornelis (* contributed equally 
to this work) 
09/08 “Capnocytophaga canimorsus impairs the ability of 
macrophages to clear bacterial infections”  
 European Macrophage and Dendritic Cell Society Meeting, 
Brescia, Italy. 
 
Poster Meyer S., Shin H., Landmann R., and G. R. Cornelis  
06/08 “Capnocytophaga canimorsus interferes with the ability of 
macrophages to kill bacteria after phagocytosis” 
 67
th
 Annual Assembly of the Swiss Society for Microbiology, 
Interlaken, Switzerland. 
 
Poster Meyer S., Shin H., Landmann R., and G. R. Cornelis 
10/07 “Capnocytophaga canimorsus prevents phagocytosis and 
killing by macrophages” 
 Roche BioValley Symposium, Basel, Switzerland. 
 
Speech  Meyer S., Shin H., Landmann R., and G. R. Cornelis  
09/07 “Capnocytophaga canimorsus prevents phagocytosis and 
killing by macrophages” 
 European Macrophage and Dendritic Cell Society Meeting, 
Innsbruck, Austria. 
 
Poster Meyer S., Shin H., Landmann R., and G. R. Cornelis  
06/07  “Capnocytophaga canimorsus prevents phagocytosis and 
killing by macrophages” 
 Swiss Molecular Microbiology Meeting, Villars-sur-Ollon, 
Switzerland. 
 
Languages   
German Native tongue 
English Fluent (spoken and written) // company language at the 
Biozentrum 
French Intermediate (spoken and written)  
Italian Basic (spoken and written) 
 
Curriculum Vitae Salome Casutt-Meyer 
 
 - 145 - 
Other Skills   
Safety Four years experience working in a biosafety level 2 
laboratory. 
 
Software PC and Mac, Microsoft Word/Excel/Power Point, CorelDraw, 
Adobe Acrobat Reader, Adobe Illustrator CS, EndNote, Cell 
Quest and FlowJo (FACS analysis programs), 
Openlab/Andor IQ and ImageJ (microscopy analysis 
programs). 
 
Teaching Supervision of a master student, an internship student, and a 
research assistant on laboratory work, project design, data 
evaluation and protocol writing.  
 Biozentrum, University of Basel, CH. 
 
 Instruction of a PhD colleague on laboratory work with 
Capnocytophaga canimorsus. 
 Biozentrum, University of Basel, CH. 
 
 Assistance and supervision of experiments and evaluation of 
protocols in the annual student’s laboratory course 
“Microbiology”. 
 Biozentrum, University of Basel, CH. 
References   
Prof. Dr. Guy R. Cornelis Biozentrum 
 University of Basel 
 Klingelbergstrasse 70 
 CH-4056 Basel 
 Tel. +41 (0)61 267 21 10 
 guy.cornelis@unibas.ch 
 
Dr. Hwain K. Shin Novartis Pharma AG 
 WSJ-340.3.18.5 
 Novartis Campus 
 CH-4056 Basel 
 Tel. +41 (0)61 324 71 31 
 hwain_kathy.shin@novartis.com 
 
Prof. Dr. Mathias Ackermann Institute of Virology 
 University of Zurich 
 Winterthurerstrasse 266a 
 CH-8057 Zurich 
 Tel. +41 (0)44 635 87 01 
 mathias.ackermann@access.unizh.ch 
 
 
 
 
Basel, November 2009 
 
 
Salome Casutt-Meyer 
 
